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Abstract 
Using a combination of hypothesis and discovery based approaches, the goal of this thesis 
was to better describe novel probiotic functions and their mechanisms while striving to better 
understand the effect of formulation on Bifidobacterium animalis subsp. lactis, Lactobacillus 
paracasei and L. rhamnosus. 
Using RNA-Seq, a bacterial metatranscriptome analysis of a commonly consumed probiotic 
yogurt showed that the organisms adapted to storage time and flavor additions. This led to 
the discovery that in addition to the probiotic health benefits, members of the L. casei group 
(L. rhamnosus and L. paracasei) produce volatile sulfur compounds mediated by a novel 
sulfur/taurine metabolism gene cluster that affect taste and texture. The benefits of selected 
probiotic strains were tested in a further series of human studies.  
A systems biology approach was developed and a double-blind, placebo-controlled clinical 
trial of post-menopausal women showed that vaginally administered probiotics could 
influence the microbiota and host responses. Changes in the vaginal microbiota were noted in 
late pregnancy in a rural Tanzanian population, and maternal intake of Moringa 
supplemented L. rhamnosus GR-1 yogurt appeared to improve the gut microbiota profile of 
the newborn babies. Having discovered that L. rhamnosus GR-1, and selected other 
lactobacilli, could sequester heavy metals in vitro, a randomized open-label pilot study was 
performed and showed a reduction in toxic metal uptake in Tanzanian pregnant women and 
school children. The latter series of findings led to the discovery, development and 
characterization of a new strain, L. rhamnosus Lr60, with high potential to reduce toxic metal 
accumulation in the host. Using a mouse model, strains of L. rhamnosus were tested to better 
understand mechanisms of protection against mercury as well as to examine potential 
modulation of host xenobiotic metabolism by probiotics.  Data suggest it is possible to 
sequester mercury and prevent it from entering the bloodstream.  
Collectively, these studies have increased our knowledge of probiotic mechanisms as well as 
lead to the development of novel applications of relevance to human health.  
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Chapter 1  
1 General Introduction 
Microbes inhabited the earth long before humans and will remain long after we are gone. 
They were our earliest ancestors and according to the endosymbiont theory, their 
descendants live within our own cells in the form of mitochondria (Thrash et al., 2011). 
Microbes have shaped our evolution both genetically and culturally (Diamond, 2000). 
We are born coated in microbes, we live immersed in microbes and eventually we die 
only to be recycled by microbes. In short, microbes are an intrinsic part of what it means 
to be human.  
Traditionally, science has focused on the detrimental effects of microbes to human 
populations such as the fall of the Incan Empire due to smallpox (Diamond, 2000), or the 
emergence of new diseases like sickle cell anemia (Aidoo et al., 2002) and cystic fibrosis 
(Gabriel et al., 1994) as a result of microbial selective pressure. Beginning in the early 
1900s with the fringe hypotheses of Nobel Laureate Élie Metchnikoff, the evidence for 
the beneficial effects of microbes has been slowly building (Mackowiak, 2013). The 
study of the body’s microbial communities is now one of the fastest growing areas of 
science, with numerous implications for both human and animal health and disease. 
1.1 The human microbiome 
The human microbiome is the sum of all the microbial communities (the microbiota), 
their genes, transcripts and metabolic byproducts both on, and within the human host. It 
has been estimated that, by absolute count, microbes outnumber their human host’s cells 
by a 10-to-1 ratio (Savage, 1977).  Despite being ubiquitous in the literature, I would 
suggest this figure is misleading for many reasons, including the size difference between 
a prokaryotic and eukaryotic cell, and the varied sizes of humans. What is far more 
tangible is that on the genomic level, our microbes encode ~150-fold more unique genes 
than our own DNA (Qin et al., 2010). Many of these genes include novel metabolic 
pathways which can have profound impacts on human physiology such as: recycling sex 
hormones including estrogen (DeRossi and Hersh, 1994; Flores et al., 2012; Plottel and 
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Blaser, 2011), synthesizing nutrients for the host including folate and vitamin B12 
(LeBlanc et al., 2013), and fermenting compounds with immunomodulatory activity 
important in disease such as short chain fatty acids in inflammatory bowel disease (Veiga 
et al., 2010). 
While much focus is on the gastrointestinal tract where cell densities can be up to 1011 
CFU/mL, the microbiotas of other body sites are also of great interest including the skin, 
oral, respiratory tract and urogenital tract communities (Costello et al., 2009).  
1.2 Microbiota dysbiosis 
As opposed to traditional microbiology which has focused on single organisms fulfilling 
Koch’s postulates of disease (Ferreira et al., 2011), microbial dysbiosis involves altered 
states of whole communities which may be associated with aberrant conditions including 
those that cause disease. 
Microbial dysbiosis is perhaps best typified in the human vagina. In the majority of 
healthy Caucasian women, the vaginal microbiota is dominated by Lactobacillus iners 
and/or L. crispatus with other species such as L. gasseri and L. jensenii occasionally 
found (Ravel et al., 2011). In the dysbiotic state of bacterial vaginosis (BV), the relative 
proportions of Lactobacillus spp. are decreased coinciding with an increase in anaerobes 
invariably including Gardnerella vaginalis, with Prevotella spp., Atopobium vaginae and 
others (Fredricks et al., 2005; Hummelen et al., 2010). BV is the most common vaginal 
“infection”, with some studies showing one third of reproductive age females presenting 
with BV at any given time (Koumans et al., 2007). The symptoms and signs of BV 
include vaginal odor, a milk-like discharge, and irritation with the latter commonly 
leading to improper self-misdiagnosis as a yeast infection. 
While it is generally accepted that a Lactobacillus-dominated microbiota is favorable in 
the vagina, what defines dysbiosis in the gastrointestinal tract is far more varied. 
Examples of the influence of the gut microbiota on health include: obesity (Le Chatelier 
et al., 2013; Turnbaugh et al., 2006), diabetes (Giongo et al., 2010), Crohn’s Disease 
(Gevers et al., 2014) and colon cancer (Devkota and Turnbaugh, 2013; Feng et al., 2015). 
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In obesity, many researchers have focused on the crude metric of the ratio of 
Firmicutes:Bacteroidetes (Ley et al., 2005; Mariat et al., 2009) suggesting that a higher 
ratio is associated with adiposity, insulin insensitivity, dyslipidemia and chronic 
inflammation. More in-depth studies of individual taxa and gene-level differences have 
examined bacterial richness and gene content (Le Chatelier et al., 2013). What is more 
relevant is do certain microbiota put a person at higher risk of obesity, and once obese, 
can alteration of the microbiota help a person lose weight?   
Since there is no definition of a ‘healthy’ gut microbiome, it is difficult to define 
normality or use the microbiota as a biomarker for an unhealthy state. Gut enterotypes 
were proposed as a way of defining groups (Arumugam et al., 2011) with three 
predominant microbiota types named by their dominant taxa: Bacteroides (enterotype 1), 
Prevotella (enterotype 2), and Ruminococcus (enterotype 3). Studies have suggested that 
diet may be a large driver of the enterotype (De Filippo et al., 2010; Wu et al., 2011). 
While it is appealing to have such a ternary classification system, it is a contentious 
notion (Jeffery et al., 2012) and it is more likely there is a gradient of normality. It is also 
not unreasonable to think that there is a balance in microbiota composition wherein one 
configuration may be beneficial for some conditions but deleterious for others. 
Furthermore, the gut microbiota is not static and changes over life (Claesson et al., 2011; 
Yatsunenko et al., 2012). 
1.3 Probiotics 
As our understanding of the role of the microbiota in health builds, the opportunities 
increase to translate this knowledge by modulating the microbiota for health. While 
antibiotics are capable of producing an immediate shift in microbiota composition 
(Dethlefsen et al., 2008), other less drastic approaches include probiotics, prebiotics and 
synbiotics (a combination pro/prebiotic). The recently refined FAO/WHO definition of 
probiotics is “live microorganisms that, when administered in adequate amounts, confer a 
health benefit on the host” (Hill et al., 2014). A prebiotic is a “non-digestible food 
ingredient that beneficially affects the host by selectively stimulating the growth and/or 
activity of one or a limited number of bacteria” (Manning and Gibson, 2004). The 
remainder of this work will focus on studies of probiotics. 
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Traditionally, the genera of Lactobacillus and Bifidobacterium have been the focus of 
probiotic study due to their historical associations with fermented foods and health 
(Farnworth, 2008; Naidu et al., 1999; Yang et al., 2014). Nonetheless, a number of other 
species being applied as human probiotics include Bacillus coagulans (Fitzpatrick et al., 
2011), Saccharomyces boulardii (Czerucka et al., 2007), Escherichia coli (Schultz, 
2008), and potentially Faecalibacterium prausnitzii (Sokol et al., 2008). Additional 
species contained within a community structure analogous to an artificial stool transplant 
are also being tested, such as against antibiotic-associated Clostridium difficile diarrhea 
(Petrof et al., 2013). 
Much of the current thesis focuses on a group of 80 prototypical probiotic strains in the L. 
casei group. This group of phylogenetically similar, facultatively heterofermentative 
lactobacilli consists of L. paracasei, L. rhamnosus, L. casei, and L. zeae. The 
differentiation and nomenclature of the L. casei group is a matter of debate and is far 
from fully established (Dellaglio et al., 2002; Dicks et al., 1996; Felis & Dellaglio, 2007; 
Sato et al., 2012). This work focuses exclusively on members of the L. rhamnosus and L. 
paracasei lineages. Though L. casei and L. paracasei are used interchangeably in the 
literature often referring to the same strain, L. paracasei is the currently accepted 
nomenclature and will be used herein to refer to a set of the 40 strains of L. paracasei 
studied in this study (Klein, 2009). Further confusions relating to the delineation of this 
group led to the initial recategorization of L. rhamnosus GR-1 used in many of the early 
studies as L. casei GR-1 (Reid et al., 1987). Despite a high degree of phylogenetic 
similarity among L. casei and L. rhamnosus strains, they can vary significantly in gene 
content and probiotic traits (Douillard et al., 2013). 
The intent of using this collection of strains was to uncover novel strain variable traits, 
and using the available genome sequences, to search for the genetic mediators of 
probiotic function. 
1.4 The host-microbiota-probiotic interactome 
How probiotic strains function is a million dollar question with no simple answer. There 
are probably a multitude of mechanisms working synergistically in a context specific 
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manor. For probiotic efficacy, the mechanisms likely involve the interactions of: (i) 
probiotic strain, (ii) host and, (iii) indigenous microbes which we refer to as the host-
microbiota-probiotic interactome (Bisanz & Reid, 2011). Traditional understanding of 
probiotics has focused on only host and probiotic, or probiotic and indigenous microbes. 
Classical examples of probiotic action include production of hydrogen peroxide and/or 
bacteriocins to combat indigenous pathogens (Reid et al., 2011) or direct interactions of 
probiotics and immune cells influencing inflammatory responses (Martins et al., 2011). 
While science often takes a reductionist approach isolating individual phenomena, I 
suspect this results in many missed opportunities to better understand how probiotics 
work. Indeed it is becoming increasingly obvious that beneficial microbes often act 
through the microbiota as an intermediate. Recent studies have indicated that probiotic 
consumption does not significantly alter the microbiota composition at the community 
level; however, the effects can be seen at the transcriptional and metabolomics levels 
through interactions with the activity of indigenous microbes (Eloe-Fadrosh et al., 2015; 
McNulty et al., 2011). 
The concept of probiotic-mediated detoxication/detoxification of environmental toxins 
presented later in this chapter is an example where a reductionist approach is 
fundamentally flawed, as it is highly likely there are multiple mechanisms acting in 
concert. We and others have known that strains of lactic acid bacteria are capable of 
interactions with a variety of environmental toxins (Halttunen et al., 2008; Halttunen et 
al., 2007; Peltonen et al., 2001) and some of these have shown efficacy in vivo 
(Hernandez-Mendoza et al., 2011; Zhai et al., 2013). Despite predominantly surface 
binding mechanisms shown in vitro, it is also clear that intestinal microbes have impacts 
on host function at distal sites including xenobiotic metabolism (including pathways 
relevant to metals) in the kidney and liver (Björkholm et al., 2009; Rawls et al., 2004). 
Furthermore, experiments contrasting conventional and germ free animals have shown 
the importance of the microbiota in protection against mercury (Nakamura et al., 1977) 
lead and cadmium (Breton et al., 2013), raising the potential that  modification of 
microbiota structure or activity could affect metal uptake. In this case, by understanding 
the probiotic-microbiota-host interactome, we will be able to capture the full spectra of 
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potential mechanisms involved in probiotic-mediated detoxification. To aid in such 
studies, cutting edge tools have become available for sequencing and data analysis. 
1.5 Tools for studying the microbial communities 
In the modern era of high-throughput sequencing technologies such as Illumina, SOLiD, 
and Ion Torrent sequencing platforms, there are numerous approaches available for 
studies of the human microbiota and microbiome depending on the researcher’s question.  
Currently, most studies of the microbiota rely on targeted amplicon sequencing of a 
particular gene or marker. The 16S rRNA gene is by far the most commonly applied 
target, and it was applied in three of the chapters in this thesis. While alternative markers 
such as Cpn60/GroEL can also be used, they are less common and lack the same level of 
pre-existing tools (Hill et al., 2004; Schellenberg et al., 2011). The 16S rRNA gene has 
been used since the 1980s (Stahl et al. 1984) and thus has large databases available for 
comparison. Though many early studies of the microbiota relied on the creation of 16S 
rRNA gene clone libraries followed by Sanger sequencing of individual inserts, the era of 
massively parallel sequencing platforms ushered a new era in microbiota analysis. 
Formerly it was necessary to ligate amplicons into plasmids, transform into E. coli and 
then pick individual colonies for sequencing (Fredricks et al., 2005). Alternatively, 
denaturing gradient gel electrophoresis (DGGE) was used (Burton and Reid, 2002) to 
separate amplicons of individual organisms followed by subsequent reamplification and 
sequencing. This approach gives limited sensitivity (Gloor et al., 2010) and is tedious and 
time consuming requiring significant operator skill. By comparison, the modern approach 
requires nothing more than a simple PCR carried out with carefully designed primers 
(Gloor et al., 2010). By introducing multiplexing DNA barcodes during PCR, hundreds 
of samples can be analyzed in a single run giving magnitudes more information at a 
fraction of the price. 
One major limitation of the high-throughput sequencing for 16S rRNA gene analysis is 
the read length. While a typical Sanger sequencer, such as the Applied Biosystems 
3730XL, can produce read lengths up to 1000 bp allowing the entire 16S rRNA gene to 
be determined in paired-end sequencing, high-throughput sequencers are significantly 
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limited. Due to this, it is necessary to carefully pick the region of the 16S rRNA gene to 
be sequenced and there is not necessarily a single best region (Soergel et al., 2012). Much 
discussion on these regions focuses on the concept of variable regions, which as the term 
implies are found to be highly variable among even closely related species. The choice of 
which region to target depends highly on the community being sampled. Primers 
targeting the 6th variable region (V6), for example, are capable of differentiating many 
species of Lactobacillus, which is beneficial if studying the vaginal microbiome or 
fermented food products, but this has limited ability to differentiate the 
Gammaproteobacteria in the gut. Primers targeting the V4 region, which are applied in 
the Earth Microbiome Project (Earth Microbiome Project, 2012), are capable of improved 
differentiation of the Gammaproteobacteria, but lack the ability to discriminate many 
lactobacilli such as L. crispatus, L. rhamnosus, and L. helveticus . Other factors may 
influence the choice of primer including the availability of databases and classifiers 
(Wang et al., 2007). 
Depending on the sequencing modality, it is also possible to cover multiple variable 
regions in a single read if the given read is long enough to span the conjoining conserved 
regions. For this reason, the Roche 454 pyrosequencer was the favored instrument for 
many years for microbiota analysis due to its ability to provide read lengths of >500 bp at 
the cost of lower read output (Caporaso et al., 2010; Finegold et al., 2010; Turnbaugh et 
al., 2009; Yatsunenko et al., 2012). The first study to use Illumina sequencing to capture 
the entire V6 region with paired end sequencing covering 76 bases was performed on 
vaginal samples (Hummelen et al., 2010). The newest incarnations of the Illumina HiSeq 
and MiSeq are capable of generating >600 bp reads and have now supplanted the 454 
sequencer as the method of choice for most microbiota studies (Di Bella et al., 2014). 
The computational analysis of microbiota datasets is time-consuming, complex and with 
no one correct method. QIIME, Quantitative Insights into Microbial Ecology (Caporaso 
et al., 2010), is one of the most commonly applied packages of tools despite having 
originally being designed for 454 pyrosequencing datasets. This tool allows relatively 
simple analysis of alpha and beta diversity. In microbial ecology alpha diversity refers to 
the within-sample diversity (such as number of species, or more complex metrics such as 
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Shannon’s Diversity Index (Haegeman et al., 2013)); while beta diversity refers to 
between-sample diversity. Weighted UniFrac (Lozupone and Knight, 2005) is a 
commonly applied technique which considers both the phylogenetic relationship of the 
organisms, as based on a user-generated tree, and also their abundances to provide a 
measure of similarity. 
A common issue that arises in the analysis is that the microbiota data are compositional 
in nature. The resulting reads, despite being discrete count data, are but random 
samplings of the sequencing library and are heavily affected by technical non-biological 
factors. Thus, without extra lines of evidence such as qPCR, it is difficult to conclude that 
the absolute abundance of organisms between two samples is different. Rather, it is 
determined that their proportional abundance between communities is different. 
Furthermore, compositional data creates a number of challenges statistically. A great 
example of this lies in the attempts to carry out correlation analysis using compositional 
data. Karl Pearson, creator of the Pearson correlation coefficient, coined the term 
spurious correlation in 1896 to describe the false conclusions drawn as a result of the 
interdependence of observations inherent to compositional data (Pearson, 1896). Various 
approaches to overcome this problem include the log-ratio approach (Aitchison and 
Egozcue, 2005), utilized in the tool ALDEx (Fernandes et al., 2013; Fernandes et al., 
2014) used for comparisons of individual community constituents in the following 
chapters. The literature is ripe with examples of ultra-low abundance organisms 
associated with disease in cross-sectional studies that are more likely to be due to 
sampling variation rather than biological reality, even in high impact papers (Hsiao et al., 
2013). The ALDEx tool models technical error based on a user-defined number of 
samplings from the Dirichlet distribution, as an additional tool to increase the confidence 
in results. 
RNA-Seq, gene expression based on digital read counts from high-throughput 
sequencing, is quickly becoming the tool of choice for transcriptome studies. When the 
mixed pool of RNA belonging to a bacterial community is studied, it is referred to as the 
metatranscriptome. While approaches such as 16S rRNA gene sequencing determine the 
constituents of a community, metatranscriptome studies answer the question of what the 
9 
 
microbes are actually doing. It is more powerful than looking at just the community 
composition or their metagenomes, however it is limited in its broad range use due to 
sample preparation, sequencing cost and computationally intensive analysis. Given that 
>95% of total RNA is not coding but rather only the rRNA (Rosenow et al., 2001), the 
bulk of the RNA must be removed prior to sequencing otherwise the vast majority of 
resultant data will be uninformative for gene expression. This can be accomplished 
through the use of magnetic beads carrying oligonucleotide capture probes for conserved 
rRNA regions such as that of MICROBExpress (Life Technologies). Additionally, in 
bacterial communities associated with a eukaryotic host, a significant portion of 
transcripts may be of host origin, therefore requiring further sample enrichment by 
depleting 3’ poly-A tail mRNAs and host rRNAs. 
While 16S rRNA gene sequencing and RNA-Seq answer the questions of what taxa are 
present, and how they transcriptionally/functionally react to stimuli, metabolomics 
identify a set of small molecules in a sampled environment. These molecules are the 
combination of microbial and host metabolism and represent the end by-products of the 
community. A limitation is that unlike sequence-based methods, it is often impossible to 
tell the origin of the molecule (microbe or host). Furthermore, as the methods have 
limited ability to identify all molecules given the dependence on spectra databases for 
identification. Despite these limitations, unlike RNA-Seq and shotgun metagenomics that 
infer functions, metabolomics is truly identifying end effector molecules. 
These tools require biological questions and studies described herein sought to apply 
them to understanding probiotic function. 
1.6 The microbiota in maternal and child health 
Successful societies share a common trait: empowerment and care of women (Kar et al., 
1999). The developmental origins of health and disease would indicate that the key to a 
long healthy life begins before birth and even before conception (Fowden et al., 2006; 
Myatt, 2006). The health of mothers, neonates and children is clearly crucial. Despite 
this, in many parts of the world, and even within Canada, many women do not receive the 
education and medical care to maximize health.  Recognizing this, Canada launched the 
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Muskoka Initiative focusing on improving health of women and children, resulting in an 
investment of  $ 2.8 billion dollars into health programs and research between 2010 and 
2015. 
David Barker’s seminal work in the United Kingdom showed that nutrition during fetal 
development impacted health of the baby into late life through increased risk of 
cardiovascular disease and metabolic syndrome (Barker et al., 1993). But, the influence 
of diet on the composition and function of the gut microbiota was not considered until 
recently. Excess food intake and poor nutrient content has been the focus of microbiota 
studies in relation to obesity (Le Chatelier et al., 2013; Turnbaugh et al., 2006), due to its 
growing prevalence in developed countries.  Logic dictates that if the gut microbiota can 
facilitate increased nutrient absorption resulting in obesity, it must also be able to 
decrease it. Furthermore, dysbiosis in the vagina (BV) certainly affects the fetus, 
increasing the risk of premature delivery (Mysorekar and Cao, 2014). Early neonatal 
sepsis, infection by group B streptococci and risk of necrotizing enterocolitis show the 
impact of an aberrant microbiota on infant health (Eickhoff et al., 1964; Wang et al., 
2009). The ability of probiotics, particularly L. rhamnosus GR-1 and L. reuteri RC-14 to 
counter BV and restore vaginal health (Reid, 2014) as well as improve infant immune 
status (Isolauri et al., 2001) and resolution of rotavirus diarrhea (Grandy et al., 2010), 
illustrates benefits of microbial species in maternal and child health. Of additional 
interest to maternal and children’s health is the issue of exposure to environmental 
pollutants and toxins.  
1.7 Environmental toxin exposure and relevance to 
human health 
As opposed to the definition of toxin in a microbiological context, environmental toxins 
are a broad group of synthetic and naturally occurring compounds which pose threats to 
human health in both chronic and acute doses (Grigg, 2004). The focus of much of this 
thesis lies on toxic metals, namely mercury, arsenic, cadmium, and lead. Toxic metals 
occur naturally in the environment, although anthropomorphic activity has served to 
increase their levels greatly since the industrial revolution (Lamborg et al., 2014; 
Schwikowski et al., 2004). While we may falsely assume the matters of toxic metal 
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exposure are limited to the developing world (Hossain, 2006) the reality is that it is a 
clear and present problem all over the world. In southwestern Ontario, a recent study 
conducted at the University of Western Ontario identified that 15% of women of 
reproductive age in Toronto have levels of mercury surpassing the minimum limit for 
adverse effects on cognitive development of their offspring (Schoeman et al., 2010). The 
massive pollution from industry around Sarnia and Windsor would suggest that levels 
could be even higher west of Toronto. The situation is worrisome in all parts of the 
developed world, with an estimated 2 million children in the European Union born with 
unacceptably high levels of mercury estimated to result in a loss of 9 billion euros (12.5 
billion CAD) to the EU economy (Bellanger et al., 2013). 
Mercury is one of the most toxic substances known to man. It is all around us and can be 
found in our food (Xue, 2007), drinking water (Mohapatra et al., 2012) and air (Tian et 
al., 2011). The diet is the most significant source of mercury in the body (Hrubá et al., 
2012; Koren and Bend, 2010). Mercury levels are low in natural water reservoirs but the 
metal is readily absorbed by algae and bioaccumulates in larger fish (Morel and Kraepiel, 
1998) resulting in tissue concentrations of up to 1 part per million (ppm) (FDA, 2010). It 
is for this reason that public health agencies such as the FDA and EPA advise limiting 
consumption of fish for children and pregnant women as it can affect development (EPA, 
2004; FDA, 2010). While high-level mercury poisoning results in acute neurological 
damage, chronic low-level exposure is associated with delayed neurological development 
in children, induction of preterm labor, as well as cardiovascular and autoimmune 
diseases (Karagas et al., 2012). Limiting fish intake is not always easy, as it is one of the 
most plentiful and nutritious food sources on earth and is the primary source of dietary 
protein for many societies (Tidwell, 2001).  
1.8 Toxicology and human metabolism of mercury 
Mercury exists in three forms in nature: elemental (Hg0), inorganic (Hg2+, Hg1+) and the 
organic form, predominantly as methylmercury (MeHg) (Morel & Kraepiel, 1998). The 
World Health Organization reports that people in North America and Europe consume 
daily 4.3 µg and 2.4 µg of inorganic and organic mercury respectively (ICPS, 1991). A 
significant source of MeHg occurs through conversion of inorganic mercury by microbial 
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processes including those performed by sulfate-reducing bacteria Desulfovibrio through a 
mechanism that has only recently been understood (Parks et al., 2013). Inorganic 
mercury is not easily absorbed in the gastrointestinal tract, however MeHg and salts of 
Hg2+ are, and may enter systemic circulation. Once in the body, mercury has a half life of 
40 and/or 70 days (Hg2+ and MeHg respectively) (Clarkson et al., 2003). The metal is 
highly mobile forming complexes with thiols such as cysteine and being co-transported 
through the body (Clarkson et al., 2007). In the case of MeHg, it is easily able to cross 
the blood-brain barrier which is why it is associated with cognitive development issues in 
children.  
1.9 Interactions of microbes and metals 
Because these toxic metals are elements, they can not truly be broken down or destroyed, 
rather they can only be transferred to less toxic forms, sequestered away from cellular 
processes to, or effluxed from, the cell (Bruins et al., 2000). Given that many of the 
metals have unique properties, the mechanisms of resistance often differ. Resistance to 
some metals (lead and cadmium) is predominantly mediated by efflux transporters (Naik 
and Dubey, 2013). Cadmium resistance is often mediated by the cadCA operon wherein 
cadA is an ATP dependent cadmium efflux protein and cadC is a transcriptional repressor 
(Bruins et al., 2000). Resistance to arsenic similarly involves the ars operon frequently 
containing arsB (encoding an efflux transporter), arsC (encoding arsenate reductase) and 
arsR (a transcriptional regulator)(Bruins et al., 2000). The ArsC enzyme is particularly 
interesting as it converts arsenate to arsenite, a more toxic form of the metal, but one that  
is more easily transferred out of the cell (Rahman & Hassler, 2013). 
In lactobacilli, toxic metals are often imported by nutrients acquisition systems, for 
example cadmium is imported through manganese transporters (Archibald and Duong, 
1985). It is thought that cadmium sensitive organisms accumulate 3-15 more cadmium 
than resistant counterparts (Trevors et al., 1986). 
Mercury is unique among the toxic heavy metals in that mechanisms of resistance 
involve a true detoxification. Classical bacterial resistance to mercury involves the 
subsequent demethylation of organic mercury to inorganic mercury (organomercurial 
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lyase MerB), followed by the reduction of inorganic mercury to elemental mercury 
(mercuric reductase MerA) (Figure 1-1). While organic mercury can diffuse into the cell 
due to its lipophilic nature, inorganic mercury (Hg2+) may be actively imported by the 
MerT transporter though this is variable among species (Bruins et al., 2000). The operon 
is regulated by MerR which is a trans-acting repressor/activator protein which acts as a 
repressor in the absence of mercury, but an activator its presence (Condee and Summers, 
1992). 
                        
Figure 1-1. The Gram-positive mer operon of pI258.  
In	  the	  mercury	  resistance	  operon	  of	  pI258	  originally	  identified	  in	  Staphylococcus	  aureus,	  the	  
gene	  product	  of	  merT	  facilitates	  the	  active	  import	  of	  inorganic	  mercury	  while	  the	  products	  of	  
merA	  and	  merB	  enzymatically	  detoxify	  mercury	  from	  organic	  mercury	  to	  elemental	  mercury	  
respectively.	  The	  operon	  is	  regulated	  by	  a	  trans-­‐acting	  repressor/activator	  MerR.	  
Much of the early study of metals focused on environmental bacteria. Much of the field 
of bacterial/metal interactions was pioneered by Simon Silver and his trainees (Silver, 
2011). It wasn’t until 1972 that the nature of mercury resistance by volatilization of 
elemental mercury was discovered (Summers and Silver, 1972) and 1987 when the 
genetic basis was uncovered (Laddaga et al., 1987). Since these early discoveries, 
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mercury resistance has been observed across a wide range of organisms including 
Escherichia, Pseudomonas, Bacillus, Staphyloccocus, and Streptococcus.  Despite being 
present in a wide range of phylogenies, there has never been a published report of 
mercury resistance elements present in species of Lactobacillus. 
Not all biotransformations of mercury are favorable. It has long been known that certain 
organisms such as Desulfovibrio and Geobacter are capable of converting inorganic 
mercury to the more toxic methylmercury species (Schaefer et al., 2011). The mechanism 
was not well understood until recently (Parks et al., 2013) where it was determined 
through comparative genomics that a two-gene cluster (hgcA and hgcB) is sufficient and 
capable of methylating mercury by acting as a corrinoid protein and a methyl 
carrier/electron donor respectively. Furthermore, not all interactions of microbes and 
metals are enzymatically mediated, and passive electrostatic interactions with the cellular 
surface represent a major mechanism of interaction. 
Early studies on interactions of bacterial cell wall used heavy metals as contrast agents in 
electronic microscopy (which was taken advantage of in Chapter 7 for imaging 
purposes). Much of this work was carried out at Western University and the University of 
Guelph in the 1980s and greatly contributed to the understanding of mechanisms in this 
thesis (Beveridge and Murray, 1980; Beveridge and Koval, 1981; Beveridge and Murray, 
1985, Beveridge, 1985; Mullen et al., 1989; Beveridge, 1989). Metals are normally found 
in association with the membrane, peptidoglycan and teichoic acid of bacterial cells 
where they have biological functions. For example, Mg2+ is essential for outer membrane 
integrity in E. coli. (Beveridge and Koval, 1981). While divalent calcium and magnesium 
are usually the preferred metals on the cell surface, it is perhaps not surprising that heavy 
metals can also be found in association with the cell surface. Some years ago, it was 
noted that different cells have varying metal binding capacities reflecting variations in the 
cell wall’s chemistry, structure and constituent polymers. Lipopolysaccharide, for 
example, contains phosphoryl groups that are thought to be a main site for metal 
interactions in Gram-negative bacteria (Couglin et al., 1983). In Gram-positive cells, the 
negatively charged phosphates of teichoic acid are the most likely repository of metals on 
the cell surface as extraction of teichoic acid from cells walls depletes most of the metal 
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content (Beveridge, 1989). Furthermore, additional cell surface features, such as the 
presence of capsule, may alter interactions. Capsule can block metals from interacting 
with the cell surface (Bitton and Frichofer, 1978) but may positively affect binding with 
the cell depending on the chemical nature of the capsule (McLean et al., 1990). While 
many studies have examined metal/microbe interactions for environmental 
bioremediation, few have considered toxic metal interactions with members of the gut-
microbiota. 
Two studies have provided strong proof for a role of the gut microbiota in modulating 
toxic metal uptake from the gut. Nakamura et al. (1977) showed that germ-free mice 
lacking a gut microbiota absorbed considerably more mercury than their conventional 
counterparts, and Breton et al. (2013) showed the same effect with both lead and 
cadmium. While the germ-free mouse is a relatively extreme model for the role of a gut 
microbiota, more subtle microbiota modulating interventions have been tested using 
antibiotics (Seko et al., 1981) and altered dietary fiber consumption (Rowland et al., 
1986). These have further implicated the gut microbiota in modulating host-mercury 
uptake. Little is known about mercury metabolism by the gut microbiota, but reference 
genomes available from the Human Microbiome Project, shotgun metagenomic 
sequencing of fecal samples by the MetaHit consortium show evidence of both mercury 
detoxifying and methylating enzymes at the genetic level (unpublished observations, JE 
Bisanz).  
Motivated by the results of studies on mercury uptake at different stages of early life 
(Rowland et al., 1983), it was hypothesized that a gut microbiota enriched in 
Bifidobacterium and Lactobacillus (prototypical probiotics) has a decreased ability to 
favorably metabolize mercury due to the lack of mercury detoxifying enzymes normally 
found in these two genera. This puts an even greater emphasis on the need to develop 
probiotic strains with these traits. 
While germ-free mouse models provided proof that the gut microbiota affects metal 
uptake from the gut, these early studies did not address an important potential mechanism 
independent of direct metal sequestration: modulation of host xenobiotic metabolism. 
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1.10 Effect of microbes on xenobiotic metabolism 
Along with the boom of microbiome studies in the mid 2000s came studies of how the 
presence of the gut microbiota affects host gene expression. One of the earliest findings 
involved differential expression cytochrome p450 oxidases (CYP enzymes) including 
CYP1A1, CYP2B6 and CYP2C19 (Rawls et al., 2004; Toda et al., 2009, Claus et al., 
2011; Bjorkholm et al., 2009). A simple explanation for this phenomenon is via the 
TLR2 receptor (Do et al., 2011) that is known to affect xenobiotic metabolism pathways. 
However, relatively little is known about how the gut microbiota and/or probiotics affect 
xenobiotic metabolism in the host and so this represents a novel field that will surely 
have profound impact on the field of pharmacology and toxicology. A recent example is 
of digoxin metabolism in the GI tract by strains of Eggerthella lenta, which metabolizes 
the drug contributing greatly to its inter-individual variability in effective dosing regimes 
(Haiser et al., 2013). 
1.11 The rationale for probiotic interventions to counter 
toxic metals 
Given that consumption of mercury and other environmental toxins is more or less 
unavoidable, how does the body counter the potentially harmful effects? We 
hypothesized that bacteria can prevent heavy metal uptake into the host. The term 
detoxication is used in this thesis to describe the microbial role of preventing uptake 
while detoxification is used to describe the formation of less toxic products from the 
parent substance. There are three foreseeable mechanisms by which microbes may 
function to protect humans and other species from environmental toxins ingested in food 
and drink: (i) enzymatic conversion of toxic compounds to less toxic metabolites, (ii) 
manipulation of host processes to decrease uptake or increase xenobiotic metabolism, and 
(iii) microbial binding or sequestering of the toxin. These potential mechanisms are 
addressed in the context of mercury in Figure 1-2 and in the following paragraph.  
We propose a model wherein lactobacilli, known to exist in the mouth, intestine and 
urogenital tract and commonly used as probiotics, can reduce mercury uptake into the 
host. This action, mediated primarily in the small intestine and colon, could be directed at 
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both organic and inorganic forms acting to make them less toxic, by sequestering or 
volatilizing them. Volatilized mercury is poorly absorbed in the GI tract and is of low 
toxicity. Lactobacilli acting on mercury may also prevent conversion of dietary inorganic 
mercury to methylmercury by resident microbes. Few probiotic strains appear able to 
colonize the gastrointestinal tract to any significant degree for a prolonged period 
(McNulty et al., 2011; Smith et al., 2011), but their administration and passage through 
the gut could sequester the toxins from the intestinal contents and carry them out in the 
feces. Such toxin-binding mediated detoxication has been demonstrated in murine models 
(Hathout et al., 2011; Hernandez-Mendoza et al., 2011; Kumar et al., 2011). In addition, 
lactobacilli could act on the host to reduce intestinal permeability and modulate host 
detoxication pathways such as those involved in xenobiotic metabolism and efflux. 
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Figure 1-2. Potential mechanisms of probiotic mediated protection against dietary 
mercury exposure. 
Orally	  administered	  probiotic	  bacteria	  may	  have	  protective	  effects	  against	  dietary	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  by:	  
(i)	  directly	  binding	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  and	  sequestering	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  (ii)	  enzymatically	  detoxifying	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  through	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  related	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  community	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1.12 Scope and purpose 
Probiotic function and mechanisms of action remain widely unknown. The purpose of the 
studies presented in this thesis was to increase our understanding of probiotic function 
and formulation as well as to develop the necessary tools to examine probiotic strain 
activity. Chapter 2 presents metatranscriptome studies of a commercially available 
probiotic yogurt, emphasising how formulation and storage can affect probiotic function. 
While being a pilot study performed early in my PhD studies (2010-2011), its primary 
purpose was to develop protocols and tools required for RNA sequencing. These were 
then used in other projects in our laboratory and are now being used to study the 
microbiota in the context of metal exposure. Chapter 3 describes a fortuitous discovery of 
a novel pathway involved in fermented food flavor and aroma. This work was initially 
focused on production of hydrogen sulfide as a potential mechanism of mercury 
precipitation; however, it is likely to be irrelevant in vivo. The discovery is important as 
production of hydrogen sulfide and volatile sulfur compounds is of great interest to food 
microbiology for their role in flavor and aroma of fermented foods. This work also 
increases knowledge of how L. casei group members adapt to their environment in 
fermented foods, and it may have yet unforeseen implications for probiotic function. 
Chapter 4 describes a clinical study of vaginally administered probiotics to treat vaginal 
dysbiosis in post-menopausal women. It was the follow up to a previous study in which I 
was a co-first author (not included in this thesis: Hummelen et al., 2011). The design of 
the study was constructed around the probiotic-microbiota-host interactome concept. 
Despite not showing a major impact on clinical parameters, novel observations were 
made in terms of how probiotics affect both host and microbiota, thereby adding to our 
understanding of how lactobacilli function in the vagina. 
The work carried out in Chapter 5 describes a study in which I am co-first author (Bisanz 
et al., 2015) on probiotic yogurt in pregnant Tanzanian women. This was the first study 
of its kind in pregnant women. It provided insight both into how the microbiota changes 
over pregnancy and how probiotic yogurt can modulate the microbiota of the newborn.  
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The human study in Chapter 6 was the first to test the probiotic-detoxication concept in 
vulnerable human populations and is the main translational component to the work 
presented in Chapter 7. We were the first to show a positive effect of yogurt containing 
probiotic lactobacilli on uptake of mercury and arsenic in pregnant women and school 
children, albeit the latter did not reach statistical significance. The study has many 
immediate real world applications. The work in chapter 7 builds on the lessons learned 
from the human studies with the intent of developing novel metal-detoxication oriented 
strains. The objective was to understand the mechanisms involved in vivo. It culminated 
in animal studies using the interactome approach of the microbiome, host and probiotic. 
We identified a new L. rhamnosus candidate probiotic strain for mercury remediation 
activity and genetically characterized a novel mercuric resistance operon in L. 
rhamnosus. 
The unifying theme of this work is the desire to understand probiotic function. Through a 
combination of discovery and hypothesis driven research, we have increased our 
knowledge of how probiotics function in the human vagina and gut, and set the path for 
further investigations. As a result of these studies, I helped establish many platforms at 
Western University and Lawson Health Research including high throughput DNA 
extraction/amplification/sequencing and tools for genetic manipulations of L. rhamnosus 
strains which was previously not possible in our laboratory. It is my hope that the results 
contained within this thesis and the other publications resulting from my PhD studies will 
have translational impacts on medical and agricultural practice while increasing our 
understanding of how microbes function in host health. 
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Chapter 2  
2 Bacterial metatranscriptome analysis of a probiotic 
yogurt using an RNA-Seq approach 
This chapter is reproduced with permission (Appendix A) from: 
Bisanz JE, Macklaim JM, Gloor GB and G Reid. 2014. Bacterial metatranscriptome 
analysis of a probiotic yogurt using an RNA-Seq approach. International Dairy Journal 
39:284-292. 
2.1 Introduction  
Yogurt is a fermented milk product created through the synergistic actions of a defined 
mixture of microbes, typically Streptococcus thermophilus and Lactobacillus delbrueckii 
subsp. bulgaricus (L. bulgaricus). It is one of the most common delivery vessels for 
probiotics, and many strains have been granted the “Generally Recognized as Safe” status 
by the American Food and Drug Administration allowing their use as food additives. 
Microbial fermentation of milk can have many effects on its contents including reduction 
of lactose allowing consumption for lactose intolerant individuals (Savaiano et al., 1984). 
Bacteria may also produce metabolites beneficial to health during fermentation, the 
classical example being bacteriocins, which are present in the food matrix and when 
ingested may exert effects in addition to the actions of the live bacteria (Simova et al., 
2010). The addition of certain bacterial strains with known health benefits transforms the 
yogurt from a basic fermented food to a probiotic. Thus, the probiotic strain selected and 
its culture conditions are of importance, as strikingly indicated by differential anti-
inflammatory signalling of L. plantarum WCFS1 depending on the growth phase in 
which it was administered (van Baarlen et al., 2009). This suggests that modification of 
culture conditions is possible to optimize probiotics for maximum beneficial health 
effects. In addition, the interactions between the organisms in the mixture can influence 
the nutritional outcome of the yogurt. In point, microarray-based transcriptome studies on 
one or both organisms indicate L. bulgaricus provides free amino acids for both strains 
while formic acid, folic acid and fatty acids are supplied by S. thermophilus leading to 
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improved growth and acid production causing fermentation (Herve-Jiminez et al., 2008; 
Herve-Jiminez et al., 2009; Sieuwerts et al., 2010). Besides being of industrial 
importance, better understanding of the interactions of the yogurt microbes may prove to 
be important to the emerging field of probiotics research.  
Given that yogurt may be stored for weeks or months after fermentation before being 
consumed, we designed an experiment to analyse which genes are being expressed and 
how the expression varies with flavors and time to product expiry. In the past, most 
transcriptome studies on lactic acid bacteria have relied on cDNA microarrays, but 
technical advances and reduced costs have made RNA-Seq, a method of obtaining digital 
expression from high throughput sequencing, available to researchers. RNA-Seq has 
several advantages over microarray-based assays including greater sensitivity, greater 
specificity and nucleotide level resolution (Wang et al., 2009). Given the interest in the 
health benefits of the commercially available probiotic yogurt in question, (Yang et al., 
2008; Guyonnet et al., 2009; Veiga et al., 2010), we sought to apply this technology to 
the study of probiotic bacteria and their associated bacterial community. A deeper 
understanding of how the yogurt milieu affects probiotic organisms may allow for 
maximization of probiotic effects and more guided utilization of these products. 
2.2 Materials and Methods 
2.2.1 Yogurt source 
A mixed pack of 100 g cups of strawberry and vanilla flavored yogurt containing the 
probiotic bacterium Bifidobacterium animalis subsp. lactis (B. lactis) strain CNCM I-
2494 was obtained from a local grocery store (London, Ontario, Canada) 23 days before 
expiry, and stored at 4 °C until further analysis. RNA isolation from pots of both 
strawberry and vanilla flavors took place 15 days before expiry (sample names: 
strawberry and vanilla) and vanilla 1 day before expiry (sample name: vanilla 2). This 
roughly represents the product at the recently purchased time point and close to expiry, 
though still in the time frame by which a consumer would be able to purchase and 
consume the product. 
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2.2.2 RNA isolation 
The extraction protocol was based on previously published methods (Macklaim et al., 
2013; Smeianov et al., 2007). Each product was thoroughly mixed and an aliquot of 10 
mL of was resuspended in 20 mL of Bacterial RNAprotect (Qiagen) containing 50 µg/mL 
rifampicin (Sigma). The samples were mixed and incubated for 10 minutes at room 
temperature to stabilize RNA. The mixture was then centrifuged at 5,000 x g for 10 
minutes, the supernatant was discarded, and the pellet was immediately frozen in liquid 
nitrogen and stored at -80°C until lysis and extraction. The pellet was next resuspended in 
10 mL of DEPC-treated water containing 20 mg mL-1 lysozyme (Sigma), 50 U mL-1 
mutanolysin (Sigma) and 100 µg mL-1 rifampicin (Sigma) and incubated at 37 °C for 30 
minutes. The mixture was then centrifuged as before and the supernatant was discarded. 
The pellet was then resuspended in 10 mL of TRIzol reagent (Invitrogen). The sample 
was fully homogenized and the sample was centrifuged for 10 minutes at 12,000 x g to 
clear excess un-dissolved milk components. The supernatant was then collected and the 
manufacturers protocol was followed to isolate total RNA  (TRIzol Reagent Manual, 
Invitrogen). Total RNA in RNase-free water was then transferred to a RNeasy column 
(Qiagen) and treated with DNaseI (Qiagen) following the manufacturers protocol. mRNA 
was enriched with the MICROBExpress kit (Ambion) according to the manufacturer’s 
protocol. mRNA purity was accessed using an BioPhotometer 6131 (Eppendorf) to 
ensure the sample was free of contaminants. Both the total RNA and mRNA were 
analysed with a Bioanalyzer 2100 (Agilent) to analyse RNA quality and confirm mRNA 
enrichment. All RNA samples used for sequencing had a RIN (RNA integrity number) 
>8.0 as total RNA. 
2.2.3 RNA-Seq 
Samples were sent to the Center for Applied Genomics (Toronto), and directional library 
preparation was carried out and the samples barcoded for 50 base pair sequencing on the 
ABI SOLiD 4 (Life Technologies). 
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2.2.4 Read mapping 
The colorspace reads were mapped to the reference genomes of the strains present in the 
yogurt (B. animalis CNCM I-2494, Lactobacillus bulgaricus strains CNCM I-1632 and 
CNCM I-1519, S. thermophilus CNCM I-1630 and Lactococcus lactis CNCM-1631). At 
the time of publishing, these genomes are available under the following GenBank 
accessions: CP002915.1, NZ_AGFO00000000, NZ_AGHW00000000, 
NZ_AGFN00000000, NZ_AGHX00000000. Mapping was carried out with Bowtie 
0.12.7 (bowtie-bio.sourceforge.net) using the ‘--best’ and ‘-M 1’ flags to report only best 
hits, and in the case of reads with multiple best hit mappings, randomly distributing them 
amongst matches. The first 10 nt at the 3’ end of each read were trimmed prior to 
mapping. Using custom Perl scripts (JEB, JMM and GBG), the reads were assigned to 
open reading frames and the number of reads per ORF was enumerated. Proportional 
mRNA abundances per taxa were calculated by three methods: (i) finding the number of 
reads mapped to the cpn60 gene of each strain and calculating the fraction of total 
mapped cpn60 reads, (ii) the fraction of total mapped rpoB reads, and (iii) calculating 
each strains’ total mapped reads as a fraction of reads mapping to all strains. 
2.2.5 Expression analysis 
For each organism’s protein coding sequence, total reads per open reading frame were 
calculated. The reads per kilobase of exon model per million mapped reads (RPKM) 
method was used to normalize expression of each gene (Mortazavi et al., 2008). DEseq 
(bioconductor.org/packages/2.6/bioc/html/DESeq.html), an open source R package, was 
used to calculate differential gene expression in each organism in each of the three 
conditions (Anders and Huber, 2010). The ‘blind’ method was used to allow statistical 
analysis without replicates. Genes were deemed to be significantly differentially 
regulated if they had a p<0.05. Genes were functionally annotated using the Clusters of 
Orthologous Proteins (COGs) database with an e-value cut off of 1E-3 to assign 
annotations and functions. Genes were also compared to the SEED subsystems database 
to assign function (ftp.theseed.org/subsystems/) and high quality matches were extracted 
(≥80% identity and e-value<1E-3). Amino acid translations of predicted coding 
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sequences were submitted to the Kyoto Encyclopaedia of Genes and Genome- 
Automated Annotation Server (genome.ad.jp/tools/kaas/) for pathways analysis.  
2.3 Results 
2.3.1 Read mapping 
A total of 48,658,804 reads (50 nt long) were successfully mapped to the reference 
database of whole genomes belonging to strains in the product. The average coding 
sequence coverage obtained for a given organism in a sample was 37.2-fold. Individual 
coverages are shown in Table 2-1 by number of reads and fold coverage of the strains 
coding sequences. Only L. lactis had poor sequencing depth having a coverage of  
≤0.390. 
Table 2-1. Reads mapping and coding sequence coverage of strains present in each 
sample. All values are mapped reads in millions (fold-coverage of coding sequences). 
Sample B. lactis  S. thermophilus  L. lactis  
L. bulgaricus 
CNCM I-1632  
L. bulgaricus 
CNCM I-1519 
Strawberry 1.13 (32.2) 1.15 (48.6) 4.76x10
-4 
(0.108) 0.48 (15.3) 0.78 (25.1) 
Vanilla 0.85 (24.2) 5.11 (215.4) 1.72x10
-3 
(0.390) 0.86 (27.9) 1.12 (37.3) 
Vanilla 2 0.82 (23.3) 1.98 (83.3) 1.03x10
-3 
(0.233) 0.26 (8.34) 0.46 (24.4) 
 
2.3.2 Microbial mRNA composition 
Figure 2-1 is a bar plot mapping microbial abundance by fraction of total cpn60 reads, 
rpoB and total reads mapped to protein coding sequence in each sample. The dominant 
organism by cpn60 mapped reads was S. thermophilus, while B. lactis and L. bulgaricus 
strains were also in high abundance. B. lactis and L. bulgaricus contributed a greater 
proportion of both rpoB mapped reads and total reads. L. lactis appeared to be present in 
relatively low abundance as compared to the other organisms both by cpn60 (≤0.01%), 
rpoB (≤0.29%), which was consistent with its low transcriptome coverage. L. lactis was 
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excluded from further expression analysis, as it did not have sufficient coverage for 
meaningful analysis. 
                     
Figure 2-1. Microbial abundance as measured by the fraction of cpn60 reads, rpoB 
reads and reads mapping to all coding sequences in the organisms.  
By	  cpn60,	  but	  not	  rpoB	  and	  total	  reads,	  S.	  thermophilus	  was	  the	  most	  abundant	  organism	  in	  all	  
conditions,	  however	  all	  strains,	  with	  the	  exception	  of	  L.	  lactis,	  appeared	  to	  be	  present	  and	  highly	  
transcriptionally	  active.	  
 
2.3.3 Gene functions expressed in yogurt 
In each organism an enrichment analysis was performed by analysing all COG functions 
present in the genome, genes expressed with a RPKM ≥200 in all samples, and genes 
expressed with a RPKM ≥1000 in all samples. This corresponds to all protein coding 
genes, the most highly expressed 22.4-37.8% and 5.26-9.94% of genes respectively in a 
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strain dependent manner. Of total genes with an assignable COG hit, the fraction of genes 
in each top-level function was calculated and is displayed in Figure 2-2. Highly 
represented functions in all organisms include translational machinery, carbohydrate 
transport and metabolism, amino acid transport and metabolism. In most strains such as 
B. lactis, there was an enrichment of genes involved in translation in the highly expressed 
genes (from 10% in the genome to 23.6% in genes with an RPKM ≥1000) with the 
exception of S. thermophilus. In this organism, at the highest RPKM cut-off, genes 
involved in this category only comprise 7.4% of genes while they comprise 8.6% in the 
genome. S. thermophilus showed higher enrichment in carbohydrate transport and 
metabolism from 6.1% in the genome to 17.2% at an RPKM cut-off of 1000. This 
included two genes annotated as LacZ beta-galactosidase, responsible for breaking down 
lactose, which was also highly expressed in L. bulgaricus strains but not B. lactis. Further 
KEGG pathway analysis showed the backbone genes of glycolysis were highly expressed 
(RPKM≥1000) in S. thermophilus leading to its higher fraction of genes involved in 
carbohydrate transport and metabolism. Both L. bulgaricus strains displayed similar 
fractions of functions at all levels of enrichment. B. lactis had a higher fraction of genes 
involved in energy production and conversion at an RPKM≥1000 with 8.9% of genes 
involved in this category. KEGG annotation showed the presence of 6 subunits of F0F1 
type ATP synthase among these genes, supported by KEGG pathway analysis.  
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Figure 2-2. Enrichment of COG functions in all conditions by increasing RPKM 
cutoff demonstrating gene functions at different levels of expression.  
Functions	  highly	  represented	  at	  the	  highest	  enrichment	  levels	  include	  those	  involved	  in	  
translation,	  and	  carbohydrate	  and	  amino	  acid	  transport/metabolism.	  There	  was	  an	  enrichment	  
of	  carbohydrate	  transport	  and	  metabolism	  genes	  in	  S.	  thermophilus	  at	  higher	  expression	  levels	  
(RPKM≥1000)	  while	  other	  strains	  displayed	  enrichment	  of	  translation,	  ribosomal	  structure	  and	  
biogenesis	  genes.	  B.	  lactis	  displayed	  an	  enrichment	  of	  genes	  involved	  in	  energy	  production	  and	  
conversion.	  Both	  L.	  bulgaricus	  strains	  displayed	  similar	  profiles	  at	  the	  genome,	  and	  highly	  
expressed	  gene	  levels.	  
2.3.4 Differential mRNA expression due to flavor and storage time 
Differential expression analysis by DESeq was performed for flavor (strawberry vs. 
vanilla) and storage time (vanilla vs. vanilla 2). Statistical analysis without replicates was 
based on the assumption that no difference exists for most genes between samples 
compared, thus samples are treated as if they are replicates with differentially abundant 
genes as outliers. This approach is generally considered to be conservative, since it 
usually leads to an overestimation of variance making reported p-values conservative  
(Anders and Huber, 2010). Differential expression was plotted in the context of SEED 
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subsystems for all analyzed strains. Figure 2-3 shows a flavor comparison and storage 
time comparison at the most general SEED subsystem level. Genes identified as 
significantly differentially expressed are indicated by the strain of origin. Genes that had 
differential expression values of infinity due to read count values of zero in one sample 
were plotted as a 6-fold change for simplicity. Only 9 of these genes had a p<0.05 
including LDBUL1519_00397, a O-acetylhomoserine sulfhydrylase. In both 
comparisons, there were many up-regulated genes involved in protein metabolism in 
strawberry compared to vanilla and vanilla compared to vanilla 2. Inspection of SEED 
subsystem level 3 revealed most of these differentially expressed genes encode ribosomal 
proteins. In particular 13 genes, 11 up-regulated, involved in protein metabolism, were 
significantly differentially regulated by B. lactis in strawberry as opposed to vanilla 
flavors ranging from -1.4 to 1.4 fold (log2). 
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Figure 2-3. Differential expression measured by Log2(fold change) in the highest 
level SEED subsystems in a comparison of flavors and storage time.  
Genes	  with	  a	  p<0.05	  are	  displayed	  according	  to	  the	  strain	  of	  origin:	  B.	  lactis	  ( ),	  S.	  
thermophilus	  ( ),	  L.	  bulgaricus	  CNCM	  I-­‐1519	  	  ( ),	  L.	  bulgaricus	  CNCM	  I-­‐	  1632	  ( ).	  Genes	  
infinitely	  differentially	  regulated	  were	  assigned	  a	  fold-­‐change	  value	  of	  	  ±6-­‐fold.	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2.3.5 B. lactis expression 
The filtered, COG-annotated gene-by-gene results of a flavor (strawberry versus vanilla) 
and time comparison (vanilla versus vanilla 2) are displayed in Tables 2-2 and 2-3 
respectively. In the flavor comparison, 90 genes were identified as being significantly 
differentially expressed with 59 being assigned COG annotations. In the storage 
comparison, 89 genes were significantly differentially expressed with 56 being assigned 
COG annotations. The most up-regulated gene in strawberry as compared to vanilla was 
upgE, a sugar transport permease (5.3-fold), while the most down-regulated was salX, an 
antimicrobial peptide transport system (-3.0-fold). In the time point comparison of vanilla 
to vanilla 2, Ssb single-stranded DNA-binding protein was most up-regulated in vanilla 
(12.6-fold) while COG1073, a hydrolase, was most down-regulated (infinitely down-
regulated). Gene functions differentially regulated in both conditions include genes that 
are predominately involved in protein translation and DNA replication, or can’t be 
assigned a function, and to a lesser extent those involved in DNA replication, 
recombination and repair, cell envelope biogenesis and transcription as demonstrated in 
Figure 2-4 which shows differential expression of COG functions in B. lactis. 
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Table 2-2. B. lactis genes with assigned COGs differentially regulated with p<0.05 in 
a comparison of the strawberry and vanilla samples (flavor comparison). 
Locus ID Fold Change P-value Best COG Hit 
BALAC2494_02066 5.28 8.79E-03 COG0395, UgpE, ABC-type sugar transport system, permease component  
BALAC2494_01335 3.98 1.15E-07 COG5017, Uncharacterized conserved protein  
BALAC2494_01292 3.66 6.58E-07 COG1403, McrA, Restriction endonuclease  
BALAC2494_00517 3.64 4.95E-06 COG3039, Transposase and inactivated derivatives, IS5 family  
BALAC2494_01290 3.47 1.02E-04 COG4974, XerD, Site-specific recombinase XerD  
BALAC2494_01337 2.76 3.01E-04 COG0451, WcaG, Nucleoside-diphosphate-sugar epimerases  
BALAC2494_01333 2.72 1.38E-04 COG1216, Predicted glycosyltransferases  
BALAC2494_00723 2.69 8.28E-04 COG0203, RplQ, Ribosomal protein L17  
BALAC2494_01334 2.55 3.48E-04 COG1216, Predicted glycosyltransferases  
BALAC2494_00235 2.48 3.05E-03 COG1507, Uncharacterized conserved protein  
BALAC2494_01304 2.33 4.28E-03 COG0224, AtpG, F0F1-type ATP synthase, gamma subunit  
BALAC2494_00734 2.18 2.01E-03 COG0256, RplR, Ribosomal protein L18  
BALAC2494_00989 2.15 2.59E-02 COG4177, LivM, ABC-type branched-chain amino acid transport system, permease component  
BALAC2494_00987 2.13 7.96E-03 COG0410, LivF, ABC-type branched-chain amino acid transport systems, ATPase component  
BALAC2494_01352 2.12 2.76E-03 COG1216, Predicted glycosyltransferases  
BALAC2494_01336 2.11 3.50E-03 COG0707, MurG, UDP-N-acetylglucosamine:LPS N-acetylglucosamine transferase  
BALAC2494_00329 2.11 2.63E-02 COG0239, CrcB, Integral membrane protein possibly involved in chromosome condensation  
BALAC2494_00130 2.09 4.69E-03 COG1546, CinA, Uncharacterized protein (competence- and mitomycin-induced)  
BALAC2494_00727 2.09 3.37E-03 COG0257, RpmJ, Ribosomal protein L36  
BALAC2494_00651 2.07 3.59E-02 COG4487, Uncharacterized protein conserved in bacteria  
BALAC2494_01817 2.02 1.46E-02 COG1203, Predicted helicases  
BALAC2494_01248 2.02 7.01E-03 COG0360, RpsF, Ribosomal protein S6  
BALAC2494_01776 2.00 8.92E-03 COG2244, RfbX, Membrane protein involved in the export of O-antigen and teichoic acid  
BALAC2494_01354 1.99 6.60E-03 COG0463, WcaA, Glycosyltransferases involved in cell wall biogenesis  
BALAC2494_01967 1.96 1.48E-02 COG0048, RpsL, Ribosomal protein S12  
BALAC2494_00758 1.85 3.54E-02 COG0102, RplM, Ribosomal protein L13  
BALAC2494_00797 1.85 1.41E-02 COG1211, IspD, 4-diphosphocytidyl-2-methyl-D-erithritol synthase  
BALAC2494_00510 1.85 1.43E-02 COG0049, RpsG, Ribosomal protein S7  
BALAC2494_00381 1.81 4.79E-02 COG0799, Uncharacterized homolog of plant Iojap protein  
BALAC2494_01353 1.79 2.00E-02 COG2244, RfbX, Membrane protein involved in the export of O-antigen and teichoic acid  
BALAC2494_01302 1.78 3.12E-02 COG0712, AtpH, F0F1-type ATP synthase, delta subunit  
BALAC2494_00554 1.78 2.09E-02 COG1061, SSL2, DNA or RNA helicases of superfamily II  
BALAC2494_01347 1.78 2.12E-02 COG1215, Glycosyltransferases, probably involved in cell wall biogenesis  
BALAC2494_00785 1.78 2.66E-02 COG0581, PstA, ABC-type phosphate transport system, permease component  
BALAC2494_00784 1.78 4.80E-02 COG1117, PstB, ABC-type phosphate transport system, ATPase component  
BALAC2494_00780 1.74 3.29E-02 COG0222, RplL, Ribosomal protein L7/L12  
BALAC2494_01492 1.73 3.33E-02 COG0118, HisH, Glutamine amidotransferase  
BALAC2494_00746 1.71 3.00E-02 COG0185, RpsS, Ribosomal protein S19  
BALAC2494_00185 1.69 4.80E-02 COG0268, RpsT, Ribosomal protein S20  
BALAC2494_01079 1.68 4.42E-02 COG1196, Smc, Chromosome segregation ATPases  
BALAC2494_00553 1.67 4.51E-02 COG1479, Uncharacterized conserved protein  
BALAC2494_00168 1.65 4.25E-02 COG0740, ClpP, Protease subunit of ATP-dependent Clp proteases  
BALAC2494_00446 -1.91 1.36E-02 COG3304, Predicted membrane protein  
BALAC2494_00316 -1.93 3.55E-02 COG0861, TerC, Membrane protein TerC, possibly involved in tellurium resistance  
BALAC2494_00765 -2.00 4.53E-02 COG4231, Indolepyruvate ferredoxin oxidoreductase, alpha and beta subunits  
BALAC2494_00398 -2.17 1.91E-02 COG1028, FabG, Dehydrogenases with different specificities  
BALAC2494_00859 -2.23 3.67E-03 COG1837, Predicted RNA-binding protein (contains KH domain)  
BALAC2494_01319 -2.30 7.10E-03 COG0251, TdcF, Putative translation initiation inhibitor, yjgF family  
BALAC2494_00825 -2.50 7.85E-04 COG0211, RpmA, Ribosomal protein L27  
BALAC2494_00591 -2.56 2.05E-03 COG0629, Ssb, Single-stranded DNA-binding protein  
BALAC2494_00637 -2.63 3.66E-02 COG1874, LacA, Beta-galactosidase  
BALAC2494_00865 -2.71 1.54E-04 COG0227, RpmB, Ribosomal protein L28  
BALAC2494_00612 -2.94 3.46E-02 COG3507, XynB, Beta-xylosidase  
BALAC2494_00415 -2.98 1.78E-02 COG1136, SalX, ABC-type antimicrobial peptide transport system, ATPase component  
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Table 2-3. B. lactis genes with assigned COGs differentially regulated with  p<0.05 
in a comparison of the vanilla and vanilla 2 samples (storage comparison). 
Locus ID Fold Change p-value Best COG Hit 
BALAC2494_00591 12.61 4.83E-08 COG0629, Ssb, Single-stranded DNA-binding protein  
BALAC2494_01069 10.79 7.53E-07 COG3464, Transposase and inactivated derivatives  
BALAC2494_01866 10.16 1.19E-06 COG3464, Transposase and inactivated derivatives  
BALAC2494_01860 9.40 2.02E-06 COG3464, Transposase and inactivated derivatives  
BALAC2494_01696 7.67 1.39E-05 COG3464, Transposase and inactivated derivatives  
BALAC2494_00118 5.70 1.65E-04 COG3464, Transposase and inactivated derivatives  
BALAC2494_00693 5.30 1.09E-02 COG1605, PheA, Chorismate mutase  
BALAC2494_01466 5.20 2.43E-04 COG1381, RecO, Recombinational DNA repair protein (RecF pathway)  
BALAC2494_00859 5.13 1.10E-03 COG1837, Predicted RNA-binding protein (contains KH domain)  
BALAC2494_01771 4.27 3.18E-02 COG0388, Predicted amidohydrolase  
BALAC2494_00728 3.95 1.34E-02 COG0361, InfA, Translation initiation factor 1 (IF-1)  
BALAC2494_01326 3.54 1.30E-03 COG1196, Smc, Chromosome segregation ATPases  
BALAC2494_00488 3.53 5.57E-03 COG0776, HimA, Bacterial nucleoid DNA-binding protein  
BALAC2494_01696 3.22 7.15E-03 COG3464, Transposase and inactivated derivatives  
BALAC2494_00232 3.20 1.31E-02 COG0600, TauC, ABC-type nitrate/sulfonate/bicarbonate transport system, permease component  
BALAC2494_00635 3.11 2.45E-02 COG1175, UgpA, ABC-type sugar transport systems, permease components  
BALAC2494_00865 3.00 1.31E-02 COG0227, RpmB, Ribosomal protein L28  
BALAC2494_00128 2.89 2.04E-02 COG0324, MiaA, tRNA delta(2)-isopentenylpyrophosphate transferase  
BALAC2494_00398 2.80 1.49E-02 COG1028, FabG, Dehydrogenases with different specificities 
BALAC2494_00770 2.77 4.57E-02 COG0234, GroS, Co-chaperonin GroES (HSP10)  
BALAC2494_00031 2.73 2.55E-02 COG1974, LexA, SOS-response transcriptional repressors (RecA-mediated autopeptidases)  
BALAC2494_00499 2.71 2.92E-02 COG1758, RpoZ, DNA-directed RNA polymerase, subunit K/omega  
BALAC2494_00364 2.66 8.73E-03 COG0739, NlpD, Membrane proteins related to metalloendopeptidases  
BALAC2494_00825 2.66 9.15E-03 COG0211, RpmA, Ribosomal protein L27  
BALAC2494_02024 2.55 1.38E-02 COG0040, HisG, ATP phosphoribosyltransferase  
BALAC2494_00909 2.47 1.74E-02 COG0527, LysC, Aspartokinases  
BALAC2494_00389 2.35 2.17E-02 COG0637, Predicted phosphatase/phosphohexomutase  
BALAC2494_00954 2.35 2.15E-02 COG4591, LolE, ABC-type transport system, involved in lipoprotein release, permease component  
BALAC2494_01319 2.30 3.55E-02 COG0251, TdcF, Putative translation initiation inhibitor, yjgF family  
BALAC2494_00446 2.30 2.57E-02 COG3304, Predicted membrane protein  
BALAC2494_01603 2.27 2.95E-02 COG1278, CspC, Cold shock proteins  
BALAC2494_01864 2.27 4.29E-02 COG2135, Uncharacterized conserved protein  
BALAC2494_00085 2.25 3.28E-02 COG0292, RplT, Ribosomal protein L20  
BALAC2494_01157 2.14 4.11E-02 COG2211, MelB, Na+/melibiose symporter and related transporters  
BALAC2494_02003 2.10 4.97E-02 COG1765, Predicted redox protein, regulator of disulfide bond formation  
BALAC2494_00341 -2.15 4.94E-02 COG0159, TrpA, Tryptophan synthase alpha chain  
BALAC2494_00168 -2.27 3.35E-02 COG0740, ClpP, Protease subunit of ATP-dependent Clp proteases  
BALAC2494_01335 -2.35 4.83E-02 COG5017, Uncharacterized conserved protein  
BALAC2494_00735 -2.46 4.24E-02 COG0097, RplF, Ribosomal protein L6P/L9E  
BALAC2494_00993 -2.46 3.50E-02 COG0239, CrcB, Integral membrane protein possibly involved in chromosome condensation  
BALAC2494_00727 -2.50 2.18E-02 COG0257, RpmJ, Ribosomal protein L36  
BALAC2494_01352 -2.55 1.49E-02 COG1216, Predicted glycosyltransferases  
BALAC2494_01292 -2.57 3.86E-02 COG1403, McrA, Restriction endonuclease  
BALAC2494_01353 -2.66 2.18E-02 COG2244, RfbX, Membrane protein involved in the export of O-antigen and teichoic acid  
BALAC2494_00397 -2.74 4.08E-02 COG0162, TyrS, Tyrosyl-tRNA synthetase  
BALAC2494_01360 -2.77 2.97E-02 COG4713, Predicted membrane protein  
BALAC2494_01248 -3.16 1.41E-02 COG0360, RpsF, Ribosomal protein S6  
BALAC2494_00732 -3.29 1.91E-02 COG1841, RpmD, Ribosomal protein L30/L7E  
BALAC2494_01304 -3.37 2.14E-02 COG0224, AtpG, F0F1-type ATP synthase, gamma subunit  
BALAC2494_00403 -3.46 1.52E-03 COG1438, ArgR, Arginine repressor  
BALAC2494_00381 -4.14 2.97E-03 COG0799, Uncharacterized homolog of plant Iojap protein  
BALAC2494_01007 -Inf 5.38E-03 COG1073, Hydrolases of the alpha/beta superfamily  
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Figure 2-4. Differential regulation of COG functions in B. lactis in both flavor (A) 
and storage time (B) comparisons.   
Differential	  expression	  is	  represented	  by	  number	  of	  genes	  passing	  the	  filter	  and	  the	  bars	  are	  
stacked	  showing	  the	  total	  number	  of	  genes	  separated	  by	  up	  and	  down-­‐regulated.	  COG	  
Functions:	  (J)	  translation,	  ribosomal	  structure	  and	  biogenesis;	  (R)	  general	  function	  prediction	  
only;	  (S)	  function	  unknown;	  (L)	  DNA	  replication,	  recombination	  and	  repair:	  (M)	  cell	  envelope	  
biogenesis,	  outer	  membrane;	  (G)	  carbohydrate	  transport	  and	  metabolism;	  (P)	  inorganic	  ion	  
transport	  and	  metabolism;	  (C)	  energy	  production	  and	  conversion;	  (E)	  amino	  acid	  transport	  and	  
metabolism;	  (D)	  cell	  division	  and	  chromosome	  partitioning;	  (I)	  lipid	  metabolism;	  (V)	  defense	  
mechanisms;	  (K)	  transcription;	  (O)	  posttranslational	  modification,	  protein	  turnover,	  chaperones;	  
(Q)	  secondary	  metabolites	  biosynthesis,	  transport	  and	  catabolism;	  (U)	  intracellular	  trafficking	  
and	  secretion;	  and	  (T)	  signal	  transduction	  mechanisms.	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2.4 Discussion 
In this report, we describe one of the first metatranscriptome analyses of a probiotic 
yogurt. High coverage of all coding sequences of the organisms present in the yogurt was 
obtained with the high read output of the SOLiD 4 sequencer. We recognize the inherent 
limitations of the single replicate experimental design, and have been conservative in our 
analysis. However, several factors suggest that the majority of the findings are robust. 
First, the high read coverage partially compensated for the single replicate experimental 
design as the abundance values can be estimated with greater precision (Fernandes et al., 
2013). Second, the analysis tool used assumes that the majority of the expression values 
between samples do not change, and only identifies the expression outliers. This 
approach is expected to be conservative (Anders and Huber, 2010). Recent work has 
determined that genes with high intrinsic variation are also identified by this tool (Li and 
Tibshirani, 2013; Fernandes et al., 2014), indicating that there may be contamination with 
genes of this type in the lists of differentially abundant genes. Validation thus will require 
additional samples. Third, many of the differentially abundant genes that are identified 
may be connected in pathways. This argues strongly for accepting as valid those genes 
that are identified as differentially abundant where multiple genes in the same pathway 
are also significantly different and share the same directionality of abundance difference. 
Given that non-protein coding RNAs make up ≥90% of total RNA, the enrichment of 
mRNA is necessary to optimize coverage of coding sequences. This makes expressed 
16S rRNA an unsuitable marker of microbial abundances as it has been largely removed 
and the removal may not be consistent across all strains. We used instead the cpn60 gene 
and rpoB, both are single copy, highly-transcribed genes with high levels of sequence 
variation allowing for unique identification of bacteria and quantification (Hill et al., 
2004; Rodrigues & Tiedje, 2007). The cpn60-mapped reads indicated that the most 
abundant organism was S. thermophilus while L. bulgaricus and the probiotic B. lactis 
also composed a large fraction of the population. Even though B. lactis may be rare 
according to cpn60, it still appears to be highly transcriptionally active as dictated by the 
proportion of total reads in the product. The proportional abundances of rpoB mapped 
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reads more closely resemble the proportional abundances determined by total reads. 
Given that two strains of L. bulgaricus were present, it was likely our quantitation may be 
skewed by an inability to distinguish between the strains given a high level of similarity 
in their 1614 bp cpn60 genes (99% nucleotide sequence identity). In all three samples we 
observe L. bulgaricus CNCM I-1519 as being in higher quantities, thus we may be 
underestimating its abundance, and overestimating the abundance of L. bulgaricus 
CNCM I-1632 as reads with common mapping in these two organisms will be equally 
assigned to both. In addition, it is possible that levels of cpn60 may fluctuate in response 
to cell stress which has been identified in L. bulgaricus (Lim et al., 2000). This may also 
skew quantification making fraction of cpn60 reads a good tool for identification of 
bacterial strains but as with any technique, it may have its own inherent biases. Indeed, 
recent studies have shown transcriptional activity is not always related to true microbial 
abundances which may suggest the need for culture or DNA-based quantification 
(McNulty et al., 2011).  
The L. lactis had extremely low coverage of ≤0.390-fold, so we were unable to study its 
role further. While we can demonstrate its presence by the detection of uniquely mapping 
cpn60 reads, there are less than 100 reads in any of the samples. This suggests L. lactis 
composes a small fraction of the total community and plays a minor role in the product as 
delivered to the consumer. Alternatively it may be present but in an extremely dormant 
state at the time of sampling with very little functional contribution in the finished 
product. Presumably during the production of the yogurt it contributes to the taste or 
texture of the product but could also function in improving growth and viability of the 
probiotic bifidobacteria strain as suggested by recent research (Yonezawa et al., 2010; 
Odamaki et al., 2011). 
When comparing flavors, two genes of L. bulgaricus CNCM I-1519 involved in 
methionine pathways were differentially regulated infinitely (no transcripts detected in 
one condition), up-regulated in LDBUL1519_01373 (adenosylhomocysteinase) and 
down-regulated in LDBUL1519_00397 (O-acetylhomoserine sulfhydrylase or O-
succinylhomoserine sulfhydrylase).  The product of adenosylhomocysteinase reactions 
are L-cysteine and adenosine while O-succinylhomoserine sulfhydrylase consumes L-
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cysteine to form L-cystathionine and succinate (KEGG Database). This may suggest a 
cellular response in L. bulgaricus to produce maximum quantities of L-cysteine in the 
strawberry flavor compared to vanilla. Cysteine can act as an antioxidant in cells (Qian et 
al., 2010). It is also used in growth media to lower the redox potential and protect against 
reactive oxygen species for anaerobes such as bifidobacteria (Qian et al., 2010). The 
importance of cysteine was underlined by the detection of a number of highly expressed 
components in the cysteine and methionine pathway during analysis of B. lactis. This 
suggests a mechanism to help protect viability of probiotics in yogurt, though as a 
double-edged sword, bifidobacteria grown in the absence of cysteine form anti-oxidant 
granules exhibiting higher acid tolerance and higher surface hydrophobicity which are 
beneficial characteristics for a probiotic to allow passage through the digestive system 
(Qian et al., 2010).  These antioxidant granules contain large quantities of polyphosphate 
and there was corresponding up-regulation of two B. lactis phosphate specific 
transporters in strawberry flavoring (PstA and PstB) that would supply phosphate for the 
production of polyphosphate.  
O-acetylhomoserine sulfhydrylase, the other potential function of the L. bulgaricus gene 
LDBUL1519_00397 as reported by the KEGG Database, consumes methanethiol to 
produce L-methionine. Methanethiol is a key volatile sulfur compound important in 
giving flavor and aroma to cheese which has the potential to give rise to subtle flavor and 
scent differences between yogurts (Hanniffy et al., 2009). 
Components of the F0F1-ATP synthase machinery of B. lactis appeared to be highly 
expressed and differentially regulated between conditions being up-regulated 
(BALAC2494_1302 and BALAC2494_1304) in the strawberry flavor and in the fresher 
vanilla sample. This machinery has been implicated as being key for bile and acid 
resistance in both B. animalis and L. plantarum by increasing intracellular ATP and 
controlling intracellular pH (Sanchez et al., 2006; Hammon et al., 2011). Improved bile 
and acid resistance may aid a probiotic strain by improving resistance to stomach acid 
and bile in the stomach and early small intestine allowing more viable organisms to reach 
their site of action. 
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The SEED subsystem analyses indicated that ribosomal proteins were differentially 
regulated in all organisms in both flavor and storage comparisons. In the flavor 
comparison many of these changes are relatively small, less than 4-fold, while in the 
storage time comparison the changes were more drastic with up-regulation of the genes 
by 2-16 fold in the fresher sample. A probable explanation of why we were able to assign 
significance to relatively small 2-fold changes in the ribosomal subunits is a function of 
their extremely high abundance that allows higher confidence in their change. Higher 
expression of these transcripts may be indicative of higher translational activity, 
especially when coupled with up-regulation of RNA polymerase subunits such as RpoZ 
(BALAC2494_00499), or of significantly greater mRNA stability of these transcripts 
upon prolonged shelf storage.  Recent work in E. coli suggests that bacterial cells have an 
upper limit on the amount of transcription supported. Scott et al. (2010) found that the 
transcription of house keeping genes such as ribosomal proteins change to compensate 
for increases in the transcription of genes expressed in response to environmental cues. 
This implies that there may be a number of smaller changes that occurred in the cell, 
however these most likely don’t pass our filters. We suggest that a larger sample set 
would help improve our ability to detect smaller changes. 
B. lactis adapts to its environment as indicated by the most up-regulated gene in 
strawberry in comparison to vanilla: upgE. It is most likely a broad specificity sugar 
uptake permease suggesting that this may be a response to differing sugar composition 
between flavors. This was further supported by the down-regulation in strawberry flavor 
of lacA β-galactosidase, a component of lactose metabolism, and xynB, β-xylosidase, an 
enzyme responsible for the break down of xylose and xylooligosaccharides, compounds 
with potential as a bifidogenic prebiotic (Lagaert et al., 2011). Up-regulation of xynB has 
recently been identified as a key response of this B. lactis strain to its environment in the 
human body, raising the question whether modulating its expression in yogurt may have a 
positive effect on the strain once it enters the body (McNulty et al., 2011). Alternately, 
the gene most up-regulated in vanilla as compared to strawberry shares significant 
similarity with SalX, an antimicrobial peptide transport component. This is of interest 
since the vanilla flavoring agent is from natural sources and vanillin, the primary 
component in vanilla bean extract, possesses anti-microbial properties (Negishi et al., 
56 
 
2009). Influence of flavoring agents has been studied in both starter culture bacteria and 
probiotic strains (Vinderola et al., 2002). It was found that probiotic strains were often 
resistant to the effects of flavoring agents and indeed our work may highlight a potential 
mechanism through which this occurs. 
In culture, the half-life of total bacterial RNA has been estimated at 6.8 minutes (Selinger 
et al., 2003), thus the gene expression of probiotic bacteria in the small intestine or distal 
colon is surely different from in the yogurt. This being said, genes expressed in the 
yogurt will likely influence the ability of the bacteria to exert a probiotic effect. For 
example, if the organisms are already expressing factors for improved acid and bile 
tolerance they will have an increased chance of passing through the acidic stomach and 
bile filled early duodenum allowing viable bacteria to reach multiple parts of the 
intestinal tract to exert their effects. 
2.5 Conclusions 
Given that to our knowledge, no publications exist on the transcriptomes of yogurt 
bacteria post-fermentation, the intent of this research was to perform a pilot study to 
rigorously, and scientifically, apply RNA-Seq to study the yogurt metatranscriptome 
post-fermentation and see the possible impacts on the organisms. This study offers a 
method for others to examine how bacterial strains in fermented food adapt to flavor and 
storage. The findings do not necessarily imply that flavor and/or storage alter clinical 
effects, but they illustrate the potential to further refine yogurt as a valuable method of 
delivering health through probiotics. 
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Chapter 3  
3 Comparative genomics demonstrates production of 
volatile sulfur compounds in Lactobacillus paracasei 
and Lactobacillus rhamnosus is mediated by a novel 
sulfur/taurine metabolism gene cluster. 
This material in this chapter is currently under review at the International Journal of Food 
Microbiology as a short communication. 
Bisanz JE, van Hylckama Vlieg JET, Wels M, Smokvina T and G Reid. 
3.1 Introduction 
Flavor of many fermented milk products is determined by a complicated interaction of 
molecules acting in combination. In many fermented milk products including cheddar 
cheese, the actions of non-starter microorganisms, including lactobacilli, impart much of 
the characteristic flavor as a result of the amino acid metabolism (Weimer et al., 1999). 
One of the most important groups of compounds in cheese flavor formation is volatile 
sulfur compounds (VSCs), including hydrogen sulfide (H2S). These impart the often-
desired scent and flavor colloquially referred to as “rotting egg”, but in lower levels they 
are required for basic cheese flavor. The lactic acid bacteria-mediated production of H2S 
and other VSCs is of great interest for their role in this process. Some work has been 
undertaken to understand this phenomenon at the molecular level (Del Carmen Martínez-
Cuesta et al., 2013).  
In the carbohydrate-limited environment of fermented milk, proteolysis is a key 
metabolic pathway for lactobacilli. The resultant methionine and cysteine produced are 
the intermediates from which VSCs are formed (Del Carmen Martínez-Cuesta et al., 
2013). An operon known as cysK-ctl-cysE, has been reported to putatively encode a 
cysteine synthase, cystathionine lyase and serine acetyltransferase (Bogicevic et al., 
2012). Further studies have demonstrated O-acetylserine sulfhydrylase and cysteine 
desulfurization activity by CysK (Bogicevic et al., 2011), as well as cystathione lyase 
activity of ctl leading to the production of VSCs (Bogicevic et al., 2013). From 
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heterologous expression of these enzymes (Alting et al., 1995; Aubel et al., 2002; 
Bogicevic et al., 2011; Bruinenberg et al., 1997) it is clear that they function in VSC 
production, but the knockout of cystathionine lyases does not lead to a complete loss of 
activity (Lee et al., 2007). Thus, we sought to identify novel pathways implicated in VSC 
production. 
Our studies were primarily focused on screening a collection of sequenced L. rhamnosus 
and L. paracasei strains for tolerance to mercury and the results initially suggested that 
precipitation of mercury by hydrogen sulfide could be a potential mechanism of metal 
tolerance and remediation. This led us to further study the impact of the cysK-ctl-cysE 
operon in VSC production as it was found to be transcriptionally up-regulated by 
exposure to sublethal concentrations of mercury (data not shown). Given the sheer 
number of strains under study, a high-throughput, rapid, and economical method of 
screening for VSC production was required for which we adapted the method of Lee and 
Simard ( 1984). Briefly, when H2S/VSCs are produced by lactobacilli grown in agar 
stabs, a black/brown PbS precipitate is formed. 
The primary goal was to determine if under the assayed conditions, the presence of the 
cysK-ctl-cysE operon was sufficient for H2S/VSC production.  
3.2 Materials and Methods 
3.2.1 Strains and genomes 
A collection of 75 strains of L. paracasei and L. rhamnosus was obtained from the 
Danone strain collection (Danone Nutricia Research, Palaiseau, France). All strains were 
maintained on MRS agar medium (Becton Dickson and Company, Mississauga, Canada) 
and incubated at 37˚C under anaerobic conditions. Lactobacillus plantarum ATCC 14917 
was obtained from the ATCC as positive control as it had previously been shown to 
produce H2S/VSCs under the assayed conditions. These strains have already been 
sequenced by 454 GS FLX (Smokvina et al., 2013). Briefly, the predicted protein coding 
sequences were determined by consensus of Genemark (Borodovsky et al., 2002), 
Glimmer, ZCurve (Guo, 2003), and Prodigal (Hyatt et al., 2010). Using OrthoMCL (Li, 
2003) a presence/absence matrix was created for all potential strains. 
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3.2.2 Determination of H2S/VSC production 
The modified lead acetate agar media was adapted from that reported by Lee and Simard 
(Lee and Simard, 1984). The media contained: 5.0 g/L proteose peptone, 15.0 g/L 
peptone #3, 1.0 g/L dextrose, 80 mg/L sodium thiosulfate, 200 mg/L lead acetate, 0.1% 
v/v tween 80, 0.005% w/v MnSO4.4H2O, and 15 g/L agar. For phenotyping the strains, 
the medium was placed in 5 mL tubes, stab inoculated and incubated for 72h at 37˚C in 
anaerobic conditions to observe blackening of the media caused by the precipitation of 
PbS. 
3.2.3 Genomic analysis  
To identify the presence or absence of the cysK-ctl-cysE pathway, a BlastP (version 
2.2.28+) was carried out to identify the corresponding gene orthologs in the 
presence/absence matrix using the predicted protein sequences previously identified in L. 
casei FAM18149 (Genbank accessions JF272516, EU340836 and JF272515 
respectively). Statistical testing of the association of gene orthologs groups with 
production of VSCs/ H2S was carried out by Fisher’s exact test. 
To further study genes implicated in the production of VSCs/ H2S, matrices of gene 
presence/absence and phenotype were inputted into the random forest algorithm approach 
implemented in Phenolink (Bayjanov et al., 2012) with default settings. GC Skew was 
visualized with Artemis 14.0.0 and IVOM analysis was carried out with Alien hunter 1.7 
(Vernikos and Parkhill, 2006). To create a pan-genome tree, the strains were clustered 
based on gene presence/absence using the dist (binary method) and hclust (UPGMA) 
functions of R (r-project.org). 
3.3 Results and Discussion 
It was determined, with positive control L. plantarum ATCC 14917, that 24h incubation 
was insufficient to observe H2S/VSC production, but after 72h production could be 
observed. Incubation for 72h gave rise to three distinct phenotypes (Figure 3-1): strong 
H2S/VSC producers (positive reaction after 24h, complete blackening of media after 
72h), weak H2S/VSC producers including L. plantarum ATCC 14917 (positive reaction 
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after 72h) and non H2S/VSC producers (no positive reaction after 72h). H2S/VSC 
production was robustly assayed in all 75 strains in three independent assays revealing 
non-producers (n=45), weak producers (n=12) and strong producers (n=12) with few 
strains providing ambiguous results (n=6).  
Little correlation was observed between H2S/VSC production and the presence of cysK-
ctl-cysE (Table 3-1, p=0.49, Fischer’s exact) so gene-trait matching was carried out using 
a random forest algorithm approach which revealed 7 genes with the highest importance 
score (Figure 3-2). Upon closer inspection the cluster was revealed at the same 
chromosomal loci in each strain including L. casei Zhang (GenBank CP001084; 
159190..166381). This cluster was robustly associated with strong H2S/VSC production 
(p=1.8e-11, Table 3-1). The gene cluster’s organization and manually curated annotations 
are shown in Fig 3-3A while the heatmap in Fig 3-3B demonstrates its association with 
VSC production. The predicted functions of these genes involve the import and 
metabolism of sulfur and taurine. Many of the weak producers lack the downstream 
hypothetical protein of unknown function. There is a difference of 5.7% in GC content 
between in the gene cluster as compared to the remainder of the genome suggesting 
horizontal gene transfer (40.8% and 46.5% respectively). Additionally, application of 
interpolated variable order motif analysis provides evidence of horizontal gene 
acquisition. 
To study the distribution of the gene cluster across L. rhamnosus and L. paracasei, a pan-
genomic tree was created showing two major branches separating the L. rhamnosus 
strains (Lr) and L. paracasei strains (Lpp and Lpt). Strains containing at least 6/7 of the 
genes were indicated demonstrating that the gene cluster is uniformly distributed over 
both lineages independent of strain or internal node. Frequently, even in two strains with 
similar gene composition will be divergent in their possession of the cluster (ex. L. 
rhamnosus Lr52 and L. rhamnosus Lr35). Of note, the cluster was present in a mix of 
strains isolated from dairy, human/animal and plant environments. 
The strength of this study compared to other gene-trait matching studies, is in the large 
number of strains and genomes. This allowed us to confidently examine the relevance of 
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the cysK-ctl-cysE operon and discover potential new pathways. Clear evidence of a novel 
gene cluster involved in VSC production has been provided but the intention is not to 
claim that cysK-ctl-cysE is irrelevant to VSC production, rather to provide evidence of an 
additional pathway. It is conceded that there are superior methods for determining VSC 
production, such as GC-MS, but our assay provided clear phenotypic traits allowing us to 
demonstrate that cysK-ctl-cysE is not the only pathway for H2S production present in L. 
paracasei and L. rhamnosus. 
The functions of the genes are putative and remain to be validated but the presence of 
domains relating to sulfur transport and metabolism offers interesting insights into 
potential mechanisms of action. The putative tauB and tauC genes are notable 
considering that taurine is a sulfur containing amino acid and high levels of taurine are 
found in many dairy products (Manzi and Pizzoferrato, 2013). In addition, taurine 
metabolism is related to methionine and cysteine metabolism. The putative pyridine 
nucleotide-disulfide oxidoreductase may be part of the H2S-forming pathway, perhaps 
together with the hypothetical protein. 
In summary, we identified a novel gene cluster involved in the formation of VSCs which 
has been previously unreported in Lactobacillus spp. Future studies are warranted to 
determine the function of these proteins in situ, in particular how they affect flavors in 
cheese.  
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Figure 3-1. VSC production phenotypes observed after 72 h incubation at 37˚C.  
The	  dark	  precipitate	  formed	  is	  the	  result	  of	  lead	  acetate	  precipitated	  with	  volatile	  sulfur	  
compounds	  to	  form	  PbS.	  
  
Strong Positive
Weak Positive
Negative
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Table 3-1. Co-occurrence of the cysK-ctl-cysE operon and newly identified sulfur 
transport/utilization cluster with VSC production.  
  
cysK-ctl-cysE 
 
Sulfur Transport 
Cluster1 
H2S/VSC Production 
 
Present Absent 
 
Present Absent 
Strong 
 
2 10 
 
12 0 
Weak 
 
4 8 
 
2 10 
Negative 
 
13 32 
 
1 44 
1Presence/absence of all 7 identified gene orthologs 
                                           
Figure 3-2. Results of gene trait matching demonstrate 7 gene orthologs with 
increased importance as identified by a random forest algorithm based approach. 
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Figure 3-3. Identification of 7-gene locus in L. rhamnosus Lr9 and L. casei Zhang 
(A) and its co-occurrence with VSC production represented in heat map form (B). 
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Figure 3-4. Pan-genome tree of strains studied with strains possessing at least 6/7 of 
the identified gene orthologs indicated in red. 
 
3.4 Acknowledgements/funding 
This work was funded by Danone Research. JEB is the recipient of a Natural Sciences 
and Engineering Council of Canada Doctoral Scholarship. The strains under study are the 
property of Danone Research and both TS and JETvHV were employees of Danone 
during the time of the studies being carried out. 
 
Lr
14
0
Lr
40
Lr
71
Lr
79
Lr
90
Lr
82
Lr
13
4
CN
CM
 I-
43
17
CN
CM
 I-
36
90
Lr
11
0
Lr
74
Lr
64
CN
CM
 I-
24
93
Lr
9
Lr
10
8
Lr
75
Lr
52
Lr
35
Lr
14
1
Lr
13
9
Lr
13
7
CN
CM
 I-
43
16
Lr
11
1
Lr
60
CN
CM
 I-
42
71
Lr
37
Lr
13
3
Lr
53
Lr
95
Lr
73
Lr
91
Lr
13
6
Lr
92
Lr
23
Lr
13
8
Lr
32
Lr
28
Lp
p4
1
Lp
p1
26
Lp
p4
8
Lp
p7
1
Lp
p1
4
Lp
p7
0
Lp
p7
CN
CM
 I-
46
48
Lp
p2
27 Lp
p1
23
CN
CM
 I-
42
70
CN
CM
 I-
46
49
Lp
p1
22
Lp
p5
7
Lp
p2
26
Lp
p2
23
CN
CM
 I-
15
18
Lp
p2
06
Lp
p4
6
Lp
p2
25
Lp
p2
2
Lp
p1
20
CN
CM
 I-
36
89
Lp
p2
21
Lp
p4
3
Lp
t1
4
Lp
t7
Lp
p7
4
Lp
p2
19
Lp
p2
30
Lp
p2
29
Lp
p3
7
Lp
p1
25
Lp
p4
9
Lp
p2
28
Lp
p1
89
CN
CM
 I-
28
77
Lp
p2
51
0.0 0.1
71 
 
3.5 References 
Alting AC, Engels W, van Schalkwijk S and FA Exterkate. 1995. Purification and 
characterization of cystathionine beta-lyase from Lactococcus lactis subsp. cremoris B78 
and its possible role in flavor development in cheese. Applied and Environmental 
Microbiology 61:4037–4042. 
Aubel D, Germond J and C Gilbert. 2002. Isolation of the patC gene encoding the 
cystathionine beta-lyase of Lactobacillus delbrueckii subsp. bulgaricus and molecular 
analysis of inter-strain variability in enzyme biosynthesis. Microbiology 148:2029-2036. 
Bayjanov JR, Molenaar D, Tzeneva V, Siezen RJ and SA van Hijum. 2012. PhenoLink - 
a web-tool for linking phenotype to ~omics data for bacteria: application to gene-trait 
matching for Lactobacillus plantarum strains. BMC Genomics 13:170. 
Bogicevic B, Berthoud H, Portmann R, Meile L and S Irmler. 2011. cysK from 
Lactobacillus casei encodes a protein with O-acetylserine sulfhydrylase and cysteine 
desulfurization activity. Applied Microbiology and Biotechnology 94:1209–1220. 
Bogicevic B, Fuchsmann P and K Breme. 2013. A preliminary study on the effect of 
Lactobacillus casei expressing cystathionine lyase1/cystathionine lyase2 on Cheddar 
cheese and the formation of sulphur-containing compounds. International Dairy Journal 
33:97-103. 
Bogicevic B, Irmler S, Portmann R, Meile L and H Berthoud. 2012. Characterization of 
the cysK2-ctl1-cysE2 gene cluster involved in sulfur metabolism in Lactobacillus casei. 
International Journal of Food Microbiology 152:211–219. 
Borodovsky M, Mills R, Besemer J and A Lomsadze. 2002. Prokaryotic gene prediction 
using GeneMark and GeneMark.hmm. Current Protocols in Bioinformatics 1:3.5:4.5.1-
4.5.16 
Bruinenberg PG, De Roo G and G Limsowtin. 1997. Purification and characterization of 
cystathionine gamma-lyase from Lactococcus lactis subsp. cremoris SK11: possible role 
72 
 
in flavor compound formation during cheese maturation. Applied and Environmental 
Microbiology 63:561–566. 
Del Carmen Martínez-Cuesta M, Peláez C and T Requena. 2013. Methionine 
metabolism: major pathways and enzymes involved and strategies for control and 
diversification of volatile sulfur compounds in cheese. Critical Reviews in Food Science 
and Nutrition 53:366–385. 
Guo FB. 2003. ZCURVE: a new system for recognizing protein-coding genes in bacterial 
and archaeal genomes. Nucleic Acids Research 31:1780–1789. 
Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW and LJ Hauser. 2010. Prodigal: 
prokaryotic gene recognition and translation initiation site identification. BMC 
Bioinformatics 11:119. 
Lee BH and RE Simard. 1984. Evaluation of methods for detecting the production of 
H2S, volatile sulfides, and greening by lactobacilli. Journal of Food Science 49:981–983. 
Lee WJ, Banavara DS, Hughes JE, Christiansen JK, Steele JL, Broadbent JR and SA 
Rankin. 2007. Role of cystathionine beta-lyase in catabolism of amino acids to sulfur 
volatiles by genetic variants of Lactobacillus helveticus CNRZ32. Applied and 
Environmental Microbiology 73:3034–3039. 
Li L. 2003. OrthoMCL: Identification of ortholog groups for eukaryotic genomes. 
Genome Research 13:2178–2189. 
Manzi P and L Pizzoferrato. 2013. Taurine in milk and yoghurt marketed in Italy. 
International Journal of Food Sciences and Nutrition 64:112–116. 
Smokvina T, Wels M, Polka J, Chervaux C, Brisse S, Boekhorst J, van Hylckama Vlieg 
JET and RJ Siezen. 2013. Lactobacillus paracasei comparative genomics: towards 
species pan-genome definition and exploitation of diversity. PLoS ONE 8:e68731. 
73 
 
Vernikos GS and J Parkhill. 2006. Interpolated variable order motifs for identification of 
horizontally acquired DNA: revisiting the Salmonella pathogenicity islands. 
Bioinformatics 22:2196–2203. 
Weimer B, Seefeldt K and B Dias. 1999. Sulfur metabolism in bacteria associated with 
cheese. Antonie Van Leeuwenhoek 76:247–261. 
 
 
 
74 
 
Chapter 4  
4 A systems biology approach investigating the effect of 
probiotics on the vaginal microbiome and host 
responses in a double-blind, placebo-controlled clinical 
trial of post-menopausal women 
The chapter is reproduced with permission (Appendix B): 
Bisanz JE, Seney S, McMillan A, Vongsa R, Koenig D, Wong L, Dvoracek B, Gloor GB, 
Sumarah M, Ford B, Herman D, Burton JP and G Reid. 2014. A systems biology 
approach investigation the effect of probiotics on the vaginal microbiome and host 
responses in a double-blind, placebo-controlled clinical trial of post-menopausal women. 
PLoS One 9:e104511. 
Supporting figures and tables (identified as S#) are available online at: 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0104511#s5 
Ethics approval documentation is provided in Appendix E 
4.1 Introduction 
The vaginal microbiota is a dynamic ecosystem that is usually mono dominated by the 
Lactobacillus genus in times of health but it can transform quickly to a dysbiotic state 
where a range of microorganisms rise in prominence and cause the polymicrobial 
bacterial vaginosis (BV) (Ma et al., 2012). The pre-menopausal vaginal microbiota and 
its constituents have been extensively studied using genome sequencing, 16S rRNA 
community profiling and RNA-seq based meta-transcriptomics (Macklaim et al., 2011; 
Ravel et al., 2011; Hummelen et al., 2010b; Macklaim et al., 2013). However, until 
recently, few studies have used similar in-depth methods to decipher the vaginal 
microbiome of post-menopausal women, despite its impact on quality of life (Santoro and 
Komi, 2009; Nappi and Lachowsky, 2009). In previous studies, we have shown using 
high-throughput sequencing methods that contrary to conventional knowledge (Cauci et 
al., 2002), the vaginal microbiome of post-menopausal women is not significantly 
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different from that of pre-menopausal women (Hummelen et al., 2011). Our study 
showed that the post-menopausal vagina appeared to have greater stability than the 
rapidly fluctuating pre-menopausal microbiome (Hummelen et al., 2011; Gajer et al., 
2012) presumably due to a lack of hormone cycling. We found that similar to 
premenopausal women, the healthy post-menopausal vaginal microbiome is dominated 
by a combination of Lactobacillus iners and L. crispatus while BV-associated organisms 
such as Gardnerella vaginalis and Atopobium vaginae are increased in states of dysbiosis 
(Hummelen et al., 2011; Burton and Reid, 2002; Burton et al., 2003). Despite some 
deficiencies, Nugent scoring is still the standard technique in most research and clinical 
settings to rapidly diagnose bacterial vaginosis (Nugent et al., 1991). The score is 
calculated by microscopic examination of a Gram-stained vaginal smear and numeration 
of cell morphotypes to assign a score from 0 to 10 where 0-3 is considered normal, 4-6 is 
intermediate and 7-10 is BV (Nugent et al., 1991). The intermediate scores are 
particularly interesting as they indicate a risk of transition to BV, or they could be a state 
that reverts to a healthy lactobacilli dominated microbiota.  
Given vaginal contact with sanitary products by menstruating women and the large 
proportion of postmenopausal women whom suffer urinary incontinence requiring 
products such as incontinence pads, also in proximity to the vagina, these products may 
offer a vehicle to deliver a prophylactic probiotic to women that routinely suffer BV or 
urinary tract infections. We were interested to determine whether the microbiota and 
Nugent scores were altered by the administration of probiotics with the potential view of 
perhaps instilling these organisms in such products. Lactobacillus rhamnosus GR-1 and 
Lactobacillus reuteri RC-14 used in this prospective study are well-characterized 
probiotic strains used in combination to prevent and treat BV (Anukam et al., 2006; Reid 
et al., 2003; Martinez et al., 2009; Hummelen et al., 2010a). In addition to clinical and 
Nugent scoring, 16S rRNA sequencing was used to examine changes in the microbiota, 
GC-MS profiled metabolome changes, the host transcriptional responses were tested 
using an Affymetrix microarray and inflammatory mediators by multiplex cytokine 
analysis. This approach was designed to provide a holistic understanding of the probiotic-
microbiota-host interactome (Bisanz and Reid, 2011). 
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4.2 Results 
4.2.1 Participant recruitment and demographics 
A total of 22 subjects were screened and 14 participants were enrolled into a 129-day 
prospective double-blind, cross-over placebo controlled study (design in Figure S1). A 
CONSORT flow diagram is displayed in Figure 4-1. 
 
Figure 4-1. CONSORT flow diagram. 
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4.2.2 Clinical outcomes 
Nugent score and vaginal pH measurements (data not shown) were taken before and after 
treatment with the probiotic and placebo. Table 4-1 shows there were no statistically 
significant improvement in Nugent scores between the treatment groups. Furthermore no 
statistical differences were observed in vaginal pH measurement. 
Table 4-1. Summary of Nugent score change - Proportion of improvement from 
baseline 
 Placebo  
 Improved1 Not Improved p-value2  
       
One-Day after last Test Article Use Probiotics: Improved 0 2(20%) 0.1573  
  Not Improved 0 8(80%)   
       
Eight-Days after last Test Article 
Use 
Probiotics: Improved 0 2(20%) 0.5637  
  Not Improved 1(10%) 7(70%)   
       
1Improvement in Nugent Score:  indicated by shift of intermediate score (4-6) at baseline to normal score (0-3) at 
follow-up visits. Baseline Nugent score for study Phase-I was collected at visit 3, and baseline Nugent score for study 
Phase-II was collected at visit 6. 
2p-value is based on McNemars test to determine results of cross-over treatment regimen.  
 
 
4.2.3 Microbiome profiling 
Sequences were successfully obtained for 104 of 106 samples with the mean number of 
reads being 33,396 (range 1,475 to 223,629) across 3 separate 316 Ion Torrent 
Sequencing Chips. A total of 221 Operational Taxonomic Units (OTUs) were defined 
with clustering at 97% identity (Table S1) at a minimum abundance of 1% in any one 
sample. A no template control was also sequenced and high-abundance contaminating 
sequences were filtered out in silico before OTU assignment. 
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Figure 4-2 shows a heat map of the 50 most abundant OTUs across all samples and time 
points. We were able to identify 2 OTUs which were assigned presumptive strain 
designations to L. rhamnosus GR-1 and L. reuteri RC-14 (OTU_12 and OTU_23 
respectively) based upon 100% ID matches to the 16S rRNA gene of private genome 
assemblies of these strains. A separate heat map was created showing only the abundance 
of these two OTUs compared to all other OTUs detected (Figure S2). Furthermore with 
one notable exception (participant 19), these strains only appeared in combination 
following the probiotic treatment period. In the case of participant 19 however, the 
proportion of reads is still quite low (2.1% and 0.1%) for both OTUs. The L. rhamnosus 
GR-1 is far more abundant than the L. reuteri which may suggest it was a L. casei group 
member other than the GR-1 used in the study as this group has high sequence homology, 
especially in the V6 16S rRNA region (Vasquez et al., 2005). In one individual 
(participant 09) both probiotic strains were detected even though only placebo should 
have been received. The probiotic strains could be unambiguously detected after 
probiotic treatment in 7 of 12 cases (04, 10, 15, 16, 17, 18, 21), which we termed 
responders. While in the non-responders (12, 14, 19, 05 and 07) the probiotic strains were 
not detected after the probiotic treatment. The abundance of L. rhamnosus GR-1 did 
appear to increase over the study period in participant 12, which may suggest temporary 
persistence or colonization. In all other cases, the probiotics were only detected in high 
abundance immediately after the treatment suggesting that the washout period chosen for 
the study was appropriate.  
Samples were clustered based upon unweighted pair group method with arithmetic mean 
(UPGMA) using weighted UniFrac distance metrics (Lozupone and Knight, 2005) 
showing that participants were generally most similar to themselves over the study period 
and as we had previously shown, the post menopausal vaginal microbiome is more stable 
than that of pre menopausal women (Figure 4-3).  
All samples were plotted on a PCoA using weighted Unifrac distances and overlaid with 
the contributions of the 20 most abundant genera (Figure S3). This shows 3 weak 
groupings, one dominated by Lactobacillus, another defined by Atopobium and 
Gardnerella, and a third defined by a large number of diverse genera. 
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Data were summarized to genus level and the relative abundance of Lactobacillus was 
considered. Increase in total Lactobacillus is significant (Figure 4-4; FDR<0.05) 
following probiotic administration though there is no significant difference in Shannon’s 
diversity index (p=0.25, Wilcoxon signed-rank test). After probiotic administration, the 
proportion of total lactobacilli increased in all participants except participant 19 who 
appears to have had an indigenous L. casei/rhamnosus present. Even those without 
significant detection of the probiotic lactobacilli have an increase in indigenous 
lactobacilli (fold increases for the ambiguous participants are 1.27, 1.21, 2.35, 14.43 and 
52.43). Additionally, in some cases, such as participant 17 (Figure 4-5), it is not only the 
probiotics that increased in proportional abundance, but also indigenous lactobacillus 
such as L. gasseri/johnsonii, (p=0.011 across all samples) which is not significant in the 
placebo group if the case of participant 09 is excluded (where probiotic appears to have 
been received rather than placebo). In the 7 individuals where the probiotics could be 
easily detected, the average fold increase was 120 fold (range 3.2 to 389). Significant 
decreases in the proportion of Atopobium were also observed after probiotic treatment 
with a trend of reduction of Gardnerella and Prevotella. Interestingly the placebo appears 
to have increased the proportion of Streptococcus (FDR<0.01) while both applications 
appear to have increased levels of Staphylococcus.  
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Figure 4-2. Microbiota heat map.  
Each	  column	  represents	  the	  microbiota	  of	  a	  single	  sample	  with	  the	  50	  most	  abundant	  OTUs	  
displayed	  with	  their	  taxonomies	  and	  the	  remainder	  pooled.	  Samples	  are	  clustered	  by	  the	  
participant	  of	  origin	  and	  organized	  from	  first	  to	  last	  visit	  from	  left	  to	  right.	  The	  time	  points	  
immediately	  following	  administration	  of	  the	  placebo	  or	  probiotic	  are	  indicated	  with	  a	  blue	  or	  
green	  arrow	  (respectively).	  OTUs	  representing	  the	  putative	  OTUs	  for	  L.	  rhamnosus	  GR-­‐1	  and	  L.	  
reuteri	  RC-­‐14	  have	  been	  bolded.	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Figure 4-3. UPGMA clustering of all participants microbiota based upon weighted 
UniFrac distances.  
In	  general,	  participants	  cluster	  most	  closely	  with	  themselves.	  Tree	  tips	  (samples)	  are	  colored	  by	  
the	  participant	  of	  origin.	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Figure 4-4. Selected genus relative abundances following probiotic and placebo 
interventions.  
(A)	  Lactobacillus,	  (B)	  Gardnerella,	  (C)	  Atopobium,	  (D)	  Prevotella,	  (E)	  Streptococcus,	  (F)	  
Staphylococcus.	  Following	  probiotic	  administration	  for	  3	  days,	  the	  proportion	  of	  Lactobacillus	  is	  
significantly	  increased	  while	  that	  of	  Atopobium	  is	  decreased	  and	  Staphylococcus	  is	  increased.	  
Placebo	  interventions	  increased	  Streptococcus	  and	  Staphylococcus	  abundance.	  	  
*FDR<0.1,	  **FDR<0.05,	  ***FDR<0.01	  
83 
 
     
Figure 4-5. Time series of participant 17. 
During	  the	  administration	  of	  probiotic	  between	  visits	  6	  and	  7,	  the	  abundance	  of	  lactobacilli	  
significantly	  increases,	  decreasing	  the	  proportional	  abundance	  of	  both	  Atopobium	  and	  
Gardnerella.	  This	  increase	  is	  not	  due	  solely	  to	  the	  probiotic	  strains	  as	  a	  significant	  increase	  in	  
indigenous	  L.	  gasseri/johnsonii	  takes	  place.	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4.2.4 Metabolome 
Using GC-MS, 68 metabolites were detected and a heat map is displayed in Figure S4. 
The Pearson’s correlation coefficient between lactate and lactate producing bacteria was 
0.47 (p<0.001), indicating a weak positive correlation (Figure S5). Among those who 
responded to probiotic intervention and had sufficient material for metabolomics analysis 
(n=4), there was an increase in lactate levels (p = 0.13), whereas there tended to be a 
decrease with placebo (p = 0.23). There was no difference in the overall metabolome of 
all subjects after probiotic or placebo intervention (Figures S6A and S6B respectfully), 
nor was there a significant difference in any one metabolite. It is worth noting that low 
yields of metabolites were obtained from some of the collected swabs so lower 
abundance analytes may not be detectable. 
4.2.5 Cytokine/chemokine analysis 
Interleukin 5 (IL-5) was found to be significantly up-regulated following probiotic 
treatment but not following placebo treatment. In other cytokines such as IL-1B, IL-6, 
TNFa and GM-CSF there were weak positive trends in increase of cytokine levels, 
however this was also observed in the placebo in some cases (Figure S7). 
4.2.6 Microarray 
Due to limited yield from RNA samples, only 2 complete sample sets (before and after 
intervention from the same individual, 4 arrays) were obtained from the probiotic 
intervention and 3 sets from the placebo intervention (6 arrays). Each sample was 
analyzed on its own Affymetrix Human Gene 2.0 ST array. Using a paired t-test design to 
account for paired-samples before and after probiotic administration, 90 probe sets were 
detected as being differentially expressed (≥2 fold change, p<0.05) of which 57 were 
coding genes or long non-coding RNA (a new feature of the Affymetrix 2.0 ST array) 
(Table S2A). Two of these were differentially regulated in both conditions (gene list 
differentially regulated by placebo is displayed in Table S2B), ANKRD20A5P 
psuedogene (ID cluster 16851230) and a long non-coding RNA (ID cluster 16851230) 
with no known biological significance.  
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Many genes of interest were differentially expressed by probiotic treatment including 
Interleukin 18 (IL18; -2.5 fold after probiotic), CR1-complement receptor (CR1; 10.4 
fold), Caspase 14 (CASP14; 5.3 fold, previously observed to function in epithelial 
development and barrier function (Denecker et al., 2008)) and Toll like receptor 2 
(TLR2; 3.84 fold) (Table S2A). To look at functional consequences, GO enrichment was 
applied showing the most highly affected functions to be pattern recognition receptor 
activity, complement receptor activity, inflammatory response and gram-positive 
bacterial cell surface binding (Table 4-2). This was mirrored in the Ingenuity Pathway 
Analysis (Figure S8). In comparison, the placebo appears to have acted on functions 
related to epithelial cell differentiation, similar to our previous study (Hummelen et al., 
2011). 
Table 4-2. Gene Ontology Enrichment in genes differentially expressed by probiotic 
intervention.  
Genes	  differentially	  expressed	  (≥2-­‐fold	  change,	  p<0.05)	  were	  subjected	  to	  GO	  enrichment	  
analysis.	  Functions	  heavily	  relate	  to	  innate	  immune	  system	  responses	  including	  responses	  to	  
both	  Gram-­‐positive	  and	  Gram-­‐negative	  bacteria.	  
Function 
Enrichment 
Score 
Enrichment 
p-value # genes in list % genes in group GO ID 
Pattern Recognition Receptor Activity 12.82 2.71E-06 3 18.75 8329 
Complement Receptor Activity 10.9319 1.79E-05 2 50 4875 
Inflammatory Response 10.4433 2.91E-05 6 1.70455 6954 
Gram-positive Bacterial Cell Surface Binding 10.4222 2.98E-05 2 40 51637 
LPS Receptor Activity 10.4222 2.98E-05 2 40 1875 
Defense Response 9.64889 6.45E-05 9 0.840336 6952 
Regulation of GM-CSF Production 8.92362 1.33E-04 2 20 32645 
Positive Regulation of Response to External Stimulus 8.83166 1.46E-04 4 2.5974 32103 
Response to Wounding 8.61585 1.81E-04 6 1.22449 9611 
Positive Regulation of Inflammatory Response 8.25985 2.59E-04 3 4.22535 50729 
 
86 
 
4.3 Discussion 
In this study, we aimed to evaluate the effect of 3 days of vaginal administration of L. 
rhamnosus GR-1 and L. reuteri RC-14 on the Nugent score of post-menopausal women 
as well as effects on the microbiota, metabolome and host. As the subjects under study 
had no symptoms of disease, not unexpectedly, the probiotic prophylaxis did not cause 
any clinical changes. There were no adverse effects of the probiotic therapy. The 
probiotic administration resulted in a temporary increase in the relative proportion of 
Lactobacillus in the vagina, which for women whose intermediate score tends to be a 
predecessor for BV, may help prevent or delay this transition. The near absence of L. 
crispatus (OTU_198), detected in only 1 of 15 women above a 1% threshold and 
throughout the study at maximum 1.4%, may indicate that the subjects were at a higher 
risk of BV, since L. crispatus is thought to play a protective role in maintaining the 
vaginal microbiota (Verstraelen et al., 2009). 
The increase in lactobacilli and potential decreases in BV-associated organisms such as 
Atopobium following probiotics could have been due to displacement of the host’s 
microbes with the total bacterial load remaining the same; or the total bacterial load 
increased as a result of adding in exogenous lactobacilli. The observation that Shannon’s 
diversity is not affected by probiotic instillation favors the second option. It is interesting 
to note the increased relative abundance of Staphylococcus as a result of placebo 
treatment, which may be the result of the antimicrobial actions of titanium dioxide used 
in the preparation. It is important to note that the probiotics may create an environment 
conducive to indigenous lactobacilli such as L. gasseri and L. johnsonii, however this 
effect may be short lived. A longer treatment time and follow-up might have determined 
if there was an effect on diversity, but we were interested in whether a short term 
probiotic application that women might find easy to administer monthly, could increase 
the lactobacilli count.  
In some individuals it was extremely clear when the probiotic strains had been applied. 
The reason for this not being universal is unclear, but could be due to a particularly 
resilient indigenous microbiota or women who were non-responders for unexplained 
reasons (Reid et al., 2010).  
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We identified a positive correlation between lactate abundance and percentage of lactate 
producers present r=0.43 (p=9.6x10-6). Although this correlation seems intuitive, to our 
knowledge it has never been directly shown. Only the relative abundance of bacterial taxa 
are measured, and therefore absolute changes affected lactate levels cannot be directly 
observed.  Certain species of Lactobacillus have been associated with lower pH and may 
produce more lactate compared to others (Ravel et al., 2011). There was a trend towards 
an increase in lactate after probiotic and decrease after placebo intervention, but as there 
were only four women whom responded to treatment and from whose samples enough 
material for metabolite analysis could be extracted, the sample size is likely too small to 
reach significance. Still, the observation that probiotics could potentially increase lactate 
levels is promising as lactate has been shown to have many beneficial properties in the 
vaginal tract such as HIV inactivation (Aldunate 2013). 
Overall, the administration of the two lactobacilli strains did not induce any more 
changes than placebo in the metabolome, but lack of material makes this result 
inconclusive. In our experience and that of others, the metabolomic patterns differ 
between health and BV, with the latter showing odorous compounds such as cadaverine 
and putrescine, but these trends were not clearly observed in this study (Yeoman et al., 
2013). 
In addition to looking at the bacterial communities, we sought to examine host responses 
to probiotic treatment. It has been well established that probiotic strains can affect host 
transcription in the gut in a strain specific manor (van Baarlen et al., 2011) but this is the 
first time similar studies have been carried out in the vagina. Our findings show that L. 
rhamnosus GR-1 and L. reuteri RC-14 had an immunomodulatory effect working on 
important central inflammatory mediators complement receptor 1, toll like receptor 2 and 
IL-18. Though limited in the number of subjects available for analysis, the strength of 
this analysis is the use a paired study design. Interleukin 18 is a proinflammatory 
cytokine inducing cell-mediated immunity via interferon gamma though it also has 
effects on B cells and IgE production (Biet et al., 2002). In the female reproductive tract 
it may be of relevance in preterm birth (Jacobsson et al., 2003) indicating microbial 
invasion of the amnion, but it also has protective roles against genital herpes simplex 2 
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(Harandi et al., 2001). The effect of probiotic treatment on IL-18 expression may not be a 
direct interaction, but rather indicative of anti-viral actions of the probiotics resulting 
which has previously been hypothesized and shown in vitro (Aldunate et al., 2013; 
Bolton et al., 2008). Alternatively it may reflect a general up-regulation of the innate 
immune system by the probiotic strains. Unfortunately, our cytokine/chemokine panel did 
not cover IL-18 to help support this finding. Alternatively the up-regulation, of 
complement receptors 1 and 3a, as well as TLR2 both are indicative of increased anti-
bacterial innate immune system activity. TLR2 specifically is involved in detection of 
Gram-positive surface markers (including lactobacilli) (Schwandner et al., 1999) while 
the complement receptors are important for phagocytosis and inflammatory cascades in 
response to bacterial infections (Zipfel and Skerka, 2009). L. plantarum has previously 
been shown to modulate TLR2 expression which may play a role in modifying infection 
response (Rizzo et al., 2013). In addition, our cytokine/chemokine multiplex results may 
indicate the up-regulation of interleukin 5 which is most commonly associated with 
eosinophil activation (Molfino et al., 2012). Though commonly associated with parasites, 
eosinophils have also been associated with Actinomyces-like organisms in the urogenital 
tract and may display some activity against bacterial infection (Kaya et al., 2012). These 
seemingly pro-inflammatory responses may be beneficial in aiding the host immune 
system to help clear BV-associated pathogens to restore a more normal microbiota of 
symbionts. Microarray analysis failed to corroborate the finding that interleukin 5 was 
up-regulated, however the two individuals surveyed by microarray did not show up-
regulation by cytokine analysis either. If all participants could have been surveyed this 
result may have been different. 
Interestingly, caspase 14 plays a role in development and barrier function of the 
epidermis (Denecker et al., 2008) and we had previously observed its differential 
regulation associated with vaginal dryness and dysbiosis in a subset of post-menopausal 
women. Its up-regulation following probiotic treatment may be evidence of improvement 
in strength and integrity of the vaginal epithelium, though further research is needed to 
verify this claim. Indeed probiotics are thought to positively act on barrier function 
(Sultana et al., 2013). 
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In conclusion, this study demonstrated the use of a systems-wide interactomics approach 
to examine how probiotic application might modulate the vagina in post-menopausal 
women. The short duration therapy increased the lactobacilli, as well as modulating 
inflammatory markers. As the transition from healthy to intermediate to BV is such a 
common occurrence, women may feel that a three day intravaginal probiotic may be 
beneficial. A larger study is needed to support this, but the present study showed no harm 
and the potential for such a benefit.   
 
4.4 Methods 
4.4.1 Participant recruiting and study design 
The protocol for this trial and supporting CONSORT checklist are available as supporting 
information; see Checklist S1 and Protocol S1. A total of fourteen post-menopausal 
women were enrolled in the study from a clinical site in Ontario, Canada. Inclusion 
criteria were individuals with an intermediate Nugent Score (4-6) who were post-
menopausal (40 to 80 years old, not having had a menstrual period for the last 12 months, 
currently in a mutually monogamous sexual relationship or not sexually active, agreeing 
to be abstinent 72 hours prior to each study visit and agreeing to refrain from intercourse 
for 48 hours after treatment, agreeing to abstain from use of other intravaginal products 
throughout the study and in good general health. Exclusion criteria were use of 
intravaginal products within three months prior to visit 1, a history of immunosuppressive 
drug therapy, chemotherapy or radiation therapy, a medical condition which might 
compromise immune system function (ex. cancer, leucopenia, HIV, organ transplant), 
antibiotic and/or antifungal medication within the last 4 weeks, oral probiotic use within 
3 months prior to visit 1, significant changes in diet during the course of the study (based 
on self report), induced menopause due to surgical/medical intervention (ex. 
hysterectomy), currently taking estrogen therapy, a history of drug or alcohol abuse,  
known allergy to either of the probiotic strains or product excipients and participation in a 
clinical trial involving an investigational product/device within the past three months or 
who are scheduled to participate in another clinical study concurrently. No formal sample 
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size calculation was carried out and the number of subjects to be randomized was based 
on feasibility and practical considerations for an exploratory study. The study was 
approved by Health Canada (Clinical Trial Application File No. 180061) and is registered 
with clinicaltrials.gov under accession number (NCT02139839). 
The study design is diagramed in Figure S1. Briefly, after obtaining written informed 
consent, participants were enrolled on day one and subsequently returned for baseline 
appointments on days 5 and 15 (visits 2 and 3 respectively). On visit 3, the participants 
were randomized to either receive 3 days of L. rhamnosus GR-1/L. reuteri RC-14 
probiotic (Chr. Hansen, minimum 2.5x109 CFU of each strain) or visually identical 
placebo (49mg Gelatin and 1mg titanium dioxide) self-administered by having the 
participant insert the capsule as far as comfortable into their vagina and then lying in a 
horizontal position for 15 minutes. Randomization was carried out using a random 
number generator. Both study staff and study participants were blinded as to the study 
treatment being given. The capsules were to be administered twice a day for 3 days with 
the participant returning on the fourth day for sampling. A feminine hygiene pad was 
applied for several hours after capsule implantation. There was then a 17 day washout 
period with sampling again at day 26. At day 36 participants were again sampled, 
individuals who received probiotic in the first treatment period then received placebo and 
vice versa. On day 40, participants returned for sampling after the treatment period and 
were followed up with on day 47 and again on day 129, only if they had positive culture 
results for the presence of the probiotic. At all visits, 5 swabs were collected: (i) Dacron 
swab for bacterial DNA extraction, (ii) Dacron swab for multiplex cytokine/chemokine 
analysis, (iii) Dacron swab for metabolomics analysis, (iv) a cytobrush (Cytobrush plus 
GT, Cooper Surgical Inc. USA) brushed against the vaginal wall and stored in 700 µL 
RNAlater for total RNA extraction (Life Technologies), and (v) Dacron swab for Nugent 
Score. McNemar’s test was applied to examine changes in Nugent score and other 
symptoms. 
4.4.2 Microbiome profiling 
Vaginal swabs for microbiome analysis were extracted using the QIAamp DNA stool 
mini kit (Qiagen). Swabs were vortexed in 1 mL buffer ASL before removal of the swab 
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and addition of 0.1mm zirconia/silica beads (Biospec Products) with 2, 30 second rounds 
of bead beating at full speed with cooling on ice in between (Mini-BeadBeater; Biospec 
Products). Sample amplification for sequencing was carried out using the forward primer 
(CCATCTCATCCCTGCGTGTCTCCGACTCAGxxxxxCWACGCGARGAACCTTAC
C) and the reverse primer 
(CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC) where xxxxx was 
a sample specific nucleotide barcode, the 5’ end is the adapter sequence for the Ion 
Torrent sequencer and the sequences following the barcode are complementary to the V6 
rRNA region. Amplification was carried out in 42 µL with each primer present at a 10µL 
(3.2 pMol/µL stock), 20 µL GoTaq hot start colorless master mix (Promega) and 2 µL 
extracted DNA. The PCR protocol was as follows: initial activation step at 95˚C for 2 
minutes and 25 cycles of 1 minute 95˚C, 1 minute 55˚C and 1 minute 72˚C. PCR 
products were quantified with a Qubit 2.0 Flourometer and the high sensitivity dsDNA 
specific fluorescent probes (Life Technologies). Samples were mixed at equimolar 
concentrations and purified with the QIAquick PCR Purification kit (QIAGEN). 
All subsequent work was carried out at the London Regional Genomics Centre (LRGC, 
lrgc.ca, London, Ontario, Canada). Briefly, samples were prepared with an Ion OneTouch 
System (Life Technologies) and sequenced on an Ion Torrent Personal Genome Machine 
sequencer on a 316 chip (Life Technologies).  
Resulting Reads were extracted and de-multiplexed using modifications of in-house perl 
and unix-shell scripts (Hummelen et al., 2011) with OTUs clustered at 97% identity. 
Table S3 displays the nucleotide barcodes and it’s corresponding sample. Reads were 
deposited to the Short Read Archive (BioProject ID: PRJNA244441). To control for 
background contaminating sequences, a no-template control was also sequenced, and any 
individual sequence unit belonging to an OTU present at ≥1% abundance in the NTC was 
removed before re-clustering with uclust 3.0.612. 
Automated taxonomic assignments carried out by examining best hits from comparison 
the Ribosomal Database Project (rdp.cme.msu.edu) and manually curated as before 
(Hummelen et al., 2011). 
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Alpha and beta-diversity analysis were made using the OSX distribution of QIIME 
(MacQIIME 1.70, wernerlab.org/software/macqiime). OTU tables were rarified to 1060 
reads for all analysis to control for uneven sampling depth. To avoid inappropriate 
statistical inferences made from compositional data, log-ratios, a method previously 
described by Aitchison and adapted to microbiome data was used (Aitchison, 1981; 
Aitchison and Egozcue, 2005; Faust et al., 2012) with paired t-tests for comparisons of 
genus and species level data. The False Discovery Rate (FDR) method was used to 
control for multiple testing with a significance threshold of FDR=0.1. All statistical 
analysis, unless otherwise indicated, was carried out using R (r-project.org). 
4.4.3 Microarray analysis 
Vaginal cytobrushes were extracted as previously (Hummelen et al., 2011). Briefly a 
vaginal cytobrush was centrifuged at 5000xg for 10 min at 4˚C and the supernatant 
discarded. The pellet was then extracted with TRIzol (Life Technologies) following the 
manufacturer’s protocol before being DNase treated with Turbo DNA-free kit (Life 
Technologies). Sample quantity and quality were determined using a Nanodrop 1000 
spectrophotometer (Thermo Fisher Scientific, Waltham, USA) and Agilent 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, USA). Samples were prepared for 
analysis on the GeneChip Human 2.0 ST array (Affymetrix, Santa Clara, USA) at the 
LRGC following standard protocols. 
Probe level data was imported into Partek Genomics Suite (Partek, St. Louis, USA) using 
the RMA algorithm. Gene expression data was deposited in the Gene Expression 
Omnibus Database with the accession number GSE54363. 
To study the effects of the probiotic and placebo treatments on host gene expression, and 
considering the study design, a paired t-test was used to evaluate gene expression changes 
in each individual immediately before and after probiotic/placebo administration. This 
yielded two individuals (14 and 16) with arrays immediately preceding and following the 
probiotic period treatment and three individuals (01, 14, 05) with arrays surrounding the 
placebo treatment period. For other participants, insufficient yield and/or quality resulted 
in a lack of paired samples, and they were thus excluded from downstream analysis. 
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4.4.4 Sample preparation GC-MS 
 Samples were collected from the mid-vaginal wall using a Dacron Swab. Vaginal swabs 
were pre-cut into 1.5 mL tubes and weighed prior to and after sample collection to 
determine the mass of vaginal fluid collected. Samples were stored at -80˚C until 
analysis. After thawing, brushes were trimmed and eluted in methanol-water (1:1) in 1.5 
mL microcentrifuge tubes. The weight of each sample was divided by the weight of the 
lightest sample and this fraction was multiplied by 200 µL to determine the volume of 
methanol-water to add to each sample. This corresponded to a volume of 200-382 µL, 
depending on the mass of vaginal fluid collected. A blank swab eluted in 200 µL 
methanol-water was included as a negative control. All samples were vortexed for 10 s to 
extract metabolites, centrifuged for 5 min at 10 000 x g, vortexed again for 10 s after 
which time the brushes were removed from tubes. Samples were centrifuged a final time 
to pellet cells and 150 µL of the supernatant was transferred to a GC-MS vial. Next, 2.5 
µL of 2 mg/mL ribitol was added to each vial as an internal standard. Samples were then 
dried to completeness using a SpeedVac. After drying, 100 µL of 2% methoxyamine•HCl 
in pyridine (MOX) was added to each for derivatization and incubated at 50˚C for 90 min. 
100 µL N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) was then added to each 
vial and incubated at 50˚C for 30 min, then transferred to micro inserts before running on 
GC-MS (Agilent 7890A GC, 5975 inert MSD with triple axis detector, 30m DB5-MS 
column with 10m duraguard column). Samples were analyzed once for untargeted whole 
metabolome analysis, and a second time on selective ion monitoring (SIM) mode specific 
for lactate using the reference ions 117, 147, 191 and 219. Solvent delay was 10 min and 
sample injection volume was 1 uL. All samples were run in random order and one was 
run multiple times throughout to ensure machine consistency.  
4.4.5 Lactate relative abundance quantification 
Chromatograms were deconvoluted in Chemstation (Agilent) and lactate relative 
abundance determined by peak area using the auto integration function. Lactate relative 
abundance was plotted against the percentage of lactate producers (Lactobacillus, 
Bifidobacteria, Atopobium, Streptococcus, Staphylococcus, Weisella) present in each 
sample to determine the correlation between lactate levels and lactate producing bacteria. 
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The correlation value was determined in R using a Pearson’s correlation. Paired Welch’s 
t-tests were used to determine if probiotic or placebo intervention had a significant effect 
on lactate levels using a significance threshold of p=0.05. 
4.4.6 Whole metabolome analysis 
Chromatogram files were converted to ELU format using the AMDIS Mass Spectrometry 
software (Stein, 1999). Chromatograms were then aligned and abundance of metabolites 
calculated using the Spectconnect software (Styczynski et al., 2007), with the support 
threshold set to low. In order to determine changes in the metabolome due to probiotic or 
placebo, Principle component analysis (PCA) was conducted in SIMCA (Umetrics) using 
the relative abundance matrix (RA) output from Spectconnect. Data were mean centered 
and pareto scaled prior to PCA. A Mann- Whitney U test was then used to determine 
metabolites that were significantly altered by intervention (p < 0.05).  
4.4.7 Cytokine/chemokine measurement 
Swabs were resuspended in 200 µL extraction buffer (20 mM Tris-HCl ph7.5, 150 mM 
NaCl, 1mM PMSF, 0.05% Tween 20 and 1 uL/mL protease inhibitor cocktail (Roche), 
vortexed, incubated overnight at 4˚C, swab removed and then 50 µL more extraction 
buffer was added before being stored at -80 ˚C. The resulting samples were thawed on ice 
and loaded onto a Milliplex Human High Sensitivity Cytokine/Chemokine Panel (EMD 
Millipore, Billerica, Mass, USA) and analyzed for IL-1B, IL-2, IL-4, IL-5, IL-6, IL-7, IL-
8, IL-10, IL-12p70, IL-13, IFNg, GM-CSF, and TNFa. Results for IL-2, IL-7, IL-8, IL-
10, IL-13, IFNg were not displayed as they were consistently outside the assay range and 
there was limited material for reanalysis.   The plate was analyzed using a Bio-Plex 200 
System (Bio-Rad Laboratories, CA, USA) with cytokine/chemokine levels being 
generated automatically from standard curves using the Bio-Plex Manager software 
(v.4.1.1 Bio-Rad). In cases where the analyte was detected, but below the limit of 
detection, ½ the LOD was used for analysis. Results were normalized to total protein as 
determined with the Qubit Protein Assay Kit and Qubit 2.0 Flourometer (Life 
Technologies, CA, USA). Paired t-tests were used to make comparisons.  
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Chapter 5  
5 The microbiota at multiple body sites during pregnancy 
in a rural Tanzanian population and the effects of 
Moringa supplemented probiotic yogurt. 
This chapter is reproduced with permission (Appendix C) from: 
Bisanz JE, Enos MK, PrayGod G, Seney S, Macklaim JM, Chilton S, Willner D, Knight 
R, Fusch C, Fusch G, Gloor GB, Burton JP and G Reid. 2015. The microbiota at multiple 
body sites during pregnancy in a rural Tanzanian population and the effects of Moringa 
supplemented probiotic yogurt. Applied and Environmental Microbiology. 
doi:10.1128/AEM.00780-15  
Ethics approval documentation is provided in Appendix E 
5.1 Introduction 
The United Nations estimates that 805 million people are chronically undernourished 
throughout the world (FAO, 2014). Malnutrition is an additional challenge for pregnant 
women in many developing countries, along with access to medical care, exposure to 
malaria and HIV, and financial burden. Limited food accessibility, access to food with 
poor nutritional value, and cultural traditions result in deficiencies in essential nutrients. 
Micronutrients are dietary components, often referred to as vitamins and minerals. Iron, 
iodine, vitamin A, folate and zinc are recommended during pregnancy (CDC, 2014), 
although unfortunately not all women are recipients. In many developing countries, 
including Tanzania, maternal and newborn death and morbidity are major issues, often 
propagated by malnourishment (UNICEF, 2013; Tanzania National Bureau of Statistics, 
2011). Efforts to reduce infant mortality by supplementation with vitamin A have failed 
(Masanja et al., 2014). Fermented foods, including dairy products, have long been part of 
tradition in many parts of the African continent. In Tanzania (Franz et al., 2014), while 
milk consumption is high (per capita milk consumption of 39 kg/annum), commercial 
yogurt is not affordable to many, and no health-promoting probiotic yogurt is sold in 
traditional retail outlets. The establishment of community kitchens in Mwanza in 2004 
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(Reid et al., 2013) has provided affordable probiotic yogurt to around 4,000 people each 
day, with some measurable benefits to immunity and gut health (Irvine et al., 2010; 
Hummelen et al., 2011).    
 There is a clear link between the gut microbiota and nutrient uptake (Hullar and Lampe, 
2012), and while the gut microbiota has been reported to be relatively stable in non-
pregnant healthy individuals (Roager et al., 2014), changes have been reported in 
pregnant American and European women, where Firmicutes, along with Bacteroides 
dominate. However, during the first and third trimesters, Proteobacteria and 
Actinobacteria increase while richness decreases (Collado et al., 2008; Koren et al., 
2012; Jost et al., 2014). Given the role of diet on shaping the microbiota (De Filippo et 
al., 2010; Cotillard et al., 2013) and the potential additional nutritional stresses within 
impoverished African rural settings, we sought to assess the gut microbiotas of Tanzanian 
pregnant women. Also, since vaginal and oral microbiomes are suspected to influence 
pregnancy outcomes  (Mysorekar and Cao, 2014), and longitudinal studies seldom have 
included sampling after birth, we aimed to better characterize these microbiotas 
longitudinally.  
Few studies have been undertaken on the human milk microbiota of African women, 
even though the transfer of these organisms to infants is critical to development, 
immunity, risk of disease later in life and cognitive function (Gruszfeld and Socha, 2013) 
In a Mozambique study, human milk was found to contain mostly lactic acid bacteria, but 
proportions were altered by HIV infection (Gonzalez et al., 2013).  
The probiotic Lactobacillus rhamnosus GR-1 was selected for use as an intervention in 
this study as it has a safe history of use (Irvine et al., 2010; Hummelen et al., 2011; 
Martinez et al., 2009) and was already produced in Mwanza, Tanzania as part of the 
Western Heads East network of microenterprise community-run kitchens (Wenner, 
2009). For the purposes of the present study, the yogurt was further supplemented with 
dried ground Moringa oleifera (Moringa), a readily available plant, rich in vitamin A, 
proteins, carbohydrate, fibre, minerals, calcium, magnesium, phosphorus, potassium, 
copper, iron, zinc, and manganese (van Tienen et al., 2011) and used commonly in 
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management of malnutrition (Thurber and Fahey, 2009). An open label study was 
conducted to test a Moringa-supplemented probiotic yogurt, and to determine if it altered 
the oral, vaginal, gut or breast milk microbiotas, and had an impact on gestation and 
health parameters in newborns.  
5.2 Materials and Methods 
5.2.1 Study design and participants 
The study protocol was approved and received ethical clearance from both the Medical 
Research Coordinating Committee of the National Institute for Medical Research 
(Mwanza, Tanzania) as well as from the Health Sciences Research Ethics Board at 
Western University (London, Canada). The study was registered with clinicaltrials.gov 
(NCT02021799). Participants provided written consent, and in the case where they could 
not write, a thumbprint was obtained before sample collection and subsequent analysis.  
Women who were attending the antenatal clinic at Nyerere Dispensary in Buswelu, 
district of Ilemela, Mwanza Region, Tanzania, were recruited into the study if they were 
between the ages of 18 and 40 as well as between the gestational ages of 12 and 24 
weeks. Gestational age was determined by last menstrual period as identified in the 
participant’s clinic records. To confirm, or if last menstrual period was unavailable, 
approximation of gestational age was based upon measurement of fundal height. 
Originally, participants were further grouped into states of nutritional status (nourished or 
under-nourished) based upon having a mid-upper arm circumference (MUAC) less than 
235 mm if undernourished, and deviations from expected weight for gestational age 
(Gueri et al., 1982). As this was a pilot study, sample size was based on participant 
availability.  
5.2.2 Probiotic yogurt 
Subjects were randomly assigned (using a random number generator) to the intervention 
group (produced fresh daily yogurt containing ~1x1010 CFU Lactobacillus rhamnosus 
GR-1 per 250 g unit confirmed by regular quality control tests, and 4.3 g of dried ground 
Moringa oleifera leaves), or control group (no intervention). Administration of the yogurt 
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amounted to 13% required daily intake of protein (9.95 g), 39% calcium (385 mg), 35% 
vitamin A (269 RAE), 81% vitamin B2 (1.1 mg) and 4% iron (1.2 mg). The probiotic 
group received the 250 g yogurt six days a week from the time of recruitment until 
exiting the study, which occurred one week to one month postpartum. Due to a lack of 
cold storage available to most participants, yogurt was delivered daily by a study 
employee who observed and recorded compliance. Participants in the probiotic group 
consumed yogurt for an average of 88 days ± 31 SD, while the control group had no form 
of intervention. 
5.2.3 Assessment and sample collection 
At the initial and monthly follow up visits from recruitment until birth, which occurred 
between August 2012 and April 2013, weight was measured to the nearest 0.1 kg using 
an analogue scale and MUAC was measured to 1mm using a tape measure. A physical 
examination was also performed at these visits, which included measurement of blood 
pressure, heart rate and general medical history. Two vaginal swabs were collected at the 
mid-point of the vagina using CultureSwab polyester-tipped swabs (BD Biosciences, 
Mississauga, Ontario); one was used for evaluation of bacterial vaginosis (BV) by 
Nugent Scoring (Nugent et al., 1991), while the second was used for microbial DNA 
extraction. Fecal samples and saliva samples were also collected in sterile collection 
containers and frozen at -80oC until analysis. A mid-stream urine sample was analyzed 
for urinary tract infection using a multi-test dipstick system (Rapid Response Urine 
Dipstick, BTNX Urinalysis, Laja Pharmacy, Mwanza, Tanzania). Hemoglobin levels 
were determined using a HemoCue® Hb 201+ analyser (HemoCue, Ängelholm, Sweden)  
Blood samples were collected from all participants at the first, mid and final visits in 
Vacutainer tubes containing potassium EDTA (BD Biosciences, Mississauga, Ontario). 
Plasma was separated from the samples before being frozen at -80oC until analysis. 
Vitamin A levels were determined by HPLC, while the total plasma protein levels were 
determined by a colorimetric Biuret assay by the London Health Sciences Laboratory 
Services Group (London, Canada).  
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The first post-partum visits occurred at 3 days after birth and the final visit occurred one 
week to one month after the first post-partum visit. The same information and samples 
were collected as during the follow-up visits, however, a human milk sample was 
collected in sterile collection containers from the mother and stored at -80oC until 
analysis. Anthropometric data were collected from the infant including, weight as 
measured on an analogue baby scale to the nearest 0.1 kg, while head circumference, 
length and MUAC were measured using a tape measure to the nearest 0.1 cm. In addition, 
the sex of the infant, place of birth, and whether the baby was born vaginally or by 
caesarean section were recorded. Fecal samples were collected from the infant’s diaper, 
and infant saliva samples were collected using a BBL™ CultureSwab™ (BD diagnostics, 
Mississauga, Ontario) and stored at -80oC until analysis.  
5.2.4 Dietary recall analysis 
Forty-eight hour dietary recall interviews were conducted by a trained study translator at 
each visit. Information from these interviews was analyzed for nutritional content and 
caloric intake using the ESHA Food Processor SQL (version 9.8) which provides access 
to an extensive database of comprehensive nutrition information to allow evaluation of a 
subject's diet and fitness. Although this program utilizes North American food 
composition tables, nutritional data for local Tanzanian foods and recipes were imputed 
into the software from Tanzanian food composition tables prepared by Muhimbli 
University of Health and Allied Sciences, Tanzania Food and Nutrition Center and 
Harvard School of Public Health (Lukmanji and Hertzmark, 2008). In addition, when 
serving sizes per se, or sizes of specific food items were not clearly stated in the 
interview, the average portion quantity, as outlined by the Tanzanian Food Composition 
Tables, was used. Nutritional data for Moringa were obtained (M. Broin, unpublished 
data) and also inputted into ESHA. The average intake of calories, protein, fat, 
carbohydrates, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty 
acids, calcium, vitamin A, folate and zinc were calculated over the 48-hour period to 
determine daily consumption. The same was done for the 48-hour dietary recalls 
collected at the first post-partum and final visits, to obtain a value representing the daily 
average intake of the above listed nutrients postpartum. 
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5.2.5 Microbial DNA extraction and sequencing 
DNA was extracted from all samples using the PowerSoil®-htp 96 Well Soil DNA 
Isolation Kit from MoBio (Carlsbad, California) as per the manufactures protocol with 
modifications as outlined by the Earth Microbiome Project (version 4_13). 
Approximately 250 mg of fecal sample, 500 µL of saliva and 500 µL of breast milk were 
used for the extractions. Samples were sequenced by amplifying the V4 hypervariable 
region of the 16S rRNA gene using bacterial/archaeal primers 515F and 806R according 
to previously described methods (Caporaso et al., 2012) modified for the Illumina MiSeq 
platform. 
5.2.6 Microbial community analysis 
Obtained reads were quality filtered and de-multiplexed using the open source software 
QIIME (split_libraries_fast.py with default parameters for Illumina sequencing) 
(Caporaso et al., 2010). A total of 974 samples were sequenced, yielding 15,596,127 
sequences total with an average of 16,012 sequences ± 11,840 SD per sample. Samples 
that generated less than 1000 sequences after quality filtering were discarded. The 
remaining sequences were then binned into operational taxonomic units (OTUs) using 
closed-reference OTU picking based on 97% identity using the May 2013 build of the 
Greengenes reference database (McDonald et al., 2012). Demultiplexed reads and 
associated metadata were deposited in the Qiita and EBI databases available through 
study ID 2024 (qiita.ucsd.edu). 
5.2.7 Statistical analysis 
All statistical analyses were carried out in R using unpaired Welch’s t-tests with 
Benjamini Hochberg’s false discovery rate (FDR) method with a q<0.05 cutoff unless 
otherwise indicated. Analysis of alpha (Shannon diversity index) and beta diversity 
(weighted UniFrac and Bray Curtis) were performed in QIIME. All plotting was carried 
out in R with OTUs summarized to genus level and filtered to only include organisms 
which composed >1% of the total dataset (vaginal heat map Figure 5-6C ) or >0.01% 
(entire dataset: Figure 5-3). For association of individual genera with yogurt/control 
treatment in infant fecal samples, the dataset was filtered to include only infant fecal 
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samples, summarized to the genus level and genera were only kept if they represented a 
minimum 0.1% of the total reads. Significantly differentially abundant genera were 
determined by comparing groups using ALDEx2 (version 0.99.2) (Fernandes et al., 2013; 
Fernandes et al., 2014) by Wilcoxon rank-sum test with FDR correction of centered log-
ratio transformed data using 1000 Monte-Carlo instances drawn from the Dirichlet 
distribution with a minimally informative uniform prior of 0.5. Taxa that had 0 counts in 
all samples were removed. This approach accurately estimates the range of technical 
variation inherent in microbiome datasets for all taxa, including those where some 
samples contain a 0 and some where they contain a positive count (Fernandes et al., 
2013; Fernandes et al., 2014). 
5.2.8 Human milk analysis 
The breast milk samples collected at the final visit for all women in the study were 
analyzed for fat, protein and lactose content. From the calculated lactose amount, total 
carbohydrates were estimated. A total of 12 milk samples were excluded from this 
analysis due to the provider being HIV positive. Thus, data was obtained for 9 
participants from the control group and 6 participants form the probiotic yogurt group. 
Samples were homogenized for 10 seconds prior to a 500 µL aliquot being removed for 
DNA extraction using a sonicator (VCX 130; Chemical Instruments AB, Sollentuna, 
Sweden). The remaining sample (approximately 500 µL – 1 mL) was used for nutrient 
analysis.  Lactose content was measured as described by Fusch et al. (Fusch et al., 2011). 
Fat was extracted from the milk using Mojonnier ether extraction and then 
gravimetrically analyzed to get total fat content (Choi et al., 2013). Protein content of the 
breast milk was determined as per the methods of Choi et al. (2013). The true protein 
content was determined by subtracting the non-protein nitrogen from the total nitrogen 
and multiplying this by 6.25 (Lonnerdal et al., 1984). 
  
108 
 
 
5.3 Results 
5.3.1 Clinical outcomes 
The women were enrolled from a 20 km area around the Nyerere Dispensary on the 
outskirts of Mwanza. No verbal or written complaints or side effects were reported from 
consumption of the yogurt. Figure 5-1 shows a CONSORT-compliant study flow chart. 
Baseline demographic data for the nourished, undernourished, probiotic and control 
groups are presented in Table 5-1 and showed no differences between groups, except for 
weight related metrics between the nourished and undernourished groups. For 
interpretative purposes, a blood level for vitamin A of 0.9 mmol/L equals 25.8 mg/dL just 
below the normal range of 30-65 µg/dL.  
Using 48-hour dietary recalls, women in both groups who were initially categorized as 
nourished or undernourished were found to have consumed similar calories and 
macronutrients. In comparison to reference dietary intake (RDI) values for Canadian 
pregnant women, the Tanzanian women only met requirements for carbohydrates and 
iron throughout pregnancy – all other micro- and macronutrients were below 90% of the 
Canadian RDI, including folate. Yet, only three babies (5%) were delivered preterm, 
while all other births occurred without adverse events, and overall, babies examined by 
the local physician were deemed to be healthy. It was noted at the study midpoint 
whereby there was increased calorie, carbohydrate, thiamine, folate and zinc intake in the 
probiotic group while blood protein levels were also higher, however these were not 
statistically supported after multiple testing corrections (Table 5-2). We noted that 
calcium levels in the probiotic group were significantly higher than all others (Tables 5-2 
and 5-3). 
Fat, carbohydrate and protein content of the breast milk and hemoglobin, blood retinol, 
and blood protein concentrations were not altered by yogurt intake, nor was gestational 
weight gain or newborn weight at the final visit (Table 5-3).  
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Figure 5-1. CONSORT flow diagram. 
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Allocated to no intervention (n=30)
- Received no intervention (30)
Allocated to probiotic (n=26)
- Received allocated intervention (26)
Excluded (n=5)
-Obese (n=5)
Randomized (n=56)
Assessed for eligibility (n=61)
 
Follow up at study midpoint (n=23)
-Participant did not return for 
 unknown reasons (n=3)
Analysis midpoint (n=20)
Excluded from analysis (n=3)
-Missed appointment (n=3)
Analysis postpartum (n=9)
Excluded from postpartum analysis
if not meeting criteria (n=11):
-Adherence <75% at birth visit
-Age of infant at final visit between 
7 and 30 days
Follow up at study midpoint (n=24)
-Participant did not return for unknown 
 reasons (n=6)
Analysis midpoint (n=22)
Excluded from analysis (n=2)
-Missed appointment (n=2)
Analysis postpartum (n=15)
Excluded from postpartum analysis 
(n=9)
-Age of infant at final visit not between 
 7 and 30 days
Follow up postpartum (n=21)
-Participant relocated for birth (n=3)
Follow up postpartum (n=20)
-Participant relocated for birth (n=2)
-Participant did not give birth by study 
 end date (n=1)
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Table 5-1. Enrolment demographics for probiotic, control, undernourished and 
nourished groups (values ± SD unless otherwise indicated). 
 
 
Table 1. Enrolment demographics for probiotic, control, undernourished and nourished groups (values ± SD unless 
otherwise indicated). 
  
Probiotic Control 
q-value 
 
Undernourished Nourished 
q-value 
(n=23) (n=24) 
 
(n=29) (n=18) 
Gestational age (weeks) 21 ± 3 20 ± 5 0.915 
 
21 ± 4 21 ± 4 0.976 
Age (years) 23.30 ± 4.42 24.38 ± 5.01 0.915 
 
24.31 ± 5.47 23.11 ± 3.12 0.958 
Height (m) 1.60 ± 0.07 1.62 ± 0.06 0.915 
 
1.61 ± 0.06 1.62 ± 0.07 0.976 
Weight (kg) 54.8 ± 5.8 57.5 ± 7.4 0.915 
 
52.6 ± 4.3 62.0 ± 5.9 3.11E-05 
% Deviationa 
    
72.71 ± 10.14 96.75 ± 6.58 2.19E-11 
MUACb (mm) 261 ± 22 262 ± 22 0.965 
 
256 ± 22 271 ± 19 0.109 
Hemoglobin (g/L) 110.48 ± 13.68 103.38 ± 17.21 0.915 
 
107.34 ± 16.70 106.06 ± 14.75 0.976 
HIV (n) 2 3  
 
3 2  
Malaria (n) 3 4  
 
4 3  
Syphilis(n) 2 2  
 
4 0  
Previous pregnancies (n) 2.09 ± 2.07 2.00 ± 1.48 0.965 
 
2.29 ± 1.94 1.67 ± 1.46 0.935 
Age of first pregnancy 18.06 ± 9.54 18.88 ± 9.20 0.965 
 
18.19 ± 1.86 19.00 ± 1.97 0.976 
Calories (kcal/day) 1695 ± 752 1759 ± 781 0.965 
 
1719 ± 754 1742 ± 789 0.976 
Protein (g/day) 57 ± 23 58 ± 21 0.965 
 
57 ± 21 58 ± 25 0.976 
Carbohydrates (g/day) 278 ± 118 276 ± 121 0.965 
 
277 ± 122 277 ± 116 0.997 
Fat (g/day) 46 ± 33 52 ± 33 0.915 
 
48 ± 32 51 ± 35 0.976 
Vitamin B12 (µg/day) 0.69 ± 0.62 0.88 ± 0.81 0.915 
 
0.80 ± 0.76 0.77 ± 0.69 0.976 
Thiamine (mg/day) 0.78 ± 0.39 0.90 ± 0.44 0.915 
 
0.86 ± 0.39 0.82 ± 0.46 0.976 
Calcium (mg/day) 187 ± 119 236 ± 175 0.915 
 
199 ± 168 233 ± 120 0.976 
Vitamin A (RAEc/day, median [IQR]) 316 (70-869) 546 (123-1019) 0.915 
 
261 (98-846) 636 (170-1018) 0.958 
Folate (µg/day) 249 ± 212 294 ± 199 0.915 
 
269 ± 206 276 ± 208 0.976 
Iron (mg/day) 49 ± 51 40 ± 41 0.915 
 
41 ± 45 50 ± 48 0.976 
Zinc (mg/day) 5.4 ± 2.7 5.9 ± 2.4 0.915 
 
5.8 ± 2.5 5.5 ± 2.6 0.976 
Blood vitamin A (mmol/L) 0.90 ± 0.27 1.02 ± 0.43 0.915 
 
1.00 ± 0.31 0.88 ± 0.44 0.958 
Blood protein (g/L) 64.4 ± 8.9 63.5 ± 6.9 0.965 
 
65.8 ± 4.7 60.9 ± 10.7 0.398 
a % Deviation was calculated based on the participants gestational age (calculated from participant recall of the last menstrual period) and height as measured at baseline. 
These were used to determine the ideal weight of the participants as outlined by Gueri et al. (25) The weight of participants measured at baseline was then used to calculate the 
% deviation from the ideal weight. 
bMUAC: Mid-upper arm circumference 
       cRAE: retinol activity equivalents 
       !
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Table 5-2. Comparison of probiotic and control group at the study midpoint. Values 
given are averages and standard deviation unless otherwise stated. 
 
  
Table 2. Comparison of probiotic and control groups at the study midpoint. Values given are averages and 
standard deviation unless otherwise stated. 
 
 Probiotic 
(n=20) 
Control 
(n=22) 
q-value 
Gestational age (weeks) 32 ± 2 30 ± 4 0.582 
Age (years) 23.5 ± 4.7 24.6 ± 5.1 0.582 
Height (m) 1.59 ± 0.06 1.62 ± 0.06 0.304 
Weight (kg) 58.5 ± 5.9 60.1 ± 7.8 0.582 
MUACa (mm) 260 ± 23 263 ± 24 0.682 
Hemoglobin (g/L) 102 ± 16 106 ± 24 0.619 
Malaria (n) 2 1 - 
Calories (kcal/day) 2065 ± 656 1701 ± 486 0.160* 
Protein (g/day) 67 ± 12 63 ± 19 0.582 
Carbohydrates (g/day) 326 ± 96 264 ± 96 0.160* 
Fat (g/day) 60 ± 35 49 ± 19 0.386 
Vitamin B12 µg/day) 1.47 ± 0.83 1.41 ± 1.48 0.851 
Thiamine (mg/day) 1.00 ± 0.28 0.82 ± 0.19 0.141* 
Calcium (mg/day) 488 ± 148 190 ± 92 1.77E-7* 
Vitamin A (RAEb/day, median 
[IQR]) 
353 (129-985) 155 (102-268) 0.336 
Folate (µg/day) 301 ± 160 224 ± 106 0.211* 
Iron (mg/day) 44 ± 34 30 ± 22 0.304 
Zinc (mg/day) 6.4 ± 2.3 5.1 ± 1.0 0.142* 
Blood vitamin A (mmol/L)  0.82 ± 0.25 0.88 ± 0.31 0.607 
Blood protein (g/L) 62.3 ± 8.6 54.8 ± 12.45 0.142* 
aMUAC: Mid-upper arm circumference 
bRAE stands for retinol activity equivalents 
*Uncorrected p-value <0.05 
 
112 
 
Table 5-3. Demographics and birth data for participants in the probiotic and 
control groups at the final visit. Values represent a mean and standard deviation 
unless otherwise indicated. 
 
  
Table 3. Demograph cs and birth data for participants in the probiotic and control groups at the final visit. 
Values represent a mean and standard deviation unless otherwise indicated. 
 
  Probiotic 
(n=9) 
Control 
(n=15) 
q-value 
 
Gestational age at birth 
(weeks) 40 ± 1 40 ± 2 
0.976 
 
 Age (years) 24.9 ± 3.4 26.0 ± 5.6 0.787 
 Height (m) 1.58 ± 0.05 1.62 ± 0.05 0.598 
 Weight (kg) 56.2 ± 2.9 55.5 ± 6.7 0.973 
 MUACa (mm) 267 ± 19 260 ± 23 0.787 
 Hemoglobin (g/L) 107 ± 12 111 ± 18 0.787 
 No. of twin sets 2 0  
Infant    
 Male 5 6  
 Female 6 9  
 Age (days) 13 ± 3 12 ± 2 0.787 
 Weight (kg) 3.5 ± 0.5 3.4 ± 0.4 0.787 
 Length (cm) 50.7 ± 2.9 48.7 ± 4.0 0.598 
 Head circumference (cm) 35.9 ± 1.3 35.3 ± 1.2 0.598 
 MUACa (mm) 11 ± 1 11 ± 1 0.787 
Diet    
 Calories (kcal/day) 1775 ± 565 2068 ± 383 0.646 
 Protein (g/day) 83 ± 38 61 ± 18 0.598 
 Carbohydrates (g/day) 283 ± 131 363 ± 53 0.598 
 Fat (g/day) 44 ± 14 49 ± 24 0.787 
 Vitamin B12 (mcg/day) 1.36 ± 1.14 0.51 ± 0.66 0.598 
 Thiamine (mg/day) 0.85 ± 0.25 1.00 ± 0.29 0.598 
 Calcium (mg/day) 394 ± 139 109 ± 11=2 0.003 
 
Vitamin A (RAEb/day, median 
[IQR]) 
190 (107-252) 85 (31-302) 0.899 
 Folate (mcg/day) 137 ± 66 157 ± 65 0.787 
 Iron (mg/day) 67 ± 38 56 ± 46 0.787 
 Zinc (mg/day) 5.1 ± 2.1 6.4 ± 1.6 0.141 
Blood    
 Blood vitamin A (mmol/L) 1.29 ± 0.34 1.58 ± 0.59 0.598 
 Blood protein (g/L) 62.13 ± 9.09 62.73 ± 12.22 0.598 
Breast milk    
 Fat (g/dL) 2.54 ± 0.26 2.80 ± 0.46 0.598 
 Carbohydrates (g/dL) 5.75 ± 0.18 5.78 ± 0.16 0.787 
 Protein (g/dL) 1.09 ± 0.06 1.14 ± 0.15 0.787 
aMUAC: Mid-upper arm circumference 
bRAE: retinol activity equivalents 
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5.3.2 Microbiome findings 
Nutritional status did not correlate with a difference in microbiota profiles between 
groups at any body site both by diversity indices (Figure 5-2) or individual taxa (data not 
shown; determined by analysis with ALDEx2, which determines differential abundances 
for taxa that are robust to technical replication and that pass a stringent false discovery 
rate cutoff (Fernandes et al., 2013; Fernandes et al., 2014)). It can be noted there was a 
non-significant trend of increased microbial diversity in undernourished mother’s breast 
milk and their infants oral cavities; this was not significant after multiple testing 
correction. After initial analysis of dietary data, blood protein and Vitamin A (Table 5-1), 
and bacterial communities, the classification based on nutritional status was rejected and 
participants were grouped as those receiving Moringa enriched probiotic supplementation 
(n=23, 14 undernourished) or those who did not (n=24, 7 undernourished).  
The mothers’ gut microbiotas were generally dominated by Prevotella (Figure 5-3) but 
the L. rhamnosus probiotic is not visible as it comprises a near-undetectable fraction of 
the fecal microbiota. For the oral microbiota, Streptococcus, Prevotella, Fusobacterium, 
Porphyromonas and other known oral commensals and pathogens were detected while 
the vaginal profiles were predominantly dominated by Lactobacillus (Figure 5-3). Clear 
clustering by body site was observed in PCoA using the Bray-Curtis dissimilarity 
measure, with the observation that the infants' oral and fecal microbiota seemed most 
closely related to breast milk (Figure 5-4A). Both 0-10 days and 10-25 days after birth, 
there was more similarity between the infant's oral microbiota and their mother’s breast 
milk microbiota, than between the infant’s feces and their mother’s milk (Figure 5-4B, 
p<0.0001, FDR corrected Welch’s T-test). 
To determine the effect of probiotic administration, differences in the microbiota of each 
group at each body site were examined chronologically relative to enrollment using 
weighted UniFrac distances (Figure 5-5A), and no clear trend was detected comparing 
probiotic to control groups. When the infants of mothers in the probiotic and control 
groups are compared by PCoA of weighted UniFrac distances, weak clustering by 
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treatment group was observed (Figure 5B). The OTUs were summarized to genus level 
which revealed a 3-fold increase in relative abundance of Bifidobacterium and a 16.8-fold 
decrease in unclassified Enterobacteriaceae in the feces of infants whose mothers 
consumed the yogurt (p<0.05 FDR-corrected Wilcoxon Rank Sum, Figure 5-5C). This 
trend was not observed in the breast milk nor was the primary macronutrient composition 
of the milk altered by yogurt intake (Table 5-3). 
The vaginal microbiota showed a distinct change in beta diversity over gestational time 
irrespective of treatment group while the oral and fecal microbiotas did not (Figure 5-
5A). To analyze this finding further, Shannon diversity index was considered over time 
(Figure 5-6A) showing a significant increase in alpha diversity in the 10 days following 
birth to a predominantly bacterial vaginosis (BV)-type communities as indicated by 
Nugent Score (Figure 5-6B, p<0.001 Welch’s t-test). In the postnatal period, there was a 
decrease in Lactobacillus with an increase in BV associated organisms such as 
Prevotella, Veillonella, Poryphromonas and Megasphaera (Figure 5-6C, n=32 
participants, p<0.05 FDR-corrected paired Wilcoxon test).  
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Figure 5-2. (A) PCoAs of weighted UniFrac distances and (B) Shannon’s diversity 
index of samples taken at enrollment and birth show no effect of nourishment-status 
(N nourished, UN undernourished) on the microbiota at studied body sites. 
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Figure 5-3. Heat map of all samples (n=974) at the genus level.  
	  
Samples	  were	  UPGMA	  clustered	  be	  weighted	  UniFrac	  distances	  showing	  strong	  clustering	  of	  
samples	  by	  body	  site	  (as	  indicated	  in	  lower	  heat	  map).	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Figure 5-4. Clustering of samples and comparison of infant and mother microbiotas. 
(A)	  PCoA	  of	  Bray-­‐Curtis	  dissimilarities	  shows	  distinct	  clustering	  of	  samples	  based	  on	  body	  site.	  
The	  infant’s	  oral	  and	  fecal	  microbiomes	  cluster	  most	  closely	  with	  the	  breast	  milk.	  Analysis	  of	  
weighted	  UniFrac	  distances	  shows	  that	  the	  oral	  sample	  of	  a	  baby	  is	  more	  similar	  to	  their	  own	  
mother	  than	  their	  fecal	  sample	  (B).	  At	  both	  0-­‐10	  days	  and	  10-­‐25	  days	  after	  birth,	  there	  was	  
more	  similarity	  between	  the	  infant’s	  oral	  sample	  and	  their	  mother’s	  breast	  milk	  (n=22	  0-­‐10	  days,	  
n=27	  10-­‐25	  days),	  than	  between	  the	  infant’s	  fecal	  sample	  (n=25	  0-­‐10	  days,	  n=29	  10-­‐25	  days)	  to	  
their	  mother’s	  breast	  milk	  (p<0.0001,	  FDR	  corrected	  Welch’s	  T-­‐test).	  There	  is	  also	  a	  non-­‐
significant	  trend	  that	  an	  infant’s	  oral	  microbiota	  is	  more	  similar	  to	  their	  own	  mother’s	  breast	  
milk	  microbiota	  than	  that	  of	  other	  mothers.	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Figure 5-5. Change in the microbiota over time and the effect of yogurt on mother 
and infant microbiotas. 
(A)	  Microbiota	  analysis	  by	  weighted	  UniFrac	  distances	  comparing	  samples	  to	  enrollment	  show	  
that	  Moringa-­‐supplemented	  probiotic	  yogurt	  does	  not	  affect	  the	  microbiota	  structure	  and	  that	  
the	  oral	  and	  fecal	  microbiotas	  remain	  stable	  over	  pregnancy.	  The	  vaginal	  microbiota	  appears	  to	  
be	  significantly	  altered	  at	  birth	  regardless	  of	  consumption	  of	  yogurt.	  (B)	  The	  fecal	  microbiota	  of	  
infants	  aged	  10-­‐25	  days	  who	  consumed	  the	  yogurt	  weakly	  clusters	  separately	  from	  controls	  by	  
PCoA	  of	  weighted	  UniFrac	  distances	  (Red=	  Control,	  Blue=Probiotic).	  (C)	  There	  is	  in	  an	  increase	  in	  
the	  relative	  abundance	  of	  Bifidobacterium	  (Bifido)	  and	  decrease	  in	  Enterobacteraceae	  (Entero)	  
(FDR	  corrected	  Wilcoxon	  Rank	  Sum	  Test<0.05)	  in	  the	  feces	  of	  the	  infants	  whose	  mother’s	  
received	  probiotic	  yogurt	  intervention	  (n=10)	  as	  compared	  to	  controls	  (n=12).	  This	  difference	  
was	  not	  present	  in	  the	  breast	  milk	  (P>0.05).	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Figure 5-6. Vaginal microbiota over pregnancy reveals dysbiosis at birth. 
(A)	  Time	  series	  of	  vaginal	  samples	  shows	  increasing	  diversity	  and	  leading	  up	  to	  and	  after	  birth.	  
Nugent	  score	  based	  on	  microscopy	  (wherein	  0-­‐3	  is	  considered	  normal,	  4-­‐6	  intermediate,	  and	  7-­‐
10	  is	  a	  state	  of	  microbial	  dysbiosis	  referred	  to	  as	  bacterial	  vaginosis)	  is	  also	  displayed.	  (B)	  
Comparison	  of	  Shannon’s	  diversity	  shows	  an	  increase	  within	  10	  days	  after	  birth.	  (C)	  Heat	  map	  of	  
genera	  composing	  >1%	  of	  vaginal	  organisms	  shows	  a	  loss	  of	  lactobacilli	  and	  an	  increase	  in	  
bacterial	  vaginosis-­‐associated	  organisms	  such	  as	  Prevotella.	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5.4 Discussion 
This study reports the oral, gut, vaginal and breast milk microbiotas of pregnant 
Tanzanian women, and assesses the effects of consumption of micronutrient-
supplemented probiotic yogurt. None of the mothers or infants died during labor. This 
finding, plus the low incidence of preterm labor, no underweight births, and no serious 
malnutrition, suggested that this particular rural population did not typify the Tanzanian 
situation as a whole, where maternal mortality rate are 38.3 times higher than Canada and 
infant mortality under 1 year of age is 7.6 times higher (UNICEF, 2013). Sample size 
aside, according to the UNICEF statistics we would expect 2 infant deaths in a cohort of 
this size. There is an association between an aberrant urogenital microbiota and preterm 
labor (Giraldo et al., 2012), but the incidence of the latter was low in this patient group 
(32%) and similar to that found in London, Canada (unpublished data, Mottola, Enos and 
Reid). Likewise, periodontal disease with poor oral hygiene has been linked with preterm 
labor (Macedo et al., 2014), but the Tanzanian women studied here did not present with 
acute periodontal disease as identified during their examinations, and their oral 
microbiotas showed no obvious abnormality. Thus, with two risk factors for preterm 
delivery being absent, it was not surprising to find such a low rate of premature births. 
Nevertheless, this is all the more laudable since many subjects had poor caloric intake. In 
Tanzania, normally only around 50% women have a skilled attendant at birthing 
according to UNICEF, and many women have poor access to obstetrical care. The 
provision of the latter in our study, may have reduced the preterm labor rate and 
improved maternal outcome, albeit the majority of the women delivered at home.  
In these settings, access to Moringa and cow’s milk is good, making it feasible to have 
the yogurt produced locally. Whilst the yogurt was provided here free of charge, the 
community kitchen continues to operate and sell the product at a price (around $0.15) 
affordable to members of the community. This is important for sustainability.  
We had expected that the daily Moringa yogurt consumption would have improved 
nutritional parameters in women presenting with mid-upper arm circumference (MUAC) 
less than 235 mm (undernourished group), since this food provided a good portion of the 
required daily intake of calcium, vitamins, and proteins. However, the baseline levels of 
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hemoglobin, blood retinol and protein concentrations suggested they were not actually 
overtly malnourished. It is highly probable our study suffered from a lack of power, and 
with an increased sample size, we may have been able to conclusively demonstrate 
clinical outcomes as a result of the Moringa-supplemented yogurt consumption. A 
previous study in Mwanza, Tanzania using a different combination of micronutrients 
supplemented in yogurt showed benefits to HIV positive subjects (Hummelen et al., 
2011).  
The mothers’ gut microbiotas were generally dominated by Prevotella, in agreement with 
previous reports on children from Burkina Faso, Malawi, and Tanzania (De Filippo et al., 
2010; Bisanz et al., 2014; Smith et al., 2013) and adults (Yatsunenko et al., 2012). 
Potentially, this reflects a high carbohydrate diet which was noted in the dietary recalls.  
The vaginal profiles were dominated by Lactobacillus species, similar to previous 
findings for American and Brazilian non-pregnant women (Romero et al., 2014; Aagaard 
et al., 2012; Gajer et al., 2012; Reid, 2008; Martinez et al., 2008) and for pregnant 
Canadian women (unpublished data, Mottola, Enos and Reid). It has long been believed 
that the vaginal tract is seeded from the rectum (Reid, 2008), and thus pathogens ascend 
and colonize. One would therefore expect that significantly different fecal microbiota 
patterns would result in differences amongst vaginal bacterial profiles. But this is not the 
case here or in other studies, suggesting that the reproductive tract has evolved receptivity 
to certain constituents of the gut, mainly lactobacilli, and an ability to repel others. This 
niche adaptation warrants further investigation. 
Rapid development of an aberrant vaginal microbiota immediately after birth is also an 
interesting finding. A similar discovery was recently reported by Huang et al. (2014), 
however, that study was limited in the following ways: it was a cross-sectional design as 
opposed to longitudinal in the present study; postpartum samples were an average of 7 
weeks after birth as opposed to 0-10 days in the present study; and sample size of 
postpartum individuals was only 5. Since our study showed stability in the fecal 
microbiota from the second trimester until after birth, this adds to previous findings of the 
microbiome across pregnancy in Finnish women (Collado et al., 2008) where first and 
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third trimesters showed dramatic community shifts. A strength of this study is that unlike 
previous reports, we examined all three communities (fecal, oral, vaginal) 
simultaneously.  
The significant increase in the relative abundance of Bifidobacterium spp. and a decrease 
in Enterobacteriaceae in the newborn gut of babies born to mothers who had received the 
yogurt is noteworthy. All the mothers breast-fed, so, since glycans in the milk promote 
bifidobacterial growth (Sela and Mills, 2014), it is not clear why only the milk from 
probiotic treated mothers further increased relative abundances of these organisms. We 
found no significant difference in milk microbiotas, fat, carbohydrate or protein 
concentrations between the two groups of women. Given the complex cocktail of 
bifidogenic glycans and bioactive compounds in breast milk, it will be necessary to apply 
further glycomic, proteomic and metabonomic approaches to study the mechanisms 
through which micronutrient and probiotic supplementation may affect breast milk 
composition and the infant’s microbiota. Perhaps specific milk oligosaccharides increase 
following micronutrient/probiotic supplemented yogurt consumption.  
The milk clearly supported a diverse range of organisms, which then colonized the 
newborn’s intestine and oral cavity. Unlike North American society where caesarian 
delivery and use of infant formula is widespread, the women in this Mwanza community 
almost all deliver vaginally and breast-feed their babies. With inflammatory bowel 
disease and allergies increasing in Canadian children, potentially linked to environmental 
factors including caesarian section and formula feeding (Benchimol et al., 2014; El-
matary et al., 2014), other lessons may be learned from studying pregnant women in 
eastern Africa. 
In summary, daily ingestion of yogurt supplemented with probiotic L. rhamnosus GR-1 
and locally sourced micronutrient-rich Moringa supplemented probiotic yogurt provided 
a safe, inexpensive food for pregnant women in rural Tanzania, without adversely 
changing gut or oral microbial diversity. The baseline nutritional deficiencies illustrated 
the problems faced by pregnant women in this region, however no effects of yogurt 
supplementation were observed in clinical parameters. The resultant improvement in the 
123 
 
gut microbial profile of infants, suggests consumption of this yogurt could be beneficial 
in this and other developing world settings but requires further work to understand the 
mechanism of action.    
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Chapter 6  
6 Randomized open-label pilot study of the influence of 
probiotics and the gut microbiome on toxic metal levels 
in Tanzanian pregnant women and school children 
This chapter is reproduced with permission (Appendix D) from: 
Bisanz JE, Enos MK, Mwanga JR, Changalucha J, Burton JP, Goor GB and G Reid. 
2014. Randomized open-label pilot study of the influence of probiotics and the gut 
microbiome on toxic metal levels in Tanzanian pregnant women and school children. 
mBio. doi:10.1128/mBio.01580-14. 
Supplemental tables (Tables S1 and S2) are available online at 
http://mbio.asm.org/content/5/5/e01580-14.full. 
Ethics approval documentation is provided in Appendix E 
6.1 Introduction 
Toxins in the environment are ubiquitous and exposure is often unavoidable. Their 
effects on human and animal life are usually seen over time, and can be serious. Acute 
exposure to high toxin levels is particularly detrimental. Anthropomorphic activity has 
only served to increase levels of toxins, such as heavy metals and pesticides, in the 
environment (Muir et al., 2009). Due to lax regulations and exploitation, many 
environmental toxins disproportionately affect the developing world. Aflatoxin for 
example, is ubiquitous in East Africa due to Aspergillus contaminated cereal and grain 
crops (Wagacha and Muthomi, 2008). Metals such as mercury are released due to human 
activity such as mining, as seen along the shores of Lake Victoria, Africa, where the 
metal reaches the food web (Campbell et al., 2003). Fish, while not as popular in the 
west, are one of the most important sources of dietary protein for many cultures (Tidwell 
and Allan, 2001). The effects of low-level mercury exposure include delayed 
neurological and cognitive development in children and more controversially, immune 
and cardiovascular diseases (Karagas et al., 2012).  
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Metal chelating drugs such as dimercaptosuccinic acid (DMSA) and 
ethylenediaminetetraacetic acid (EDTA) are indicated for the treatment of acute 
exposure, however they are not intended for long term use and there is a lack of 
regulatory approved consumer products for chelation. Thus, alternative approaches are 
needed. Species of lactic acid bacteria including the L. rhamnosus GR-1 strain used here 
in the probiotic yogurt are known to have an affinity for many toxic metals including lead 
and cadmium in vitro (Ibrahim et al., 2006), and we have also shown activity against 
mercury, arsenic and various organic pesticides (manuscripts in preparation). The 
mechanism is thought to be passive sequestration, however we have also discovered 
putative probiotic strains that have active enzymatic pathways for detoxification such as 
mercury demethylation and reduction. The concept of probiotic-mediated detoxification 
has recently been demonstrated in murine models (Tian et al., 2012), but we explored 
whether such food-grade microbes could prevent up-take in the gastrointestinal tract  
(Monachese et al., 2012). 
Logic dictates that if probiotic organisms have these protective capacities, endogenous 
microbes of the GI tract, termed the microbiota, could also be of importance. 
Experiments contrasting conventional and germ free animals have shown the importance 
of the microbiota in protection against accumulation of mercury (Nakamura et al., 1977), 
lead and cadmium (Breton et al., 2013a). Furthermore, levels of indigenous lactobacilli 
appear to increase in response to metal exposure in murine models (Breton et al., 2013b), 
perhaps conveying a natural protective effect. We sought to better understand the 
composition of the human gut microbiota exposed to toxic metals. 
Two of the most vulnerable populations at risk from environmental toxin exposure are 
pregnant mothers and children. We suspected that in Mwanza, Tanzania, due to its 
proximity to Lake Victoria, and the fish-rich diet, women and children would have 
elevated toxic metal exposure and be ideal candidates for intervention. Furthermore, 
Mwanza is site to a network of community run probiotic yogurt kitchens that service 
people at the bottom-of-the-pyramid (Reid et al., 2013). The aims of this study were: (i) 
determine the blood metal levels in the local population and from potential fish sources, 
(ii) measure if consumption of a probiotic yogurt has an effect on blood metal levels, and 
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(iii) characterize the gut microbiome of children to determine if there are bacterial genera 
associated with metal levels. 
6.2 Results 
6.2.1 Participant recruitment 
Between November 2012 and December 2012, a total of 44 individuals were recruited 
into the 25-day study of school-aged children (SAC), with 22 in the control group 
receiving milk and 22 in the group receiving probiotic yogurt. Eight individuals withdrew 
during the course of the study, one due to suspected lactose intolerance which was not 
known to the child’s guardian at the time of enrollment, and 7 for unknown reasons 
including not being present for final sample collection. A total of 24 individuals were 
selected for inclusion into blood metal analysis in the pregnant women (PW) group based 
on adherence of over 75% and matching of nutritional status and fish intake. A summary 
of recruitment is provided in Figure 6-1.  Relevant participant demographics are 
represented in Table 6-1. Z scores based on weight-for-age indicate that the children 
enrolled were not malnourished at the point of enrollment. Based on the SAC enrollment 
questionnaire, 37% of children consumed local fish on a daily basis, 55% consumed 
multiple courses of fish a week and 8% multiple times a month. No guardians reported 
their children did not consume fish regularly as part of their diet. 
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Figure 6-1. CONSORT flow diagram detailing participant enrollment, allocation, 
follow-up and analysis. 
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Table 6-1. Participant demographics for pregnant women (PW) and school-aged 
children (SAC) control and yogurt groups (mean ± SD).  
All	  relevant	  metrics	  are	  not	  statistically	  significant	  between	  groups.	  Z	  scores	  were	  calculated	  
from	  WHO	  5-­‐19	  year	  old	  children	  BMI-­‐for-­‐age	  tables	  
(who.int/growthref/who2007_bmi_for_age/en/index.html).	  
 PW SAC 
 
Control Yogurt Control Yogurt 
Participants n=12 n=12 n=22 n=21 
Age (years) 24.5 ± 3.9 23.5 ± 3.6 8.3 ± 1.1 8.4 ± 1.2 
Weight (kg) 58.0 ± 6.8 55.0 ± 4.9 23.1 ± 3.6 23.6 ± 3.2 
Height (cm) 162.0 ± 3.9 157.0 ± 5.0 119.3 ± 7.5 119.6 ± 5.8 
BMI (kg/m2) 22.0 ± 1.9 22.3 ± 2.0 16.2 ± 1.9 16.5 ± 2.0 
Z score  
  
-0.4 ± 1.1 -0.3 ± 0.8 
Gender (M/F) 
  
6/16 6/15 
Fish Intake (g/day) 150.4 ± 60.1 120.7 ± 52.9   
Adherence (%) 
 
90.6 ± 5.4 89.8 ± 10.0 86.1 ± 11.4 
 
6.2.2 Dietary and blood metal levels 
Levels of metals across fish types for cadmium, lead, total mercury and total arsenic are 
shown in Table 6-2. Surprisingly the smaller fish type, Silver cyprinid, contained 
significantly higher levels of mercury and arsenic compared to the other piscine species 
tested. 
Measures of blood lead, total mercury, total arsenic and cadmium are presented in Table 
6-3 for both the SAC and PW groups. When comparisons were made to levels present in 
a developed country (Canada), lead and mercury were found to be elevated in both SAC 
and PW by up to 6.8 times. Levels of arsenic and cadmium appeared on par or lower than 
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the Canadian population values. The PW group tended to display lower levels of metals 
than the SAC group. 
Table 6-2. Toxic metal levels in commonly consumed fish in the Mwanza Region. 
Mercury and arsenic are reported as total levels. 
Species Mercury  
(ng/g ±SD) 
Lead 
(ng/g ±SD) 
Arsenic 
(ng/g ±SD) 
Cadmium 
(ng/g ±SD) 
Tilapia 
(Oreochromis niloticus) 
18.3 ± 17.1 58.0 ± 13.0 22.3 ± 2.5 158 ± 254 
Nile Perch 
(Lates niloticus) 
56.0 ± 15.1 86.7 ± 18.2 30.3 ± 14.3 33.7 ± 37.5 
Silver cyprinid 
(Rastrineobola argentea) 
77.3 ± 40.5  78.0 ± 18.3 664.3 ± 159.9 113.0 ± 54.7 
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Table 6-3. Blood metal levels at the time of recruitment and comparisons to levels 
found in a developed country. 
 
Average (±SD) Range 
Canadian 
Average1 
Reference 
Range2 Fold Difference 
SAC      
Pb (µg/L) 47.1 ± 16.2 22.5 - 91.3 9.0 0.0 - 17.7 5.2 
Hg (nmol/L) 9.5 ± 5.3 3.0 - 37.4 1.4 0.0 - 5.5 6.8 
As (nmol/L) 6.5 ± 2.1 2.7 - 10.8 7.8 0.0 - 21.4 -1.2 
Cd (nmol/L) 1.2 ± 0.7 0.9 - 4.4  0.89 0.0 - 4.6 1.3 
      
PW      
Pb (µg/L) 22.6 ± 9.6 7.3 - 40.5 8.9 0.0 - 45.0 2.5 
Hg (nmol/L) 8.8 ± 3.1 4.0 - 16.0 3.5 0.0 - 18.0 2.5 
As (nmol/L) 3.0 ± 1.6 1.3 - 6.7 11.7 0.0 - 21.4 - 3.9 
Cd (nmol/L) 1.1 ± 0.6 0.0 - 2.7 3.2 0.0 - 8.9 - 2.9 
1 Canadian averages are geometric means of males and females aged 6-11 (SAC) and 
females aged 20-39 (PW) based on the Canadian Health Measures Survey (2007-2009 
(Health Canada, 2010). 2 Reference ranges provided by Trace Elements Laboratory- 
London Laboratory Services Group. 
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6.2.3 Effect of probiotic yogurt on blood metal levels 
Before and after intervention, samples were successfully collected from 36 individuals in 
the SAC group, 18 in each group. One individual was excluded from the control group 
after gut microbiome analysis showed a high number of reads presumptively mapping to 
the probiotic strain indicating non-compliance. After quantification by HR-SF-ICP-MS, 
no statistically significant differences were detected in blood metal levels of SAC 
receiving probiotic or milk control though it is noted that there was a weak trend of 
reduced lead and arsenic (Table 6-4). In the PW cohort, this effect was noted to a 
statistically significant level (P<0.05). It is noteworthy that levels of mercury and arsenic 
increased in the control groups (P<0.05) but remained stable in the probiotic group, 
indicating a protective effect of probiotic consumption. 
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Table 6-4. Blood metal levels between control and probiotic groups before and after 
intervention in school aged children (SAC) and pregnant women (PW)  
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6.2.4 Gut microbiome and association with metal levels 
A total of 74 fecal samples from the children were collected and processed for 
sequencing. For all but one of these samples, 16S rRNA gene sequences were 
successfully obtained with a total number of reads being 1,150,628 averaging 15,762 
reads per sample. With clustering at 97% nucleotide identity, 177 OTUs were obtained at 
≥1% abundance. These data were summarized to the family level and presented in Figure 
6-2. Nearly all samples contained Prevotella as the dominant genera and the 
Prevotellaceae as the dominant family. Administration of the probiotic was not observed 
to have an effect on the gut bacterial community composition based on analysis of 
weighted and unweighted UniFrac metrics (Lozupone and Knight, 2005; data not shown), 
as previously reported (McNulty et al., 2011). The use of 16S rRNA sequencing also 
gave the unique opportunity to presumptively validate probiotic administration, as one 
OTU could be mapped back to the genome of L. rhamnosus GR-1 (OTU_140). This OTU 
was not observed in any sample prior to the start of the study and with only one 
exception, was only observed in the group that received probiotic yogurt. The exception 
(PDTX25) was excluded from analysis of probiotic efficacy in the SAC group. 
To analyze the association between blood lead levels and the microbiotas, the initial 
analysis focused on only the first visit and the most extreme cases (n=3 per group) based 
upon visual inspection of the distribution of blood levels. Two OTUs were found to be 
elevated in conditions of high blood lead and to have a raw P-value <0.05: OTU_1 
(P=0.0205) and OTU_215 (P=0.0498) representing Succinivibrionaceae and 
Gammaproteobacteria respectively. Due to the relatively small sample numbers used in 
this analysis, significance was not obtained with multiple testing corrections. In order to 
leverage the full power of the dataset, all samples regardless of visit or participant were 
considered. Quartile values for Q1 and Q3 based on blood lead concentration were used 
as cut offs to separate the microbiota samples (n=16 low, n=18 high). These two 
conditions were then compared using an FDR cutoff of 0.05, and again the increased 
proportional abundance of OTU_1 (2.9-fold, FDR=0.022) and OTU_215 (3.7-fold, 
FDR=0.023) with elevated lead levels was found (Figure 6-3). Significant associations 
were not found in the cases of mercury and arsenic. 
141 
 
 
                                
Figure 6-2. Heat map representation of the gut microbiomes of SAC at beginning 
and end point of study.  
Data	  were	  summarized	  to	  family	  level	  and	  plotted	  as	  percent	  abundance.	  Across	  nearly	  all	  
participants,	  the	  Prevotellaceae	  were	  the	  most	  dominant	  family	  observed	  while	  an	  unclassified	  
Succinivibrionaceae	  is	  also	  of	  variably	  high	  abundance	  across	  many	  participants.	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Figure 6-3. Association of (A) OTU_1 (Succinivibrionaceae) and (B) OTU_215 
(Gammaproteobacteria) with elevated blood lead levels in a comparison of upper 
and lower quartiles of all samples (FDR<0.05). 
6.3 Discussion 
This is the first study to simultaneously evaluate toxic metal levels, associated microbiota 
and the potential for probiotics to convey a detoxification effect. It is also the first to 
assess the impact of a probiotic food on toxic metals in people living in the developing 
world.  
Levels of metals in the fish tested were consistent with previous reports in Lake Victoria 
(Campbell et al., 2003; Oyoo-Okoth et al., 2010). Mercury limits in fish are well 
described but they are less well defined in the case of lead, cadmium and arsenic. It is 
greatly concerning to observe such high levels of metals in Silver cyprinid, as its daily 
consumption is common, especially in the economically disadvantaged due to its 
affordable price. This creates a disproportional burden on these individuals. Furthermore, 
this goes against the typical dogma that larger fish species are a greater concern for toxic 
metal exposure due to biomagnification (Bryan et al., 1979). 
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Metal exposure from dietary fish intake likely explains why we see elevated levels of 
mercury in both the SAC and PW groups when compared to reported levels in Canadians, 
but the case of Cd and As is interesting as these were not dissimilar between the two 
countries.  It is difficult to speculate why this was the case, and further studies of lake 
metal levels, and concentrations in other foods are needed. Unfortunately metal levels, 
particularly lead, were highly elevated in the SAC group where their effects may be 
particularly deleterious. The difference between the adults and children could be due to 
longer term exposure in adults as only 5-15% of ingested lead is absorbed in the gut 
while in children absorption can be up to 40% (International Programme on Chemical 
Safety, 1996). 
The studies provided the first positive evidence for the use of yogurt containing probiotic 
lactobacilli to combat toxic heavy metal exposure in vulnerable human populations. The 
results comparing the short term and long term interventions (SAC vs PW) suggest that 
probiotic consumption does not have a fast acting effect like DMSA or EDTA, but rather 
acts over longer-term. This is likely because the mechanism of action is preventing 
uptake into the body from the GI tract, rather than scavenging what is already in the body 
as in chelation therapy. Alternatively it may be reflective of differing metabolic or 
hormonal differences and/or different indigenous microbes in the PW as compared to the 
SAC. Further studies involving time course interventions will be necessary to resolve this 
discrepancy and to rule out potential effects of nutrition affecting metal uptake. 
Interestingly, in both study groups the mercury and arsenic increased in the control 
groups. A delay between sample collection and analysis was unavoidable due to the lack 
of instrumentation locally. But, sample storage of mercury, should not interfere with the 
analysis (Varian-Ramos et al., 2011), and is more likely explained by seasonal changes in 
diet/exposure. Thus probiotic administration may be especially advocated at peak 
exposure times.  
A high degree of homogeneity in a Prevotella-dominated microbiota is noteworthy. This 
profile, referred to as enterotype two (Arumugam et al., 2011) has been previously 
observed to be predominant in African populations (De Filippo et al., 2010) and is 
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presumed to be due to a carbohydrate rich diet (Wu et al., 2011). Interestingly, enterotype 
two is often co-associated with Desulfovibrio spp. (Wu et al., 2011). While we cannot 
definitively show the presence of these organisms due to their low abundance and lack of 
sequence diversity in the V6 rRNA region, they are associated with mercury methylation 
through a mechanism that was only recently understood (Parks et al., 2013), and which 
could facilitate increased mercury uptake in the gut. In addition, mucin-degradation by 
this microbiome configuration could facilitate increased metal uptake by affecting gut 
barrier function (Wright et al., 2000), putting these individuals at greater risk from metal 
exposure. 
There are a number of mechanisms through which the Succinivibrionaceae and 
Gammaproteobacteria may function to facilitate greater lead uptake, including host-
interactions and influencing other members of the microbiota. In fact, the mechanism 
may be relatively simple, since the cell wall structure of Gram-negative bacteria has 
lower metal binding activity than Gram-positive organisms (Beveridge and Fyfe, 1985). 
Given that probiotic treatment was not found to affect relative abundance of either of 
these two groups, or any bacterial population, this suggests the mechanism of action is 
independent of altering the microbiota, at least at the community structure level. 
In summary, this work has demonstrated the potential value of long-term probiotic-based 
interventions to counter mercury and arsenic exposure in vulnerable populations, 
particularly in pregnant women. This approach can be disseminated at an affordable cost 
(equivalent of pennies) in developing countries where individuals are at high risk, 
however it could also be applied to developed world citizens and wildlife, for example 
those living near mining facilities. We hope that these studies help provide a framework 
for further human trials. Though it is reasonable to presume health benefits due to 
reduced toxin levels, long-term multi-year studies would help determine if reduction in 
toxin levels by probiotic foods results in improvements in physical and cognitive 
development in children. 
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6.4 Materials and Methods 
6.4.1 Study design and participants 
Two populations were recruited in the Mwanza region, Tanzania for this study: (i) 44 
school aged children aged 6-10 years which will be further referred to as SAC, and (ii) a 
subset of 60 pregnant women in their first trimester who were being recruited for a 
separate study on nutrition and the microbiome which will be referred to as PW.  
In the SAC group, consent was obtained from the child’s guardian, as identified by 
school records, and assent was obtained from the child. If a signature could not be 
provided, a thumbprint was used in its place. Inclusion criteria was that the child was 
aged 6-10 years and in good health, the only exclusion criteria was known milk allergies 
and/or lactose intolerance. The guardians were surveyed for basic dietary information 
about their child, including the frequency with which they consumed fish and the species 
consumed. Blood was collected for determination of metal levels and feces was collected, 
stored on ice for less than 4 hours and stored at -80˚C until processing and DNA 
extraction. Participants were then randomly assigned (using a random number generator) 
to receive either a locally produced yogurt containing 1x1010 CFU Lactobacillus 
rhamnosus GR-1 per 250 gram unit or an equivalent portion of ultra-heat treated milk as 
a control devoid of lactic acid bacteria. For 19 of the next 24 days, the children were 
supervised during administration of either yogurt or milk. Five days were missed due to 
logistical issues in administration/yogurt production. Upon completion of the study, 
blood and fecal samples were again collected. 
As part of a separate study on maternal nutrition and the microbiome (PW), 60 pregnant 
women were recruited, of which 26 received a probiotic yogurt containing 1x1010 CFU L. 
rhamnosus GR-1 per 250 gram unit and supplemented with 4.3 g of Moringa, a 
micronutrient rich plant to enhance maternal nutrition. All women recruited were 
between 12 and 24 weeks pregnant and aged 18 to 40 years.  Until their final visit after 
birth, individuals in the yogurt group received the product for six days a week with an 
average number of days consuming yogurt of 102 days ± 19 SD. The control group had 
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no form of intervention. For blood trace metal analysis, individuals with ≥ 75% 
compliance in the probiotic group were selected along with controls of appropriate age, 
nutritional status, and matched fish intake resulting in 12 PW per group. Given that this 
was a pilot study, sample size was based upon participant availability. 
Both studies were registered with clinicaltrials.gov (NCT01904513, NCT02021799) and 
approved in Canada by the Health Sciences Research Ethics Board at Western University 
(#102881, #18850) and in Tanzania by the Lake Zone Institutional Review Board. 
6.4.2 Dietary exposure 
To assess potential exposure to dietary toxic metals via fish consumption, three of the 
most commonly consumed fish were collected. All samples were obtained from the main 
fish market in downtown Mwanza in early December 2012. Three specimens of each fish 
species were collected: Nile Perch (Lates niloticus), Tilapia (Oreochromis niloticus) and 
Dagaa/Silver Cyprinid (Rastrineobola argentea). Each was caught from a different area 
along the Mwanza coastline. Muscle tissue was removed from the Nile Perch (Lates 
niloticus) and Tilapia (Oreochromis niloticus) and frozen at -80 ˚C until analysis. Dried 
R. argentea was frozen whole. Samples were digested in aqua regia and analyzed for 
lead, mercury, arsenic and cadmium by ICP-MS (Agilent 7700) at the UWO, Analytical 
Services Laboratory, London Canada. 
6.4.3 Blood metal quantification 
Samples were collected in Vacutainer Trace Elements Blood Tubes (Becton Dickinson) 
and frozen at -80˚C until analysis. Whole blood samples were digested in ultrapure nitric 
acid before being analyzed on an ELEMENT 2 HR-SF-ICP-MS (Thermo Scientific) 
according to the standard operating procedures of the Trace Elements Laboratory of the 
London Health Sciences Centre for a panel of toxic metals (mercury, arsenic, cadmium, 
lead). 
147 
 
6.4.4 Microbiome analysis 
DNA was extracted from frozen fecal samples of the SAC group using the E.Z.N.A Stool 
Kit (Omega Biotek) according to the manufacturers’ instructions. Amplification of the 
V6 region of the 16S rRNA gene was carried out using the primers 
CCATCTCATCCCTGCGTGTCTCCGACTCAGnnnnnCWACGCGARGAACCTTACC 
and CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC where nnnnn 
is a sample specific nucleotide barcode. Amplification was carried out in 42 µL reactions 
with 10 µL of 3.2 pMol/µL of each primer, 20 µL GoTaq hot start colorless master mix 
(Promega) and 2 µL purified DNA. The PCR protocol was: 2 minutes 95 ˚C, and 25 
cycles of: 1 minute each 95˚C, 55˚C, 72˚C. PCR yield was assessed with a Qubit 
Flourometer (Life Technologies) and samples were pooled at equimolar concentrations 
before a final cleanup with the QIAquick PCR Purification kit (Qiagen). Library 
preparation and sequencing was carried out at the London Regional Genomics Centre 
(London, Canada) on an Ion Torrent Personal Genome Machine (Life Technologies) with 
316 chip following the manufacturers’ instructions. 
Resulting reads were extracted, de-multiplexed and grouped into operational taxonomic 
units (OTUs) at 97% identity in the manor previously reported (Gloor et al., 2010). Reads 
were deposited into the Short Read Archive (BioProject ID: PRJNA244107) and 
barcodes and their corresponding sample IDs are available in Supplemental Table 1. 
Taxonomic assignments were made by extracting best hits from the Ribosomal Database 
Project (rdp.cme.msu.edu) Seqmatch tool. These were manually curated by comparison 
to the NCBI non-redundant database and the Green Genes database (greengenes.lbl.gov). 
OTU IDs, sequences and taxonomies have been supplied in Supplemental Table S2. 
Further analysis was carried out using Quantitative Insights Into Microbial Ecology 
(QIIME) (Caporaso et al., 2010) and R (R-project.org). To better handle comparisons of 
compositional data, the centered log ratio transformation of Aitchison (1982) adapted to 
microbiome data (Fernandes et al., 2013; Fernandes et al., 2014) was used and then 
tested using ANOVA with FDR multiple testing corrections. Cadmium was excluded 
from analysis due to the limited range of concentrations observed. 
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Chapter 7 
7 Mercury-resistant lactobacilli to remediate toxic metals 
in vitro and in vivo. 
Bisanz JE, Trinder M, Gloor GB, van Hylckama Vlieg JET, Smokvina T, Burton JP, Ple 
C, Foligne B and G Reid. 
7.1 Introduction 
Many heavy metals including copper and chromium serve biological functions within 
multicellular organisms through specialized functions including as acting as enzyme co-
factors (Mertz, 1981). Some metals such as mercury, lead, cadmium and arsenic have 
virtually no biological function and are considered detrimental at any concentration. 
Nonetheless, these compounds exist in our environment and have increased in 
concentration due to anthropogenic activity (Lamborg et al., 2014; McConnell and 
Edwards, 2008). The detrimental effects of these elements often include delayed 
neurological development in children (Dovydaitis, 2008), cancer (Hughes et al., 2011) 
and more controversially cardiovascular and autoimmune disease (Gallagher and 
Meliker, 2012; Karagas et al., 2012). New concepts are required to counter these 
problems for human and animal health. Most interventions within the field of 
bioremediation focus on environmental applications; however given that much exposure 
to toxic metals is through the diet, we ask the question: if we cannot remove metals from 
food supply, can we prevent their absorption from the gut? The use of food-grade 
organisms, including probiotic strains, offers one such possibility. 
We have recently shown that probiotic yogurt containing lactobacilli can counter toxic 
metal uptake in children (aged 6-10) and pregnant women (Bisanz et al., 2014).  We 
selected the Lactobacillus rhamnosus GR-1 strain based on unpublished in vitro metal 
binding data and the strain’s safe history of use in vulnerable populations (Anukam et al., 
2006; Hummelen et al., 2010; Hummelen et al., 2011a). When a 25 day intervention was 
applied in children, toxin adsorption lowered but the levels failed to reach statistical 
significance; however, a significant effect was observed in protection against mercury 
and arsenic in pregnant women given the intervention for an average of 88 days.  
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It had previously been established that lactobacilli have strong affinity for lead and 
cadmium (Halttunen et al., 2007b) so it is puzzling that effects were seen in the case of 
mercury and arsenic, but not cadmium or lead. This suggested there may be additional 
mechanisms of action that are not directly related to a surface binding mediated 
sequestration as the literature would suggest. The results of our human studies indicated 
that we need to develop new and improved strains specifically tailored for remediation of 
toxic metals to improve efficacy. This required further mechanistic studies. 
We hypothesize there may be at least four distinct mechanisms involved in probiotic 
mediated protection against toxic metals: (i) passive sequestration as previously reported 
against cadmium, lead and arsenic (Halttunen et al., 2007a; Halttunen et al., 2007b), (ii) 
direct enzymatic detoxification to metal species of reduced toxicity or uptake in the GI 
tract, (iii) modulation of host xenobiotic metabolic pathways to favorable alter host 
metabolism and elimination of toxic substances, and (iv) modulation of microbiota 
composition or function.  
As toxic metals are elements, they cannot be truly destroyed, but rather converted to less 
toxic forms. In the case of mercury, this is possible through the organomercurial lyase 
and mercuric reductase enzymes frequently found in bacterial mercury resistance 
(Nascimento and Chartone-Souza, 2003). The end product of this pathway, volatile 
elemental mercury (Hg0), is negligibly absorbed in the GI tract while the starting product, 
methylmercury (MeHg) is nearly fully absorbed with the intermediate inorganic mercury 
(InHg) being absorbed at variable rates (Gochfeld, 2003). Not all interactions of bacteria 
and mercury are favorable as it is known many strains also have the capacity to methylate 
mercury and at least one human gut isolate (Methanomassiliicoccus luminyensis) has 
been show to possess the necessary determinants for mercury methylation (Parks et al., 
2013). This suggests modulating of the microbiota’s capacity for mercury species 
interconversion may impact host mercury uptake. Our previous work would suggest there 
is no shift in microbiota composition after L. rhamnosus GR-1 consumption which 
partially discounts this theory with the caveat of 16S rRNA sequencing being a somewhat 
course method to study composition which tells little about function. 
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Modulation of host xenobiotic metabolism represents a novel and unreported potential 
mechanism relevant to both toxic metals and a range of environmental pollutants as well 
as having pharmacological implications. Zhai et al., (2014)  demonstrated that orally 
administered Lactobacillus strains could protect against liver damage from 
intraperitoneally administered cadmium despite not having an impact on cadmium uptake 
and tissue distribution. Furthermore, studies in germ-free mice have indicated microbes 
play a role in expression of metallothioneins (Breton et al., 2013) and cytochrome p450 
enzymes at distal sites such as the liver (Toda et al., 2009). Mechanistic studies of how 
microbes can impact function at distal sites are an exciting avenue in probiotic and 
microbiome research requiring further studies. 
Given previous reports of strain specific toxin sequestering activity (Halttunen et al., 
2007b; Hernandez-Mendoza et al., 2009; Ibrahim et al., 2006) we sought to screen a 
collection of 80 L. rhamnosus and L. paracasei strains with draft genomes (Smokvina et 
al., 2013) for activity against toxic metals to allow the opportunity to apply comparative 
genomics to identify the genetic basis for strain variability and potential effectors. 
The goals of this study were to identify novel strains specifically tailored for activity 
against toxic metals. Binding and mercury resistance assays were used as a proxy to 
uncover lactobacilli harboring mercury-detoxifying enzymes. The strains were further 
characterized and the genomic basis of resistance was determined. Finally these strains 
were applied in murine models to determine the effect of mercury detoxifying enzymes in 
vivo. 
7.2 Results 
7.2.1 Binding of lead and mercury by strains of L. rhamnosus. 
Consistent with previous reports of passive sequestration of lead by lactobacilli, all 
studied L. rhamnosus strains were capable of binding a significant portion of the 50 
µg/mL lead inoculum in a strain variable manor (Figure 7-1A). Binding efficiencies 
varied from 42% (Lr64) to 99% (Lr60 and Lr63). Binding to InHg (as Hg2+) was assayed 
in strains Lr64 and Lr60 at 1 µg/mL (Figure 7-1B) and 10 ng/mL (Figure 7-1C) 
concentrations revealing up to 95% InHg removal by strain Lr60 with greatest removal at 
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higher concentrations. At the 1 µg/mL concentration, Lr60 demonstrated significantly 
higher InHg removal than strain Lr64 which was not observed at 10 ng/mL. Neither 
strain resulted in production of MeHg from InHg. Removal of MeHg (as CH3Hg+) was 
also assayed again at 1 µg/mL and 10 ng/mL (Figures 7-1D and 7-1E) showing 
significant removal with a maximum of 45% MeHg removed from solution by strain 
Lr60. The effect of viability was also examined in strain Lr60 where it was found that 
there was a statistically significant loss of mercury removal ability with a heat-killed 
strain, while other strains including Lr136 show no difference. The loss of mercury 
removal by Lr60 was coupled with a 16% difference in recovery of mercury by nitric 
acid digestion suggesting a loss of mercury from the system. 
To examine passive binding, electron microscopy was used. TEM micrographs show the 
presence of metal precipitates in association with the cell in the case of both lead and 
mercury (Figure 7-2A-C). These precipitates do not appear to be in the surrounding 
capsule but rather in close association with the cell. To confirm the composition of the 
precipitates, SEM/EDX (representative image of Lr60 with InHg Figure 7-2E) was 
applied confirming the composition of the mercury precipitates (Figure 7-2F) and lack of 
metals in control cells (Figure 7-2D). 
To further characterize the Lr60 strain as well as to screen the collection for the presence 
of mercury detoxifying enzymes, mercury resistance was screened in all strains. No strain 
showed increased resistance to MeHg and no L. paracasei strain displayed clear 
increased resistance to InHg (data not shown). Two strains showed elevated resistance to 
mercury in liquid media (strain Lr60 and Lr63), the organisms previously identified as 
displaying the highest lead sequestering activity (Figure 7-3A).  Lr60 and Lr63 
additionally displayed elevated resistance in disk diffusion assays with a difference of 6 
mm in the zone of clearing (Figure 7-3B). To determine if resistance to mercury was an 
adaptive response, strains Lr60 and Lr63 were precultured in ½ of their minimum 
inhibitory concentration (MIC) (6.25 µg/mL) and then were tested again in a MIC assay. 
Both strains showed a 2-fold increase in MIC as well as a reduced lag-phase during 
growth at 6.25 µg/mL (Figure 7-3C; Lr60 shown as representative of both strains). 
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Figure 7-1. Removal capacities of lead and mercury by L. rhamnosus strains. 
(A)	  Lead	  binding	  by	  40	  strains	  of	  L.	  rhamnosus.	  Mercury	  removal	  by	  select	  L.	  rhamnosus	  strains	  
at	  1	  µg/mL	  InHg	  (B),	  10	  ng/µL	  InHg	  (C),	  1	  µg/mL	  MeHg	  (D)	  and	  10	  ng/mL	  MeHg	  (E).	  The	  effect	  of	  
viability	  on	  mercury	  removal	  by	  strains	  Lr60	  and	  Lr137.	  Error	  bars	  ±	  SEM,	  *	  p<0.05	  vs.	  control	  
unless	  otherwise	  noted.	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Figure 7-2. TEM and SEM/EDX analysis of metal precipitates in association with L. 
rhamnosus Lr60. 
TEM	  micrographs	  of	  L.	  rhamnosus	  Lr60	  incubated	  with	  Pb2+	  (B),	  Hg2+	  (C),	  or	  HEPES	  control	  (A).	  
EDX	  compositional	  analysis	  of	  individual	  metal	  precipitates	  for	  mercury	  (F)	  and	  control	  (D).	  
Representative	  SEM	  image	  of	  Lr60	  incubated	  with	  Hg2+	  for	  selecting	  individual	  precipitates	  for	  
EDX	  analysis	  (E).	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Figure 7-3. Mercury resistance screening in L. rhamnosus strains. 
Growth	  across	  a	  gradient	  of	  InHg	  by	  L.	  rhamnosus	  strains	  demonstrates	  two	  strains	  of	  increased	  
resistance	  (A).	  Disk	  diffusion	  assays	  confirm	  increased	  resistance	  (6mm)	  in	  Lr60	  and	  Lr63	  as	  
compared	  to	  Lr136	  and	  Lr64	  (B).	  Induction	  in	  ½	  MIC	  reduces	  growth	  inhibition	  upon	  re-­‐culturing	  
at	  ½	  MIC	  as	  compared	  to	  Non-­‐induced	  control	  (C).	  
7.2.2 Genetic determinants of mercury resistance in L. rhamnosus 
At the time of this genomics work (2012-2013), no publically available genome of 
Lactobacillus were found to contain a full-length mercuric reductase (merA) or 
organomercurial lyase (merB).  There has been a recently sequenced genome (Tanizawa 
et al., 2015) of Lactobacillus hokkaidonesis JCM 18461 isolated from silage that likely 
contains a merA gene. It was determined that many Lactobacillus genomes contain a 
miss-annotated dihydrolipoamide dehydrogenase gene which is identified as merA due to 
homology in the pyridine nucleotide-disulphide oxidoreductase and dimerization 
domains. The dihydrolipoamide dehydrogenase critically lacks the N-terminal heavy 
metal associated domain containing two cysteine residues to bind the mercury ions. A 
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clustal alignment of the MerA of Lr60 and two miss-annotated dihydrolipoamide 
dehydrogenases is included in Figure 7-4. 
To determine the genetic basis for increased mercury resistance in L. rhamnosus Lr60 
and Lr63, a comparative genomics approach based on the machine learning approach 
used in chapter 3 was attempted which failed to yield meaningful results. Direct searches 
for merB and merA by BLASTP to validated Gram-positive genes discovered the 
presence of a full-length merA exclusively in the genomes of strains Lr60 and Lr63. It 
was determined that during clustering of orthologous protein groups, the true merA of 
Lr60 and Lr63 was inappropriate clustered with the dihydrolipoamide dehydrogenase 
present in other strains. 
Due to low coverage in the initial genome sequencing, the genomes of strain Lr60 and 
Lr63 were resequenced via Illumina MiSeq. This resulted in draft genome assemblies for 
Lr60 (28-fold coverage, n50=125430bp) and Lr63 (27-fold, n50=100067bp) that were 
sufficient to resolve the genomic context of the merA gene. The mercuric reductase was 
found in a presumed operon structure with a merR transcriptional regulator (Figure 7-
5A). Co-transcription of the merR and merA genes was verified by nested PCR from 
cDNA (Figure 7-5B) while their up-regulation in response to mercury was verified by 
qPCR (Figure 7-5C). Maximal up-regulation (10.6-fold merA; 11.3-fold merR) after 1 
hour was observed at ½ MIC (6.25 µg/mL). 
The merRA operon appears to be found in an identical 10 kb horizontally acquired region 
in both Lr60 and Lr63 as determined by a significant GC-skew and interpolated variable 
order motif analysis (Vernikos and Parkhill, 2006) (Figure 7-5A).  Additionally the 
insertion appears to have occurred in the vicinity of tRNA genes and it has remnants of 
transposon machinery, which is further indicative of horizontal gene transfer. The 
transfer also appears to have carried a cadD cadmium efflux protein as well as copper 
resistance determinants. Comparison to the Insertion Sequence database (https://www-
is.biotoul.fr) reports no hits. The merA has high nucleotide identity to that of oral 
streptococci  (99% nucleotide ID, 96% coverage; S. oralis Genbank: AJ582645.1, S. mitis 
Genbank:AJ582646) though the putative horizontally acquired region appears to be a 
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mosaic of other organisms, including regions homologous to Bacillus cereus RC607, thus 
it is not possible to identify a single possible source of the gene transfer. Additionally it 
was determined that Lr60 and Lr63, both isolates from fermented cereal, are extremely 
similar sharing 99.97% average nucleotide identity (ANI). This level of similarity may 
indicate they are in fact isolates of the same strain. For reference, Lr60 and L. rhamnosus 
GR-1 have a 99.20% ANI while the earlier 454 assembled draft genome of Lr60 and the 
newer MiSeq assembly have an ANI of 99.95%. The 16S rRNA, cpn60, gyrB, dnaJ and 
ldhL genes are also identical in nucleotide composition. Finally predictions of unique 
genes, based on reciprocal blasts of all predicted protein coding sequences suggest few 
genes with assignable functions unique to each strain. Further studies focused solely on 
strain Lr60 given the extreme similarity between the Lr60 and Lr63 strains. 
 
Figure 7-4. Clustal alignment of the MerA of Lr60 with the dihydrolipoamide 
dehydrogenase frequently misannotated as a mercuric reductase. 
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Figure 7-5. Genomic and transcriptional characterization of mercury resistance in 
L. rhamnosus Lr60. 
(A)	  A	  minimal	  mercury	  resistance	  operon	  (merRA)	  was	  located	  in	  a	  horizontally	  acquired	  region	  
as	  indicated	  by	  skewed	  GC	  composition	  and	  interpolated	  variable	  order	  motif	  analysis	  prediction	  
of	  horizontally	  acquired	  regions	  (in	  blue).	  (B)	  It	  was	  determined	  that	  merR	  and	  merA	  are	  co-­‐
transcribed	  as	  indicated	  by	  a	  1889	  bp	  product	  bridging	  the	  genes	  amplified	  from	  cDNA	  prepared	  
from	  DNA-­‐free	  RNA	  from	  Lr60.	  (C)	  merRA	  is	  up-­‐regulated	  by	  exposure	  to	  InHg	  in	  a	  dose-­‐
dependent	  manor.	  
7.2.3 Validation of merA function 
Given that a mercuric resistance operon (merRA) has never been described in a 
Lactobacillus species, we sought to validate the function of the genes through mutant 
analysis.  The merRA operon from Lr60 was cloned into pLAB1301, a Lactobacillus-E. 
coli shuttle vector and electroporated into the mercury sensitive L. rhamnosus GR-1.  
MIC analysis of the resultant GR-1 pLAB1301-merRA showed a 4-fold increase in MIC 
as opposed to the WT and vector controls (Figure 7-6A). The merRA of Lr60 was 
knocked out through allelic exchange with chloramphenicol acetyltransferase (cat) (Lr60 
∆merRA::cat) revealing a 4-fold loss in MIC which was complemented by pLAB1301-
merRA (Figure 7-6B). To demonstrate that the merRA operon results in volatilization of 
mercury as expected from the merA, the X-ray film method was used which demonstrated 
volatilization from the Lr60 WT and complemented strains, but not in the Lr60 
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∆merRA::cat strain (Figure 7-6C). Mercury volatilization is determined by darkening of 
the film due to reaction of Hg0 with the silver halides in the film. 
 
Figure 7-6.  Validation of merA function by mutant analysis and volatilization assay. 
(A)	  Expression	  of	  merRA	  amplified	  from	  Lr60	  in	  the	  mercury	  sensitive	  L.	  rhamnosus	  GR-­‐1	  strain	  
results	  in	  a	  4-­‐fold	  increase	  in	  resistance	  to	  mercury	  as	  indicated	  by	  MIC	  assay.	  (B)	  Knock-­‐out	  of	  
merRA	  in	  Lr60	  results	  in	  a	  4-­‐fold	  loss	  in	  mercury	  resistance	  which	  is	  reverted	  by	  
complementation.	  (C)	  X-­‐ray	  film	  demonstrates	  production	  of	  Hg0,	  as	  indicated	  by	  a	  dark	  spot	  
over	  the	  film,	  in	  WT	  and	  complemented	  Lr60,	  but	  not	  the	  knock-­‐out	  strain.	  
7.2.4 Protective effects of lactobacilli in murine models of acute 
and sub-chronic metal exposure 
To test the effect of lactobacilli on both acute and sub-chronic dosing schemes of both 
mercury and a combination of toxic metals (Hg, Pb, Cd; Figure S1), as well as to 
determine the effect of the Lr60 merRA operon in vivo, Balb/C mice were used. The 
ultimate endpoint was quantification of blood and tissue metals that will differentiate the 
effect of mercury resistance determinants. This analysis has been pending for 5 months 
due to logistical issues at the University Hospital of Lille and thus is unavailable for the 
purposes of this thesis. 
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As a marker of heavy metal toxicity, kidney histology was examined due to the extreme 
toxicity that these metals have for the kidney. Figure 7-7A shows representative images 
of the H&E stained transverse kidney sections from the saline control while 7-7B and 7-
7C show the sections from the Hg and heavy metal cocktail (HMC) groups. It can be 
noted in both the mercury and HMC groups, that there is a loss of regularity and 
noticeable hypertrophy at the renal corpuscle. In the groups treated with L. rhamnosus 
Lr60, this damage seems to have been negated demonstrating a protective effect of Lr60 
in vivo. Similar effects were observed in the sub-chronic dosing scheme but no 
differences were observed between the mutants of Lr60. 
 
Figure 7-7. Histological analysis of effect of strain Lr60 on protection against 
mercury and a mixture of toxic metals. 
H&E	  stained	  kidney	  sections	  of	  mice	  in	  acute-­‐dosing	  study	  from	  control	  (A),	  mercury	  (B),	  heavy	  
metal	  cocktail	  (C),	  mercury	  +	  Lr60	  (D)	  and	  heavy	  metal	  cocktail	  +	  Lr60	  (E)(representative	  
images).	  Kidneys	  treated	  with	  metals	  alone	  (B	  and	  C)	  show	  damage	  at	  the	  level	  of	  the	  renal	  
corpuscle	  (arrows).	  This	  damage	  appears	  to	  be	  negated	  by	  treatment	  with	  Lr60	  (D	  and	  E).	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7.2.5 Modulation of xenobiotic metabolism by L. rhamnosus GR-1 
Given the previous effects of L. rhamnosus GR-1 in human populations and its 
previously observed abilities to act at distal sites from the gut (Gan et al., 2014), it was 
selected for potential studies on modulation of xenobiotic metabolism. Balb/C mice were 
orally gavaged with either L. rhamnosus GR-1 or saline vehicle control daily for 3 days 
before sacrifice. The liver, kidneys and duodenum were harvested and RNA extracted 
and transcriptionally profiled by microarray and qPCR. Genes determined to be 
significantly differentially expressed (p<0.05, ±2-fold) were subjected to GO enrichment 
analysis demonstrating that xenobiotic metabolic processes were significantly enriched in 
transcripts in the liver but not the kidney (p<0.05). Table 7-1 contains a list of genes of 
interest related to xenobiotic metabolism and damage and which were found to be 
differentially regulated by L. rhamnosus GR-1. A subset of these genes was confirmed by 
qPCR (Figure 7-8) demonstrating significant increased expression of Por (8.3-fold), 
Fmo2 (7.1-fold) and Fmo3 (5.0-fold) in the liver after administration of L. rhamnosus 
GR-1. 
Table 7-1. Differentially regulated liver transcript by L. rhamnosus GR-1 with 
functions related to xenobiotic metabolism. 
Gene Annotation 
Fold-Change  
(GR-1 vs. Control) 
Por P450 Oxidase 2.58324 
Fmo2 Flavin containing monooxygenase 2 2.45478 
Fmo3 Flavin containing monooxygenase 3 2.07543 
Il1b Interleukin 1 beta -2.68131 
Cyp2b10 Cytochrome P450 2b10 -2.82371 
Gstm3 Glutathione S-transferase (mu-3) -2.13694 
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Figure 7-8. qPCR validation of por, fmo2, and fmo3 genes show up-regulation of 
transcripts by L. rhamnosus GR-1. *p<0.05 
7.3 Discussion 
The work described in this manuscript represents our intent to mechanistically understand 
how strains of lactobacilli may have protective effects against toxic metals in vitro and 
builds upon previous knowledge of binding-only mediated mechanisms. 
Our results agree with others (Halttunen et al., 2007b; Peltonen et al. , 2001; Stidl et al., 
2008) indicating lactobacilli have the capacity to interact with a variety of environmental 
pollutants via a passive binding. Given the surface of most Gram-positive bacteria is 
negatively charged, it makes sense that they should be able to interact with metals 
through electrostatic interactions and the nature of strain-variable binding of metals 
suggests altered composition of the cell surface (Beveridge and Fyfe, 1985). By far, the 
worst metal binding strain observed in these studies was strain Lr64, which is interesting 
as it is has a unique mucoid phenotype when grown on solid media suggesting the 
presence of a large amount of extracellular polysaccharide (EPS). Though not the focus 
of these particular studies, the machine learning approach previously applied (chapter 3) 
would suggest that there is a negative association between a number of EPS-related 
glycosyltransferases and lead binding capacity. Furthermore, our TEM figures show little 
evidence of metal precipitates in the extracellular polysaccharides surrounding Lr60, but 
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rather in close association with the cell. Further localization would require ultra thin-
sectioning but recent work would suggest that localization within the cell may depend on 
the particular metal under study (Monachese, 2012). The capsule has been suggested as a 
potential binding site for metals (McLean and Beauchemin, 1990) however the present 
data suggest the EPS of lactobacilli lacks this capacity. The observation of distinct 
precipitates on the cell begs the question of what may be the nucleation site and if there 
may be a more specific site of binding than negatively charged groups in the 
peptidoglycan and teichoic acid (Beveridge, 1989). 
While binding has been shown to be the predominant mechanism of interaction with lead 
and cadmium, the case of mercury is more interesting given its known bacterial pathways 
of detoxification (Nascimento & Chartone-Souza, 2003). Highest mercury removal was 
obtained with InHg, but significant levels of removal were still observed with MeHg. The 
reduced capacity may be due to the lower positive charge of MeHg, however significant 
binding still occurred at very low levels (10 ng/mL). Our initial hypothesis that mercury-
resistant lactobacilli would be superior remediators of metals resulted in the discovery of 
the Lr60 and Lr63 strains. While in vitro, the predominant mechanism is most likely 
binding, as indicated by elevated rates of removal by non-viable Lr60, there is a highly 
reproducible loss of removal efficiency coupled with increased recovery of mercury from 
the system indicating a volatilization mechanism as well. The sensitive Lr136 strain, also 
a strong binder of metals, shows no difference in mercury removal when killed. We 
would hypothesize that improved metal removal would be expected from non-viable 
strains due to a dissipation of the proton motive force increasing the net negative charge 
of the cell surface (Mera et al., 1992).  
The identification of mercury resistance in L. rhamnosus Lr60 and Lr63 is a novel 
finding in lactobacilli. Unlike common antibiotics in typical clinical isolates, agencies 
such as the Clinical and Laboratory Standards Institute have not established thresholds 
for mercury resistance in lactobacilli. The term resistance is used in this work due as the 
observed phenomenon fits two key criteria of resistance: (i) the resistant strains can grow 
in concentrations that kill the majority of the strains of the same species, (ii) the presence 
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of genetically encoded resistance elements with an observable phenotype when 
transferred to sensitive strains. 
The discovery of a novel horizontally acquired minimal mercury resistance operon 
(merRA) present in the Lr60 and Lr63 strains is a unique observation. While there appear 
to be remnants of transposon machinery, the region is unlikely to still be mobile as it 
lacks the typical inverted repeats of a bacterial transposon (Foster et al., 1981) and may 
represent a composite of multiple gene rearrangements in this region. Given that the 
acquired region also contains cadmium and copper resistance elements, it can be 
suggested that this acquisition was due to the exposure of the strain to toxic metal levels 
in the past, which could have occurred for any number of reasons. Despite being 
speculative, it is possible that transfer from streptococci could have occurred in the oral 
cavity due to mercury exposure from dental amalgam fillings. 
To test the hypothesis that mercury-detoxifying enzymes confer increased mercury 
remediation capacity in vivo required the use of animal models, however due to logistical 
issues outside the control of the investigators, not all of this data are available for this 
thesis. Nonetheless, preliminary investigation by histology has demonstrated a protective 
effect against kidney damage by both the Lr60 and GR-1 strains in agreement with the 
observations of our previous human studies (Bisanz et al., 2014). 
Finally, the exploratory analysis of how oral probiotics may affect distal function in the 
liver is an exciting area for future research. The finding of the cytochrome P450 
reductase (por) expression up-regulated by L. rhamnosus GR-1 is significant given that 
Por is an obligate electron donor for many of the cytochrome P450 enzymes which are 
key components in xenobiotic metabolism. Thus the altered regulation of cytochrome 
P450 reductase likely represents a significant alteration in the broad functions of many 
CYP enzymes. There is likely cross-over between the mechanisms by which the gut 
microbiota, and orally administered probiotics can modulate xenobiotic metabolism. 
Differential regulation of a number of the other CYP enzymes including Cyp2B10 is also 
noteworthy given links between gut microbiota modulation of xenobiotic metabolism 
through the CAR receptor (Björkholm et al., 2009).  Altered expression of the 
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inflammatory mediator interleukin 1 beta (IL1B) could represent one mechanism by 
which decreased liver damage could be observed without direct interaction of the metals 
and lactobacilli as demonstrated by Zhai et al. ( 2014) in models of intraperitoneally 
cadmium and oral lactobacilli administration.  While modulation of cytochrome P450 
function is of less significance to toxic metals, up-regulation of glutathione S-transferase 
(gstm3) is directly relevant as the glutathione S-transferases are important in countering 
metal-mediated oxidative damage as well as direct conjugation of metals to glutathione 
(Casalino, 2004; Gregus and Varga, 1985).  In this case however, expression of gstm3 
was down-regulated by L. rhamnosus GR-1 which demonstrates on our limited 
understanding of how microbes may affect xenobiotic metabolism. This set of 
experiments sheds light on modulation of host xenobiotic metabolism as a potential 
mechanism through which lactobacilli may exert beneficial effects. This is not limited to 
toxic metals, but a broad range of dietary toxins as well as having implications for 
pharmacology. 
We hypothesized multiple mechanisms involved in probiotic mediated protection against 
toxic metals and have provided evidence of three in the current manuscript: (i) passive 
sequestration, (ii) direct enzymatic detoxification, and (iii) modulation of host xenobiotic 
metabolic pathways to alter host metabolism and elimination of toxic substances. In 
addition we have characterized new strains specifically tailored to counter toxic metals. 
The strength of this study is that it provided multiple lines of evidence and attempted to 
describe probiotic function at the gene level. Future analysis and studies branching from 
this work will help to increase our understanding of probiotic function and create strain-
level microbial therapies to counter environmental toxins. 
7.4 Materials and Methods 
7.4.1 Culture conditions 
All Lactobacillus strains except L. rhamnosus GR-1 were obtained from the Danone 
Research collection (Palaiseau, France) and were maintained on de Man, Rogosa and 
Sharpe (MRS; BD Biosciences) agar at 4˚C after culture at 37˚C for 48 hours under 
anaerobic conditions (BD GasPack, BD Biosciences). Master stocks were maintained at -
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80˚C in MRS supplemented with 20% glycerol. L. rhamnosus GR-1 was obtained from 
an in-house strain collection and was originally isolated from the urogenital tract of a pre-
menopausal woman (Reid et al., 1987). When required, MRS was supplemented with 5 
µg/mL erythromycin or 15 µg/mL chloramphenicol. Lactobacilli were heat-killed as 
needed by incubation at 60˚C for 30 min followed by confirmation by plating on MRS 
agar and 72 hour incubation in anaerobic conditions at 37˚C. Strains were subcultured 
twice in MRS broth (1 % v/v inoculum) before use in assays. Electrocompetent 
Escherichia coli TOP10 was obtained commercially (Thermo Fischer/Life Technologies) 
and used as the host for all cloning experiments. E. coli TOP 10 was maintained on LB 
(lysogeny broth; BD Biosciences) or BHI (Brain Heart Infusion; BD Biosciences) 
supplemented with 100 µg/mL ampicillin or 200 µg/mL erythromycin where appropriate. 
Bacillus megaterium MB1, a mercury resistant strain used a positive control was obtained 
from CC Huang (National Chung Hsing University, Taiwan). 
7.4.2 Metal binding assays 
Lead binding assays were carried out in duplicate experiments with 3 technical replicates 
each using modified methods of Halttunen et al. ( 2007b). Strains were normalized to an 
OD600nm=2.0 corresponding to a count of ~2x109 CFU/mL and 200 µL of normalized 
culture was centrifuged at 5,000 g for 20 minutes before being washed twice in Milli-Q 
H2O (pH=5) and recentrifuged as before with the supernatants discarded. Cells were then 
resuspended in 200 µL Milli-Q H2O (pH=5) containing 50 µg/mL Pb2+ (prepared from 10 
mg/mL analytical standard; Sigma Aldrich) before incubation for 4 hours at 37˚C. After 
incubation, cells were centrifuged at 5,000 g for 20 minutes and the supernatant removed. 
The supernatant was acidified with 40 µL of 20% Nitric Acid (VWR) and frozen for 
analysis by inductively coupled plasma- atomic emission spectroscopy (ICP-AES) at the 
Biotron Facility (University of Western Ontario). Results were normalized to an 
uninoculated control and 50 µg/mL standard and converted to a percentage bound by the 
following formula 100 x (1-([sample]/[uninoculated control])). 
Mercury removal assays were performed by using 10 mL of culture normalized as before 
which was centrifuged for 20 minutes at 5,000 g. The supernatant was removed and 
replaced with 10 mL of MRS containing either 1 µg/mL or 10 ng/mL InHg (HgCl2; 
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Sigma Aldrich) or MeHg (CH3HgCl; Sigma Aldrich) from 10 mg/mL stocks prepared in 
Milli-Q H2O or 100% ethanol respectively. After 24h of incubation at 37˚C, the cultures 
were centrifuged as before and the supernatant immediately frozen for analysis by cold 
vapor atomic absorption spectroscopy at the Biotron Facility (University of Western 
Ontario). Samples were normalized as before. When cultures were digested in 20% nitric 
acid to recover bound mercury, they were resuspended in 12 mL nitric acid and heated at 
60˚C overnight. Wet mass (average = 300 mg) and cell concentration (average = 2x109 
CFU/mL) after experiments were recorded to ensure consistent normalization of cultures. 
7.4.3 Electron microscopy 
For both transmission electron microscopy (TEM) and scanning electron microscopy 
(SEM), 1 mL cultures were centrifuged at 5,000 g for 10 minutes and washed 3 times in 
50 mM HEPES buffer before being resuspended in 10 mL 50 mM HEPES buffer 
containing 1 mM Hg2+ or Pb2+. Cultures were incubated for 4 hours at 37˚C. For TEM, 10 
µL was spotted directly on to electron microscopy grids (Formvar carbon film on 400 
mesh copper, FCF400-CU; EMS Diasum) and allowed to dry. The whole mounts were 
then imaged using a Philips 420 Transmission Microscope at an accelerating voltage of 
80 kV and approximate magnification of 19,000X. For SEM, the cultures were filtered 
through a 0.22 µM nitrocellulose filter that was then dried and coated with osmium 
tetroxide (5 nm; OPC80T Filgen Biosciences and Nanosciences). The filters were then 
imaged with a LEO 1540XB scanning electron microscope (Zeiss) fitting with EDX 
module (Oxford Instruments) for determining elemental composition at 10 kV and a 
working distance of 8.6 mm using backscatter electron detector mode. 
7.4.4 Mercury resistance phenotyping. 
Cultures normalized to an OD600nm=2.0 were subcultured at 2.5% v/v into MRS media 
containing various concentrations of mercury prepared from mercury stocks as previously 
described in 96-well microplates (Corning Life Sciences).  Plates were incubated for 24 
hours at 37˚C. Plates were either scanned after 24 hours or continuously read every 30 
min (Figure 7-3C) at OD600nm in a Multiskan Ascent (Thermo Fisher) plate reader. 
Minimum inhibitory concentration was defined as the lowest mercury concentration in 
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which no growth could be observed. Disk diffusion assays were prepared by swabbing 
(BD Culture Swab, BD Biosciences) cultures normalized to 1x108 CFU/mL (equivalent 
cell density to 0.5 McFarland E. coli standard) on 55 x 16 mm petri dishes (VWR) 
containing 10 mL MRS agar. Disks were prepared by placing 100 µg HgCl2 in Milli-Q 
H2O on ¼ inch diameter paper disks (BD Biosciences) and air drying. Mercury 
volatilization assays were carried out using the X-ray film method of Nakamura and 
Nakahara (1988) with Amersham Hyperfilm ECL film (GE Life Sciences) using Bacillus 
megaterium MB1 as positive control (Oyetibo et al., 2015). Mercuric reductase 
expression was induced by 24 hours growth in 1 µg/mL HgCl2 before assaying. 
7.4.5 Genome sequencing 
Original draft genomes were prepared by 454 pyrosequencing as previously described 
(Smokvina et al., 2013). Resequencing of L. rhamnosus Lr60 and Lr64 was carried out 
by extracting gDNA from late-exponential cultures grown in MRS using the Purelink 
Genomic DNA kit with RNase kit (Life Technologies/ Thermo Fisher). The sequencing 
library was prepared with the Illumina Nextera XT kit and sequencing by Illumina MiSeq 
(London Regional Genomics Centre) using paired 2x150 bp reads. Reads were assembled 
using the Velvet short read assembler (Zerbino, 2010) using a 31 bp k-mer size and 
automatic coverage estimation with a minimum contig length of 100 bp. Gene predictions 
and annotations were carried out using the Rapid Annotation using Subsystem 
Technology pipeline (RAST.nmpdr.org). Comparison of genomes was carried out using 
command-line BLASTN and BLASTP (BLAST+ v2.2.30+) and average nucleotide 
identity was calculated using online tools (LM Rodriguez and K Konstantinidis; enve-
omics.ce.gatech.edu/ani/). Prediction of horizontally acquired regions was carried out 
using GC-skew (Artemis Genome Browser) and interpolated variable order motif 
analysis (Vernikos & Parkhill, 2006). 
7.4.6 Gene expression 
RNA was extracted for all samples using TRIzol reagent (Invitrogen) and the Purelink 
mRNA Minikit with on-column DNase treatment following the manufacturers protocols 
(Life Technologies/ Thermo Fisher). RNA concentration and purity was accessed using 
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Qubit 2.0 Fluorometer (Life Technologies/ Thermo Fisher) and Nanodrop ND-1000 
(Thermo Fisher) where required. RNA integrity was confirmed by Bioanalyzer analysis 
(Agilent Technologies) when required.  
Bacterial samples were pretreated before RNA extraction by preservation in 2 volumes of 
Bacterial RNA Protect (Qiagen) following the manufacturers recommendation followed 
by 30 minute enzymatic treatment with 20 mg/mL lysozyme and 50 U/mL mutanolysin 
(Sigma Aldrich) at 37˚C in pH=7 TE buffer. Cultures for merRA relative quantification 
were harvested at mid exponential growth (~6 hours) and repeated in triplicate 
experiments.  
cDNA was prepared using the high-capacity reverse transcription kit (Life Technologies/ 
Thermo Fisher) from between 200ng-2µg total RNA following the manufacturers 
protocols. qPCR was performed in 10 or 20 µL reactions using Power SYBR Green 
master mix (Life Technologies/ Thermo Fisher) using gyrB and B-actin as endogenous 
reference genes for Lr60 and Mus musculus respectively. qPCR results were analyzed 
using SDS RQ 6.3 manager software (Applied Biosystems). Primers used for qPCR 
analysis and their amplification efficiencies are listed in Table S7-1. All target probe sets 
had an amplification efficiency within 5% of the endogenous reference gene. Nested PCR 
of cDNA to confirm co-transcription of merR and merA was accomplished using the 
merA forward and merR reverse qPCR primers to confirm an 1889 bp amplicon. 
Microarrays were prepared and analyzed as before (Hummelen et al., 2011b) with the 
Affymetrix Mouse Gene 2.0 ST array platform. 
7.4.7 Mutant construction 
The erythromycin resistance carrying pLAB1301 plasmid was derived from the 
CMPG10208 plasmid provided by S. Lebeer (U Antwerpen, Belgium) by the excision of 
the dlt promoter in the EcoRI site and re-ligation. The merRA fragment was amplified 
from Lr60 gDNA using the primer pair merRA_f_EcoRI and merRA_r_EcoRI and 
ligated into the EcoRI site of pLAB1301. Primers used for cloning are provided in Table 
S7-2. Orientation was confirmed by double-digest, PCR and sequencing. The construct 
174 
 
was then electroporated into L. rhamnosus GR-1 following the protocol of De 
Keersmaecker et al. (2006) followed by recovery on MRS supplemented with 
erythromycin. Potential transformants were screened by colony PCR using the primer 
pair merRA_f_ECOR1 and merA reverse qPCR primer to screen for successful 
transformants. Colony PCR of L. rhamnosus was accomplished by microwaving for 3 
minutes on high (Proctor Silex model 87007 microwave oven) prior to 35 cycles of PCR 
with AmpliTaq Gold hot start enzyme (Life Technologies/ Thermo Fisher). The parent 
strain was verified by ERIC-PCR to ensure the correct genetic background (Ventura & 
Zink, 2006). 
For knockout of merRA, the method of Li et al. (2011) using the temperature sensitive 
plasmid pG+host5 carrying erythromycin resistance (Biswas et al., 1993) was applied. 
1000 bp of upstream (HR1) and downstream regions (HR2) of the merRA operon was 
amplified using the primer pairs KO_merRA_HR1_f_SalI/KO_merRA_HR1_r_EcoRV 
and KO_HR2_f_BamHI/KO_HR2_r_XbaI. These were sequentially cloned into 
pG+host5 flanking the chloramphenicol resistance gene (cat) of pLi50 amplified using 
the primer pair pLI50_cat_f_EcoRV/pLI50_cat_r_BamHI. The new plasmid, pG+host5-
HR1-cat-HR2 was electroporated into Lr60 as before and transformants were selected on 
5 µg/mL erythromycin with 48 hours incubation anaerobically at 30˚C. To facilitate 
integration, successful transformants were then incubated at 40˚C under chloramphenicol 
selection. Recovered clones carrying chloramphenicol and erythromycin resistance were 
then reverted to 30˚C without selection for sequential subculturing without antibiotic 
selection to facilitate excision and curing of the plasmid. Final clones were screened for 
chloramphenicol resistance (due to merRA/cat exchange) with the absence of 
erythromycin resistance. Allelic exchange was verified by colony PCR and sequencing of 
the locus. 
7.4.8 Mouse experiments 
For the metal experiments, a total of 88 female Balb/C aged 6 weeks were randomly 
assorted into 11 groups of 8 as outlined in Figure S1. The mice were housed with ad 
libitum food and water at a temperature of 22˚C on a 12h light/ 12h dark light cycle. 
These experiments were performed according to the policies of the Institut Pasteur de 
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Lille Animal Care and Use Committee. The study was covered under the protocol 
approved (number: 04/2011) by Nord-Pas-de-Calais Ethics and Welfare Committee for 
Experiments on Animals. All animals received daily oral gavage with 1x109 CFU of L. 
rhamnosus GR-1, Lr60 WT, Lr60 ∆merRA::cat, Lr60 ∆merRA::cat pLAB1301-merRA or 
saline vehicle control. After 3 days of wash-in, metal dosing began. In the acute dosage, a 
single oral gavage was given of either mercury alone (5 mg/kg b.w. in a 2:1 ratio of 
MeHg:InHg mimicking human daily exposure) or a heavy metal cocktail (1 mg/kg Hg, 
10mg/kg Pb2+ and Cd2+). After 24 hours, sacrifice occurred. Similarly, in the sub-chronic 
dosing scheme, after 3 days wash-in, mercury (0.5 mg/kg/day) or a cocktail (0.3 
mg/kg/day Hg, 1 mg/kg/day Cd and Pb) were administered through the drinking water for 
28 days along with continual daily oral gavage of lactobacilli as before. Every 4 days, 
food and water consumption were measured to ensure consistent metal dosing between 
groups. On day 28 sacrifice occurred. 
Prior to sacrifice by cervical dislocation, blood was collected by retro-orbital bleeding. 
Immediately after sacrifice, a portion of liver, kidney and a 1 cm segment of the 
duodenum were collected in RNA later while SI and caecal contents were collected for 
microbial DNA and RNA extraction (analysis pending). A portion of kidney, liver and 
spleen were additionally collected for metal quantification as well as histology by 
preservation in 4% formalin/PBS. 
For the xenobiotic metabolism experiments, mice were orally gavaged with either L. 
rhamnosus GR-1 (n=7) or saline vehicle control (n=7) daily for 3 days before sacrifice. 
The liver, kidneys and duodenum were harvested and RNA extracted and 
transcriptionally profiled by microarray and qPCR as described in section 7.4.6. 
 
7.4.9 Histology 
 After ≥48 hours of fixation in 4% formalin/PBS, tissue samples were sequentially 
passaged through 50% and 70% ethanol for 30 minutes each, 95% ethanol for 2 hours, 
and 100% ethanol over night. The ethanol was then replaced with toluene for 30 minutes 
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before being transferred to paraffin wax overnight. Samples were then embedded in 
paraffin blocks before sectioning into 5 µM sections using a Leica RM2235 microtome 
(Leica Biosystems). After drying overnight, samples were deparaffinized and rehydrated 
through subsequent xylene and ethanol baths before staining with haematoxylin and eosin 
(Sigma Aldrich). Slides were then rehydrated and mounted using Permount medium 
(Sigma Aldrich). Images were obtained with a Zeiss Axioscope microscope with a total 
magnification of 100X using Northern Eclipse software (EMPix Imaging). 
 
Figure S1. Murine study design. 
Table S1. Primers used for qPCR. 
 
 
Acute
Sub-chronic
-3 -2 -1 0  1
-3 -2 -1 0  1  28
Day
Day
2x109 CFU L. rhamnosus (Oral Gavage)
Acute metal dose (Oral Gavage)
Chronic metal dose (Drinking Water)
Mouse Sacrifice
Group Metal L. rhamnosus strain
I - -
II - GR-1
III - Lr60 WT
IV Hg -
V Hg GR-1
VI Hg Lr60 WT
VII Hg Lr60 merRA::cat
VIII Hg Lr60 merRA::cat pLAB1301-merRA
IX Cocktail -
X Cocktail GR-1
XI Cocktail Lr60 WT
Metal Acute Dose 
(mg/kg b.w.)
Sub-chronic Dose 
(mg/kg/day)
Hg1 5.0 0.5
Cocktail2 Hg: 1.0
Cd: 10.0
Pb: 10.0
Hg: 0.3
Cd: 1.0
Pb: 1.0
1 2:1 MeHg:InHg
2 1000 x EPA RfD
Gene Forward Primer Sequence Reverse Primer Sequence Efficiency R2 
gyrB CCGCAGTTGTTTCGGTCAAG CGTCAGCCGGATGTTCCATA 94.2 0.998 
merA GCGCTCGTTAATCGGGAAAC ATGCGCCCCTAACACTTTCA 97.6 0.999 
merR CAAGAACCTCACCGAACGGA CCCAACACGCTTAACGTCATC 93.8 0.999 
B-actin GATGTATGAAGGCTTTGGTC TGTGCACTTTTATTGGTCTC 96.1 0.997 
fmo2 AAAGAGTTAACCTGTTTGGG GTACTGGTAGGAATTACAGGG 92.0 0.991 
por CTCCAAGATCAGGTATGAATC GGAACGGATGCTTCTTATTC 92.4 0.979 
fmo3 CCTTTAAACAGAACACTCAGG GTGAACTCCTTTACATTAGGC 93.1 0.969 
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Table S2. Primer sequences used for cloning. 
Primer 5' Extension RE site Primer 
merRA_f_EcoRI GGTGGT GAATTC TCCGTCGATGTGGAGAAATTGT 
merRA_r_EcoRI ATCATC GAATTC TCCCAGAAGGTAGATCCGCA 
KO_merRA_HR1_f_SalI GGTGGT GTCGAC ACTGTAGGTGCCGTCAGTTG 
KO_merRA_HR1_r_ECORV ATCATC GATATC ACATCCCACCAGAAAATCCGA 
pLI50_cat_f_EcoRV GGTGGT GATATC ACTTCAACGCACCTTTCAGC          
pLI50_cat_r_BamHI ATCATC GGATCC TTATAAAAGCCAGTCATTAGGCC   
KO_merRA_HR2_f_BAMHI GGTGGT GGATCC CTCCCTATTCAAGTGAACCAGC 
KO_merRA_HR2_r_XbaI ATCATC TCTAGA AGCCCGTGCCTAGATATTGC 
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Chapter 8 
8 General Discussion 
Harnessing the power of the microbiome is increasingly finding its way into medical 
practice and indeed everyday life. This can be seen through the recent fascination with 
the effects of fecal transplants (Kelly et al., 2015). Despite a recent boom in the 
probiotics sales, consumer interest and demand invariably requires constant 
documentation of benefits, an understanding of probiotic mechanisms, and support from 
caregivers who use them in clinical practice. Education programs on how microbe-
mediated therapies can be best manipulated for health have not yet reached mainstream 
healthcare providers.   
A relative of mine was recently prescribed Lactobacillus after visiting their general 
practitioner. No mention of what strain, formulation, or dosing regime was given: simply 
a written note saying “Lactobacillis”. More personally, on a recent visit to the dentist 
where I was prescribed antibiotics, my dentist, unaware of my background, advised that I 
should probably take probiotics to avoid antibiotic associated diarrhea (AAD). This is 
commendable. The problem lies in that they then recommended I take Activia, or that if I 
wanted a “real probiotic”, I should go to the health food store. There is no literature that 
suggests Activia would be effective in preventing AAD, despite a number of 
formulations providing protective effects (Goldenberg et al., 2013). Additionally the 
current regulatory environment seems inappropriate where the word probiotic is all but 
banned in the European Union (Reid, 2011) yet it can be used virtually without restriction 
in the natural health supplements in Canada and the USA. Recently, when making a 
protein-shake I discovered that for the past 2 years I have been unknowingly consuming 
L. fermentum probiotics in the protein powder I purchase. There is no mention of the dose 
nor do I suspect that L. fermentum can survive particularly well in protein powder. 
Furthermore, no information on the strain is supplied despite many probiotic effects 
being strain specific.  
The difficulty lies in that any competent microbiologist could go to the farmer’s market, 
bring home an artisan cheese, and isolate a handful of “probiotic” lactobacilli. Without 
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adequate testing in human populations we can never be sure of function. My intent is not 
to solely place the blame on clinicians or regulatory agencies, but perhaps we in the 
probiotics research field must also do more to force better control over products and 
generate understanding on how strains work. For probiotics to move into routine medical 
practice, convincing and reproducible clinical data is required with some understanding 
of mechanisms of function. Certainly in the case of AAD or necrotizing enterocolitis, 
convincing data is available (AlFaleh and Anabrees, 2014; Goldenberg et al., 2013). It is 
also hard to convince clinicians when probiotic studies are frequently underpowered and 
apply different probiotic strains in different formulations that may affect efficacy. One 
cause of this is that probiotic research lacks the levels of the funding frequently found in 
the pharmaceutical industry. Unlike a drug with a defined chemical structure, it is more 
difficult to obtain a proprietary strain that cannot be easily copied. In the case of general 
probiotic function, there is nothing to suggest that company X’s probiotic could be any 
better than company Y’s. Thus it is difficult to justify the considerable financial 
investment in developing new probiotic technologies, as it would be difficult to get 
adequate intellectual property protection. I believe the answer to these problems is the 
development of new strains and formulations with defined mechanisms of action. 
8.1 Effect of formulation on probiotic function 
The results of chapter 2, while not conclusive, are valuable for the questions they raise. In 
probiotic formulation, there is a general assumption that if the product can maintain a 
consistent viable bacterial count over the shelf life, other aspects are fairly irrelevant. 
While the transcriptional responses of a probiotic strain will differ between its time in the 
product and those in varying portions of the gastrointestinal system, how the strain has 
adapted to initial entry into the body is of importance. Bacteria can transcriptionally 
respond to stimuli in a matter of minutes (Selinger et al., 2003) but when we consider that 
an orally consumed probiotic will transit from the mouth to the stomach in a matter of 
seconds (Cordova-Fraga et al., 2008), surely any effect of formulation that affects acid 
resistance will be of importance in aiding survival through the gut as was observed in 
chapter 2. 
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While fermented foods were primarily the focus of this thesis, chapter 4 used a probiotic 
administered as a suppository in capsule form, which presents a range of additional 
considerations in function. Because the bacteria in these capsules have been lyophilized 
and preserved, we must consider the time it takes for them to return to an active 
metabolic state from their dormancy. Enteric-coated tablets seem like an attractive 
approach for delivering probiotics as they will protect the cells through the harsh acidic 
conditions of the stomach and begin to release the cells in the small intestine. In this case 
however, the site of action must be carefully considered. If the site of action is suspected 
to be in the small intestine, as we would suspect protection against toxic metals or altered 
nutrient uptake would be, perhaps an enteric coated capsule is the wrong formulation to 
be delivered as we want metabolically active cells through their entire passage in the SI. 
The capsules applied in chapter 4 were indeed formulated for oral consumption and 
proved difficult to dissolve in water for metabolite analysis (observations of A. 
McMillan). This could partially explain why probiotic administration could not be 
observed in all participants as if the capsules did not fully dissolve in the vagina, dosing 
would have been highly inconsistent. Furthermore, when considering the appropriate 
control, many placeboes contain nothing more than a sugar. In the case of studies on 
microbial populations, perhaps a placebo containing a fermentable sugar is the incorrect 
control as the sugars could be readily metabolized by the indigenous microbiota and thus 
inadvertently be biologically active. 
Formulations offer potential ability to potentiate probiotic function. In the case of 
mercuric reductase, there is a basal level of expression, but it is greatly up-regulated upon 
exposure to mercury. Ideally we would want to administer a probiotic that has already 
up-regulated its mercury detoxifying machinery before coming into contact with mercury 
in the body. It would seem foolish to attempt to induce the machinery by including 
mercury in the formulation, but perhaps there are other non-toxic metals that could drive 
increased expression. Alternatively, in the case of genetically engineered strains, the 
genes could be expressed from strong constitutive promoters active both in culture 
outside the body and during passage through the GI tract such as ldhlP (Oozeer et al., 
2005). This would ensure the strain was always prepared to detoxify mercury upon 
exposure. Additionally, perhaps probiotic function in the gut can be altered by diet. In the 
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case of E. lenta, its digoxin metabolizing pathways are repressed by arginine allowing 
dietary protein to modulate its function (Haiser et al., 2013). Though these examples of 
formulation affects function solely at the level of individual organisms, they are also 
relevant when considering the manipulations of the microbiome. 
8.2 What is a healthy microbiome? 
As identified in the Chapter 1, what constitutes health in the pre-menopausal vagina is 
well established. Until the work carried out in chapter 4 and its predecessor study 
(Hummelen et al., 2011), what constituted health in post-menopause was less well 
established. Since production of glycogen is under the control of estrogen, estrogen is 
depleted after menopause, and vaginal lactobacilli use glycogen as a nutrient source, it 
had been suspected that the vaginal microbiota of post-menopausal women was also 
depleted in lactobacilli (Cauci et al., 2002). Work presented in this thesis showed this to 
be incorrect where in fact, the majority of healthy post-menopausal women are in fact 
colonized predominantly by Lactobacillus species. The work in chapter 4 was unique in 
that it attempted to enroll only women in the intermediate stage between health and 
bacterial vaginosis. Despite an abundance of L. iners, there was virtually no L. crispatus 
identified in these women which fits with the hypothesis that L. crispatus is protective 
against transitioning to dysbiotic states (Verstraelen et al., 2009). The one detail which 
does differ significantly between pre- and post-menopausal women lies in the stability of 
the microbiome. We found that the microbiota was extremely stable in post-menopausal 
women and that over time, the majority of women bore the greatest similarity with 
themselves. In pre-menopausal women the community shifts over the estrus cycle (Keane 
et al., 1997). 
The case of what defines healthy in the gut remains a complex issue. The children studied 
in chapter 6 had remarkably similar microbiotas that were nearly all dominated by 
Prevotella species (enterotype 2). Due to this homogeneous background we were able to 
determine that there was an association between Succinovibrionaceae and increased 
blood metal levels. Of the three predominant enterotypes (Arumugam et al., 2011), there 
is not one that is healthier per se. Rather I suspect that the effects are contextual and that 
there is no one size fits all microbiome configuration that is beneficial in all settings. We 
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hypothesized in chapter 6 that a Prevotella enriched microbiota might predispose one to 
higher uptake of toxic metals and that perhaps a Gram-positive dominated microbiota 
such as the Ruminococcus-dominated enterotype 3 may be beneficial. However given that 
Ruminococcus, as a member of the Firmicutes, may have the effect of increased nutrient 
uptake (Ley et al., 2005), this could predispose an individual to obesity. In the context of 
a resource-poor developing country such as Tanzania, this could be favorable to aid in 
nutrient absorption while in the context of the North American diet, be a dangerous 
predisposition to obesity and metabolic disease. Perhaps given the extreme control diet 
appears to have over microbiome composition, it is possible to modulate the microbiota 
to whatever configuration may best suit the current concerns of an individual at a given 
time (Carmody et al., 2015; David et al., 2014; Halmos et al., 2015). 
8.3 How can probiotics modulate the microbiota? 
As identified in the previous section, using probiotics to modulate the composition of the 
gut may be putting the cart before the horse as we do not necessarily know exactly how 
we want to modulate the microbiome. There are certain cases such as inflammatory 
bowel disease where we may clearly want to increase Faecalibacterium (Sokol et al., 
2008) but for the most part, the desired modulation is unknown. Both the work presented 
in chapters 6 and 7 demonstrated that L. rhamnosus GR-1 is unable to modulate the gut 
microbiota composition, yet it can still confer a benefit. It has also been observed that the 
B. animalis subsp. lactis strain studied in chapter 2 is unable to modulate the microbiota 
(McNulty et al., 2011) yet its inclusion in a yogurt modulated the function of the 
microbiota. It is not necessarily the bacteria present in the ecosystem that are important, 
but their functional roles. A recent study (Zhang et al., 2014) has identified that L. casei 
Zhang may be capable of modulating microbiota composition, but it should be noted that 
this study lacked a control group and included samplings across large time frames in a 
population with a seasonal diet. 
Again the vagina (chapter 4) appears to be unique. We found that the vaginally applied L. 
rhamnosus strain is capable of modulating the composition of the microbiota. While there 
was an immediate influx of lactobacilli driven by administration of 109 CFU of probiotic 
added, they were unable to colonize in the majority of individuals. Nonetheless they were 
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capable of restoring levels of the indigenous lactobacilli such as L. gasseri/johnsonii. The 
mechanism for this was not fully determined, however it could be speculated that the 
large influx of exogenous lactobacilli was able to re-acidify and condition the vaginal 
ecosystem to one more conducive to the growth of lactobacilli and deleterious for vaginal 
dysbionts. 
Given the inability of probiotics to modulate gut microbiota composition, perhaps 
alternative methods such as prebiotics or dietary interventions should be considered. 
While prebiotics are conventionally defined as selectively or specifically enriching 
certain microbes (Manning and Gibson, 2004), a new controversial definition supported 
by recent metagenomic studies (Bindels et al., 2015) includes a broader definition of 
altering ecological and functional features of the microbiota. Ultimately without a greater 
understanding of mechanisms of both how the microbiota and probiotics affect health, we 
will never know exactly how it is we wish to modulate the microbiota of the gut. 
8.4 Novel probiotic strains 
Traditional selection of probiotic strains focused on traits such as acid/bile resistance, 
adhesion and colonization abilities, bacteriocin production, and immunomodulatory 
capability (Papadimitriou et al., 2015). While these are justified desirable traits as for a 
general-purpose strain, I firmly believe the future of probiotics in clinical practice lies in 
strain-specific niche applications.  
The final chapter of this work attempted to identify novel strains specifically selected to 
counter toxic metal exposure and resulted in the identification of L. rhamnosus Lr60. 
This strain delivered superior removal of both lead and mercury and its’ ability to 
actively detoxify mercury was further investigated leading to the first description of a 
mercury resistant Lactobacillus with gene function validated through cloning and 
characterization of mutants. Given the apparent rarity of mercury resistance elements in 
Lactobacillus species, this discovery is all the more exciting in that we found a proverbial 
needle in a haystack. 
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While we were able to find a strain of L. rhamnosus carrying mercury-resistance 
elements, it would also be possible to engineer one for this purpose given the ubiquity of 
known genetic sequences for merA and merB. With the apparent absence of 
organomercurial lyase activity (merB) in the L. casei group, it is possible to engineer 
strains to carry it. In fact, work on this has already begun through a synthetic construct of 
a ldhl promoter fused to a codon optimized version of merB from Bacillus megaterium 
(Huang et al., 1999). If a more broad-range metal sequestering strain was required, it 
would also be possible to express metallothioneins on the bacterial cell surface to 
potentiate sequestering activity (Deng and Wilson, 2001). Given the difficulties in 
genetically manipulating strains of Lactobacillus, this approach could be applied in 
Lactococcus species that are far more amenable to genetic manipulation (Pontes et al., 
2011). 
While we tend to constrain our thoughts of new probiotics to those granted generally 
recognized as safe status (GRAS) by the FDA, the use of new species such as Bacillus 
coagulans (Fitzpatrick et al., 2011) expands the landscape of available strains to apply. 
Indeed, it may be worth further studies on Bacillus megaterium MB1 to determine its 
safety profile to see if it could be applied directly to human and animal hosts forgoing the 
need for heterologous expression in food-grade vector organisms. 
While the focus of these studies was primarily in the context of human health, these 
concepts should not be limited to humans or even mammals, as they are equally relevant 
to agricultural applications. An exciting and yet unexplored application of the mercury 
sequestration/detoxification probiotic technology lies in aquaculture. Probiotics are an 
emerging concept for commercial fish farming (Irianto and Austin, 2002; Mohapatra et 
al., 2012) and it has been noted that levels of environmental pollutants are just as high or 
higher in commercially farmed fish (Bustnes et al., 2011). Strains such as Lr60 could be 
incorporated into the feed as an additive. These approaches should be tested in 
aquaculture to determine if they could be used to potentially lower mercury in farmed 
fish, which may ultimately improve both production yields, and lower mercury in the 
human food supply. 
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8.5 How can we improve study design? 
As identified in the general discussion, probiotic studies frequently suffer from problems 
of inconsistent strain selection, formulations and a lack of statistical power and the 
studies presented in this work possess some of the same issues. 
The issue of sample size and power estimations is difficult in microbiota and probiotic 
studies as they present a number of unique traits not found in typical drug studies.  If the 
primary end point of the study is an easily definable clinical parameter then traditional 
power estimations are valid. Where pre-existing literature on the effect is limited, as is 
the case with metal-detoxication, a pilot study is warranted to give a rough estimate of the 
effect size and variance of the response. While options to repeat the studies found in 
chapter 6 are being investigated, we can now predict based on the data obtained in the 
pregnant women that we would need 86 participants to show a 2 nmol/L difference 
(~23%) in mercury levels with power of 0.9, i.e. a 90% probability that the study will 
detect a treatment difference in a two-treatment parallel-design study. Alternative study 
designs such as a cross-over study should be also considered as should formulation of the 
probiotic yogurt. Milk, or no intervention depending on the cohort, was applied in the 
control group in the studies in chapter 6 due to logistical challenges of operating in 
Tanzania. It would be more ideal to carry out the study in a double-blinded method using 
a non-fermented control dairy product such as acidified, gelatinized, or heat compressed 
milk heat to rule out potential effects of nutrients affecting uptake (Zhai et al., 2015). 
Furthermore, while the study in chapter 5 was not designed to differentiate the effects of 
micronutrients and probiotics, future studies should isolate the two effects and exclude 
the micronutrients from the formulation to allow study of probiotic function. 
Alternatively, a capsule formulation could be applied given careful design and testing to 
ensure timely release to be active in the small intestine. 
How to estimate power in studies of microbiota modulation is far more complicated (La 
Rosa et al., 2012). One issue lies in the sheer number of potential measurable outcomes 
such as alpha and beta diversity, or modulation of individual taxa. Number of reads per 
sample, which is often difficult to precisely control and estimate, heavily affects power as 
does the diversity of the environment. The vaginal sample of an average healthy women 
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may only have 1-3 major constituents, but the gut will have hundreds or thousands. 
Furthermore, the number of taxa (as measured by operational taxonomic units) is heavily 
influenced by upstream data processing, clustering and minimum abundance thresholds 
which vary from study to study. To control for multiple testing, approaches such as False 
Discovery Rate corrections are frequently applied (Fernandes et al., 2013). This issue lies 
in that with the sheer number of OTUs frequently encountered in complex microbiome 
datasets, statistical significance can be near impossible to obtain even in the case of 
biological truth. The 16S rRNA dataset presented in chapter 6 demonstrates this 
phenomenon. At enrollment, no participant has detectable levels of any L. casei group 
member (the limit of resolution of the V6 hypervariable region is to the L. casei group so 
this group includes the probiotic L. rhamnosus GR-1). After intervention, the L. casei 
group is only detected in the group who received probiotic with one exception. 
Nonetheless, after multiple testing corrections for false discovery rate, this finding is not 
significant. One solution to this problem is to use these datasets as discovery tools and 
confirm all changes by a complimentary approach such as qPCR or culture. Alternatively 
the sample size could be greatly increased. Alternatively animal models informed by 
observations in human populations are becoming a tool to confirm effects of the 
microbiota as at the end of the day “phenotype trumps all” (personal communication, GB 
Gloor, 23 April 2015). 
8.6 Future directions 
There were many observations of the microbiota and probiotic function in this work that 
cannot be immediately pursued by me. Excellent examples lie in our observations that the 
infants of women who received the L. rhamnosus GR-1 probiotic yogurt have elevated 
levels of Bifidobacterium (chapter 5) or our hypotheses of microbiota structure effecting 
toxic metal uptake. Human-animal crossover models represent opportunities to address 
these questions in a controlled and mechanistic fashion. Traditionally this has involved 
the adoptive transfer of human communities to germ-free mice in an attempt to reproduce 
human phenotypes (Smith et al., 2013). Alternatively gnotobiotic mice, with a defined 
microbiota controlled by the researcher can be applied or even built with a defined 
humanized gut microbiota (McNulty et al., 2011). By feeding a humanized-microbiota 
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mouse breast milk from either women who received L. rhamnosus GR-1 or controls and 
selectively culturing or qPCR enumerating bifidobacteria, this finding could be 
confirmed. Individual components of the breast milk could be identified and tested in this 
model to identify the effectors. To study how microbiota affects metal uptake, 
gnotobiotic mice could be seeded with monocultures of Succinovibrionaceae, 
Desulfovibrio or Lactobacillus. Additionally, whole fecal samples from individuals with 
communities representative of the major enterotypes could be seeded to test our 
hypotheses. 
Prior to initiating a new collaboration with Benoit Foligne at the Institut Pasteur de Lille, 
we did not have the capacity to carry out animal models with environmental toxins and 
this past winter we started our first experiments armed with the tools we need to establish 
the mechanisms behind probiotic mediated detoxication in vivo. Our studies have 
branched out from mercury to include a range of other environmental toxins such as 
aflatoxin, pesticides, nitrosamines and heterocyclic aromatic amines and it is my hope 
that these studies will lead to the development of new technologies which can be 
disseminated into both industrial and medical practice. Indeed through our partnerships 
with WORLDiscoveries, we are currently investigating opportunities worldwide. 
A unique opportunity in this thesis was to have a great amount of interaction with 
industry sponsors (Danone and Kimberly Clark), which gave me a unique view on 
translation of basic research. At the end of the day, the work carried out needed to have 
relevance to practical applications. Although this created unique obstacles and 
frustrations not experienced by many of my peers, it also provided uncommon 
opportunities for which I am truly grateful. As I go forward in my research career I will 
constantly draw from the diverse and varied skill set that my graduate studies fostered. It 
is my sincere wish that both the work included in this thesis and the other publications 
resulting from my graduate studies have improved our understanding of probiotic 
function and formulation while creating new areas of studies into novel probiotic 
applications. 
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